CitationsEvery claim ROOT & REIGN makes, and its source

Check us against the evidence.

581 claims · 256 studies · 8 references · 122 synthesized

Claims still under review are not listed until they clear.

The claims listed here carry the record behind them and a direct link to it. Nothing here asks you to trust us.

By concern
acneacne bodybaby skinbarrierbarrier repairdry feetdry handseczema psoriasisfine linesfitzpatrickhair breakagehyperpigmentationintimate areamakeuppost acnerazor bumpsskin of colorsqueaky cleansun protectionsweatwound carelibrary pagesguidespracticesother cited claims
By ingredient
azelaic acidceramideshoclhydroquinoneniacinamideretinoidstranexamicvitamin c
Concern19 claims · 14 studies · 1 synthesized

acne

C35-1
52% of people who quit acne treatment quit for ineffectiveness, within 3 months.
VerifiedOne source behind this claim
The record
Lam Hoai et al. 2021, PMID 34409359
C35-2
Malassezia folliculitis present in 28.8% of clinically-diagnosed acne.
VerifiedOne source behind this claim
The record
Paichitrojjana & Chalermchai 2022, PMID 36531566
C35-3
MF commonly misdiagnosed as acne, persists on acne meds, associated with antibiotic use.
C35-4
MF mimicry leads to inappropriate antibiotic use.
VerifiedOne source behind this claim
The record
Chalupczak & Lipner 2025, PMID 41003208
C35-5
Acne = loss of C. acnes phylotype balance + dysbiosis, not hyperproliferation; antibiotics induce dysbiosis.
VerifiedOne source behind this claim
The record
The Skin Microbiome: A New Actor in Inflammatory Acne.
Dréno B, Dagnelie MA, Khammari A, Corvec S · 2020 · American journal of clinical dermatology 21:18-24
C35-6
IA1 phylotype biofilm + increased antibiotic tolerance.
VerifiedOne source behind this claim
The record
Cavallo et al. 2022, PMID 36473894
C35-7
Pre/pro/postbiotic systematic review: postbiotic reduces lesions more than control but between-group difference nonsignificant; adjuncts only.
VerifiedOne source behind this claim
The record
Warp/Bilik/Ferrari/Keri 2026, PMID 41703218
C35-8
BP vehicle irritancy (surfactants/preservatives/alcohols); low-% formula without them well-tolerated.
VerifiedOne source behind this claim
The record
A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne.
Gold MH · 2009 · The Journal of clinical and aesthetic dermatology 2:44-8
C35-9
Azelaic acid — 4 mechanisms (antimicrobial, tyrosinase inhibition, free-radical scavenging, reduced neutrophil ROS).
VerifiedOne source behind this claim
The record
The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications.
Sauer N, Oślizło M, Brzostek M, Wolska J, Lubaszka K, Karłowicz-Bodalska K · 2023 · Postepy dermatologii i alergologii 40:716-724
C35-10
Azelaic acid also keratolytic.
VerifiedOne source behind this claim
The record
Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.
Del Rosso JQ, Baum EW, Draelos ZD, Elewski BE, Fleischer AB, Kakita LS, Thiboutot D · 2006 · Cutis 78:6-19
C35-11
Azelaic acid probably less effective than benzoyl peroxide on PGA (Cochrane RR 0.82).
VerifiedOne source behind this claim
The record
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
Liu H, Yu H, Xia J, Liu L, Liu GJ, Sang H, Peinemann F · 2020 · The Cochrane database of systematic reviews 5:CD011368
C35-12
Azelaic acid is first-line topical alongside retinoids and BP.
VerifiedOne source behind this claim
The record
Eichenfield et al. 2021, PMID 34812859
C35-14
Azelaic acid antifungal activity + exploratory support in seborrheic dermatitis (Malassezia-driven).
C35-15
Hidradenitis suppurativa >3x more prevalent in Black vs White; more severe, longer diagnostic delay.
VerifiedOne source behind this claim
The record
Exploring the Experience of Black Americans Living with Hidradenitis Suppurativa in the United States Healthcare System: A Narrative Review.
Negbenebor NA, Riley JM · 2025 · Dermatology and therapy 15:2715-2727
CLED-2
An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
CLED-8
FDA 510(k) K210948 describes Omnilux CLEAR as an over-the-counter mask intended to emit red and blue LED energy for mild-to-moderate acne vulgaris of the face; the FDA comparison table lists approximately 630-nm red and 412.5-nm blue wavelengths.
CMASK-1
A clay mask formulated with kaolin and bentonite, used twice weekly for 4 weeks by 75 adults with oily/combination skin, produced significant improvements in acne lesion counts, sebum content, stratum corneum hydration, and TEWL, with reduced dryness/irritation and high self-reported tolerability; pore area and porphyrin area did not change significantly.
CPEEL-6
A single-session 30% salicylic acid peel performed equally to Jessner's solution for acne and post-acne hyperpigmentation; complications were burning/stinging/exfoliation; PIH occurred in 1 of 36 subjects.
HUNT0906-6
A 2-MNG-containing depigmenting serum treats post-inflammatory hyperpigmentation in subjects of Fitzpatrick phototype IV-VI with acne-related PIH.
C35-REASON1
15-minute post-workout HOCl mist window.
SYNTHESIZED

Synthesized by us. No study is claimed for this.

Concern6 claims · 6 studies

acne body

C35-5
Acne = loss of C. acnes phylotype balance + dysbiosis, not hyperproliferation; antibiotics induce dysbiosis.
VerifiedOne source behind this claim
The record
The Skin Microbiome: A New Actor in Inflammatory Acne.
Dréno B, Dagnelie MA, Khammari A, Corvec S · 2020 · American journal of clinical dermatology 21:18-24
C35-8
BP vehicle irritancy (surfactants/preservatives/alcohols); low-% formula without them well-tolerated.
VerifiedOne source behind this claim
The record
A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne.
Gold MH · 2009 · The Journal of clinical and aesthetic dermatology 2:44-8
C35-9
Azelaic acid — 4 mechanisms (antimicrobial, tyrosinase inhibition, free-radical scavenging, reduced neutrophil ROS).
VerifiedOne source behind this claim
The record
The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications.
Sauer N, Oślizło M, Brzostek M, Wolska J, Lubaszka K, Karłowicz-Bodalska K · 2023 · Postepy dermatologii i alergologii 40:716-724
C35-10
Azelaic acid also keratolytic.
VerifiedOne source behind this claim
The record
Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.
Del Rosso JQ, Baum EW, Draelos ZD, Elewski BE, Fleischer AB, Kakita LS, Thiboutot D · 2006 · Cutis 78:6-19
C35-11
Azelaic acid probably less effective than benzoyl peroxide on PGA (Cochrane RR 0.82).
VerifiedOne source behind this claim
The record
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.
Liu H, Yu H, Xia J, Liu L, Liu GJ, Sang H, Peinemann F · 2020 · The Cochrane database of systematic reviews 5:CD011368
C35-15
Hidradenitis suppurativa >3x more prevalent in Black vs White; more severe, longer diagnostic delay.
VerifiedOne source behind this claim
The record
Exploring the Experience of Black Americans Living with Hidradenitis Suppurativa in the United States Healthcare System: A Narrative Review.
Negbenebor NA, Riley JM · 2025 · Dermatology and therapy 15:2715-2727
Concern3 claims · 2 studies

baby skin

C34-7
Infant acid mantle is not yet established; still building toward adult pH over weeks-months.
VerifiedOne source behind this claim
The record
Chiou & Blume-Peytavi 2004, DOI 10.1159/000076015 (no PMID in-doc)
C34-9
pH regulates the enzymes holding the stratum corneum together; infant mantle is mid-construction.
VerifiedOne source behind this claim
The record
Taïeb 2018, DOI 10.1111/pde.13482 (no PMID in-doc)
CBAN-4
True soap/high-pH cleansers vetoed for babies — infant acid mantle still forming, pH regulates the enzymes holding the stratum corneum together.
VerifiedOne source behind this claim
The record
Taïeb 2018, DOI 10.1111/pde.13482 (no PMID in-doc)
Concern18 claims · 19 studies · 7 synthesized

barrier

C2-7
In cultured melanocytes and keratinocyte-melanocyte models, tranexamic acid reduces melanin content, tyrosinase activity and tyrosinase protein by acting on signalling upstream of the enzyme, rather than being characterised as a direct tyrosinase-enzyme inhibitor. It does so both through a keratinocyte paracrine route (tranexamic acid raised keratinocyte TGF-beta1, which suppressed melanogenesis in melanocytes) and directly on melanocytes (ERK-MITF degradation; cAMP-PKA-CREB-MITF; VEGF-receptor signalling). The evidence is in vitro; in a 30-patient refractory-melasma series, oral tranexamic acid was followed by lower epidermal pigmentation and Melan-A staining.
VerifiedOne of 5 sources behind this claim · see the others
The record
Xing X, Xu Z, Chen L, Jin S, Zhang C, Xiang L. Exp Dermatol 2021 Dec 17;31(4):633-640. PMID 34862827
VerifiedOne of 5 sources behind this claim · see the others
The record
Bae YJ, Lee EJ, Kim JY, Park S, Hwang S, Kwon IJ, Alqahtani JM, Oh SH. Exp Dermatol 2025;34(12):e70194. PMID 41392597
VerifiedOne of 5 sources behind this claim · see the others
The record
Nagaraju D, Bhattacharjee R, Vinay K, Saikia UN, Parsad D, Kumaran MS. Dermatol Ther 2018;31(5):e12704. PMID 30253023
C5-1
Hard water dramatically increases barrier damage from surfactant cleansers — calcium/magnesium ions bind to surfactants and remain on skin after rinsing.
VerifiedOne source behind this claim
The record
The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects.
Danby SG, Brown K, Wigley AM, Chittock J, Pyae PK, Flohr C, Cork MJ · 2018 · The Journal of investigative dermatology 138:68-77
C5-2
Skin surface pH averages ~4.7-5.5; acidic pH keeps resident flora attached, alkaline disperses it; below-5 skin is in better barrier condition.
VerifiedOne source behind this claim
The record
Natural skin surface pH is on average below 5, which is beneficial for its resident flora.
Lambers H, Piessens S, Bloem A, Pronk H, Finkel P · 2006 · International journal of cosmetic science 28:359-70
C10-3
Sodium hypochlorite solution pH is 11-12; disrupts skin acid mantle on contact.
C13-4
Skin pH rises after a single wash and takes hours to recover; soap causes the greatest pH rise of any cleanser type tested.
C14-4
Skin's optimal surface pH sits around 4.5-5.5; a single alkaline exposure measurably raises pH and recovery takes hours.
C25-1
Ambient humidity and temperature strongly affect the stratum corneum; colder/drier regions show markedly higher population-level dry-skin burden than warm/humid ones.
VerifiedOne of 2 sources behind this claim · see the other
The record
Climate, Humidity, and Population-Level Interest in Dry Skin: Infodemiology Analysis Using Google Trends Across the United States.
Aframian K, Naimi S, Xu J, Bae G · 2026 · JMIR dermatology 9:e93639
VerifiedOne of 2 sources behind this claim · see the other
The record
Ambient humidity and the skin: the impact of air humidity in healthy and diseased states.
Goad N, Gawkrodger DJ · 2016 · Journal of the European Academy of Dermatology and Venereology : JEADV 30:1285-94
C25-2
Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface.
VerifiedOne source behind this claim
The record
Effects of water activity and low molecular weight humectants on skin permeability and hydration dynamics - a double-blind, randomized and controlled study.
Albèr C, Buraczewska-Norin I, Kocherbitov V, Saleem S, Lodén M, Engblom J · 2014 · International journal of cosmetic science 36:412-8
C27-2
Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash.
C34-1
Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours.
C34-5
In elderly dry skin, high TEWL tracks high pH, low hydration, low surface lipid.
VerifiedOne source behind this claim
The record
Thune 1988, PMID 2459871
CFRAG-1
The EU Cosmetics Regulation (EC No 1223/2009, Annex III) requires named fragrance allergens — historically 26, including linalool, limonene, citronellol, geraniol and eugenol — to be individually declared on cosmetic ingredient labels when present above 0.001% in leave-on or 0.01% in rinse-off products; Commission Regulation (EU) 2023/1545 (26 Jul 2023) expands the declarable list to 80+ substances (compliance deadlines Jul 2026 / Jul 2028). A 'fragrance-free' claim does not preclude these compounds appearing on-label under their own names.
CLIPID-1
Triterpene constituents of shea butter's unsaponifiable fraction have anti-inflammatory activity.
VerifiedOne source behind this claim
The record
Akihisa T, Kojima N, Kikuchi T, Yasukawa K, Tokuda H, T Masters E, Manosroi A, Manosroi J. J Oleo Sci 2010;59(6):273-80. PMID 20484832
CLIPID-2
Shea butter is a component of evidence-backed eczema barrier formulations.
VerifiedOne source behind this claim
The record
Micali G, Paternò V, Cannarella R, Dinotta F, Lacarrubba F. G Ital Dermatol Venereol 2018 Jan;153(3):396-402. PMID 29368843
CLIPID-3
Traditional wound-healing use of shea butter is documented.
VerifiedOne source behind this claim
The record
Anyanwu EG, Onuchukwu CL, Ojukwu CP, Anyanwu CN. J Ethnopharmacol 2026 Jan;361:121293. PMID 41619863
CMIST-2
The water-transport resistance of a deposited occlusive or emulsion film can increase stratum-corneum hydration and alter permeability and TEWL; the relevant mechanism is the film left on skin.
CPAN-1
Panthenol (pro-vitamin B5) accelerates post-procedure skin barrier recovery, reduces transepidermal water loss, and improves stratum corneum moisture and barrier markers.
CSHEA-2
No study located shows shea BUTTER fades hyperpigmentation: the published melanogenesis-inhibition result is for a lab extract of the defatted kernel, not the butter; the Library declines the "shea fades dark spots" claim.
VerifiedOne source behind this claim
The record
Zhang J, Kurita M, Shinozaki T, Ukiya M, Yasukawa K, Shimizu N, Tokuda H, Masters ET, Akihisa M, Akihisa T. Phytochemistry 2014 Oct;108:157-70. PMID 25446237
RBAR-1
A thinned barrier lipid layer plausibly lets water leave faster and lets irritants in more easily; extrapolated from ceramide-profile/barrier-function evidence and the experimental barrier-disruption + UV pigmentation finding; C25-4 is Unconfirmed.
SYNTHESIZED
Synthesized from:
  • C29-3 Ceramide subclass composition is tightly linked to barrier function; a skewed or altered ceramide profile correlates with barrier dysfunction. DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
RBAR-2
For skin of color with documented low upper-layer ceramide and prominent xerosis, topical ceramide- or urea-based moisturizers are a reasonable direct response; extrapolated from low-ceramide findings and the barrier-repair evidence; no trial of ceramide top-up specifically in Fitzpatrick IV-VI.
SYNTHESIZED
Synthesized from:
  • C29-1 African American skin was characterized by low ceramide levels in the uppermost layers of the stratum corneum, interpretable alongside the high prevalence of xerosis in Black skin. DOI
  • C31-10 African American skin is characterized by low ceramide levels and high protein cohesion in the uppermost stratum corneum, interpreted in relation to the high prevalence of xerosis. PMID 20654785 DOI
  • C28-2 Evidence-based skin repair rests on gentle pH-balanced cleansing, ceramide- or urea-based moisturizers, and photoprotection. DOI
  • C29-3 Ceramide subclass composition is tightly linked to barrier function; a skewed or altered ceramide profile correlates with barrier dysfunction. DOI
RBAR-3
Oils and butters act mainly as occlusives that slow evaporation of water already in the skin and do not add water; applied to dry skin without a humectant or water they may seal dryness in. Extrapolated from the humectant/occlusive mechanism.
SYNTHESIZED
Synthesized from:
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
RBAR-4
Applying a humectant (urea, glycerin) or working the next step into damp skin first, then an occlusive over it, is a reasonable order that follows from the humectant and occlusive mechanisms; no trial of the sequence in Fitzpatrick IV-VI.
SYNTHESIZED
Synthesized from:
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • CJOJ-1 Jojoba oil (Simmondsia chinensis seed oil) has documented anti-inflammatory and wound-healing activity and functions as a wax-ester sebum-mimetic rather than a true triglyceride oil. PMID 24442052 PMID 29280987
RBAR-5
Sealing harder with an occlusive over a humectant in cold dry air and going lighter in hot humid air follows from climate effects on stratum-corneum hydration; no trial of climate-adjusted routines.
SYNTHESIZED
Synthesized from:
  • C25-1 Ambient humidity and temperature strongly affect the stratum corneum; colder/drier regions show markedly higher population-level dry-skin burden than warm/humid ones. PMID 42184334 PMC13200769 DOI PMID 27306376 DOI
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
RBAR-6
A breached barrier plausibly lets irritants in, and the resulting inflammation drives pigment overproduction on skin of color; stands on the injury->melanocyte pathway and the experimental barrier-disruption + UV finding; the barrier-admits-irritants row is Unconfirmed.
SYNTHESIZED
Synthesized from:
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
RBAR-7
Layering several strong actives or using sharp-particle scrubs adds irritant and mechanical injury; because irritation can trigger PIH on skin of color, starting low and titrating is the clinical approach.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
Concern5 claims · 6 studies

barrier repair

C5-1
Hard water dramatically increases barrier damage from surfactant cleansers — calcium/magnesium ions bind to surfactants and remain on skin after rinsing.
VerifiedOne source behind this claim
The record
The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects.
Danby SG, Brown K, Wigley AM, Chittock J, Pyae PK, Flohr C, Cork MJ · 2018 · The Journal of investigative dermatology 138:68-77
C5-2
Skin surface pH averages ~4.7-5.5; acidic pH keeps resident flora attached, alkaline disperses it; below-5 skin is in better barrier condition.
VerifiedOne source behind this claim
The record
Natural skin surface pH is on average below 5, which is beneficial for its resident flora.
Lambers H, Piessens S, Bloem A, Pronk H, Finkel P · 2006 · International journal of cosmetic science 28:359-70
C25-1
Ambient humidity and temperature strongly affect the stratum corneum; colder/drier regions show markedly higher population-level dry-skin burden than warm/humid ones.
VerifiedOne of 2 sources behind this claim · see the other
The record
Climate, Humidity, and Population-Level Interest in Dry Skin: Infodemiology Analysis Using Google Trends Across the United States.
Aframian K, Naimi S, Xu J, Bae G · 2026 · JMIR dermatology 9:e93639
VerifiedOne of 2 sources behind this claim · see the other
The record
Ambient humidity and the skin: the impact of air humidity in healthy and diseased states.
Goad N, Gawkrodger DJ · 2016 · Journal of the European Academy of Dermatology and Venereology : JEADV 30:1285-94
C25-2
Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface.
VerifiedOne source behind this claim
The record
Effects of water activity and low molecular weight humectants on skin permeability and hydration dynamics - a double-blind, randomized and controlled study.
Albèr C, Buraczewska-Norin I, Kocherbitov V, Saleem S, Lodén M, Engblom J · 2014 · International journal of cosmetic science 36:412-8
C27-2
Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash.
Concern1 claim · 1 study

dry feet

C28-1
A fragrance-free barrier-repair cream with hyaluronic acid healed pedal fissures as effectively as urea 40% in a double-blind RCT (n=48), without the burning/irritation salicylic-acid formulas can cause.
VerifiedOne source behind this claim
The record
Comparative Efficacy of Novel Skin Barrier Repair Cream and Urea 40% for the Management of Pedal Fissures
Abigail Jane Ross, Joel Pereira, Rebecca Moellmer, Chandler Hubbard, Reina T. Deogracias, Faiza Zahid · 2025 · Journal of the American Podiatric Medical Association 115
Concern9 claims · 12 studies

dry hands

C2-7
In cultured melanocytes and keratinocyte-melanocyte models, tranexamic acid reduces melanin content, tyrosinase activity and tyrosinase protein by acting on signalling upstream of the enzyme, rather than being characterised as a direct tyrosinase-enzyme inhibitor. It does so both through a keratinocyte paracrine route (tranexamic acid raised keratinocyte TGF-beta1, which suppressed melanogenesis in melanocytes) and directly on melanocytes (ERK-MITF degradation; cAMP-PKA-CREB-MITF; VEGF-receptor signalling). The evidence is in vitro; in a 30-patient refractory-melasma series, oral tranexamic acid was followed by lower epidermal pigmentation and Melan-A staining.
VerifiedOne of 5 sources behind this claim · see the others
The record
Xing X, Xu Z, Chen L, Jin S, Zhang C, Xiang L. Exp Dermatol 2021 Dec 17;31(4):633-640. PMID 34862827
VerifiedOne of 5 sources behind this claim · see the others
The record
Bae YJ, Lee EJ, Kim JY, Park S, Hwang S, Kwon IJ, Alqahtani JM, Oh SH. Exp Dermatol 2025;34(12):e70194. PMID 41392597
VerifiedOne of 5 sources behind this claim · see the others
The record
Nagaraju D, Bhattacharjee R, Vinay K, Saikia UN, Parsad D, Kumaran MS. Dermatol Ther 2018;31(5):e12704. PMID 30253023
C27-2
Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash.
C27-3
Surfactants remove not just grease and dirt but also corneocytes, lipids, and proteins; repeated over-exposure causes irritant dermatitis.
C27-4
Management of hand-hygiene-driven irritant contact dermatitis is choosing less-irritating products plus frequent moisturizer, not washing less.
VerifiedOne source behind this claim
The record
Contact Dermatitis from Hand Hygiene Practices in the COVID-19 Pandemic.
Tan SW, Oh CC · 2020 · Annals of the Academy of Medicine, Singapore 49:674-676
CLIPID-1
Triterpene constituents of shea butter's unsaponifiable fraction have anti-inflammatory activity.
VerifiedOne source behind this claim
The record
Akihisa T, Kojima N, Kikuchi T, Yasukawa K, Tokuda H, T Masters E, Manosroi A, Manosroi J. J Oleo Sci 2010;59(6):273-80. PMID 20484832
CLIPID-2
Shea butter is a component of evidence-backed eczema barrier formulations.
VerifiedOne source behind this claim
The record
Micali G, Paternò V, Cannarella R, Dinotta F, Lacarrubba F. G Ital Dermatol Venereol 2018 Jan;153(3):396-402. PMID 29368843
CLIPID-3
Traditional wound-healing use of shea butter is documented.
VerifiedOne source behind this claim
The record
Anyanwu EG, Onuchukwu CL, Ojukwu CP, Anyanwu CN. J Ethnopharmacol 2026 Jan;361:121293. PMID 41619863
CMIST-2
The water-transport resistance of a deposited occlusive or emulsion film can increase stratum-corneum hydration and alter permeability and TEWL; the relevant mechanism is the film left on skin.
CSHEA-2
No study located shows shea BUTTER fades hyperpigmentation: the published melanogenesis-inhibition result is for a lab extract of the defatted kernel, not the butter; the Library declines the "shea fades dark spots" claim.
VerifiedOne source behind this claim
The record
Zhang J, Kurita M, Shinozaki T, Ukiya M, Yasukawa K, Shimizu N, Tokuda H, Masters ET, Akihisa M, Akihisa T. Phytochemistry 2014 Oct;108:157-70. PMID 25446237
Concern11 claims · 9 studies

eczema psoriasis

C10-1
HOCl is produced endogenously by neutrophils as part of the innate immune response.
C10-3
Sodium hypochlorite solution pH is 11-12; disrupts skin acid mantle on contact.
C31-1
Eczema in skin of color shows greater extensor involvement, dyspigmentation, and papular/lichenified presentations; erythema is harder to appreciate, leading to underestimation of disease severity.
VerifiedOne source behind this claim
The record
Diagnosing Atopic Dermatitis in Skin of Color.
Adawi W, Cornman H, Kambala A, Henry S, Kwatra SG · 2023 · Dermatologic clinics 41:417-429
C31-2
Eczema in skin of color may appear psoriasiform, lichenoid, scaly or papular with a violaceous color, with higher prevalence of PIH than White patients.
VerifiedOne source behind this claim
The record
Atopic dermatitis in skin of colour. Part 2: considerations in clinical presentation and treatment options.
Gan C, Mahil S, Pink A, Rodrigues M · 2023 · Clinical and experimental dermatology 48:1091-1101
C31-3
Higher prevalence, persistence, and severity of atopic dermatitis in skin-of-color populations; erythema assessment can underscore severity; greater risk of nodularity and hyper/hypopigmentation.
VerifiedOne source behind this claim
The record
Managing Atopic Dermatitis in Patients With Skin of Color.
Davis CM, Flohr C, Gupta MR, Koplin JJ · 2023 · The journal of allergy and clinical immunology. In practice 11:1376-1383
C31-4
Black children are at roughly six times greater risk for severe atopic dermatitis than white children.
VerifiedOne source behind this claim
The record
Atopic dermatitis in adolescents with skin of color.
Poladian K, De Souza B, McMichael AJ · 2019 · Cutis 104:164-168
C31-5
Pigmentary sequelae (hyper-, hypo-, depigmentation) are a distinct feature of atopic dermatitis in skin of color; xerosis is more visible in melanin-rich skin.
VerifiedOne source behind this claim
The record
Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes.
Alexis A, Woolery-Lloyd H, Andriessen A, Callender V, Gonzalez M, Heath C, Han G · 2022 · Journal of drugs in dermatology : JDD 21:462-470
C31-6
In psoriasis on skin of color, erythema is often less apparent, plaques may appear violaceous or dark brown; delayed diagnosis, greater biopsy reliance, reduced diagnostic accuracy; greater body-surface involvement, thicker scale; PIH can persist for years after resolution.
VerifiedOne source behind this claim
The record
Psoriasis in skin of color: clinical presentation, diagnostic challenges, and therapeutic considerations.
Costa A, Romiti R · 2026 · Anais brasileiros de dermatologia 101:501365
C31-7
Plaque psoriasis prevalence is lower in people with skin of color but tends to be more severe; less likely to receive biologic treatment; worse quality-of-life impact.
VerifiedOne source behind this claim
The record
Psoriasis in People With Skin of Color: An Evidence-Based Update.
Gkini MA, Nakamura M, Alexis AF, Londoño-Garcia A, van de Kerkhof PCM, Doss N, Griffiths CEM, Kaufman B, Kleyn CE, Lebwohl M, Redfern JS, Takeshita J, Rajagopalan M, El Sayed MH · 2025 · International journal of dermatology 64:667-677
C31-9
Black skin shows increased transepidermal water loss, decreased ceramide levels, and lower stratum corneum pH; management emphasizes low-pH products and emollients.
VerifiedOne source behind this claim
The record
Pruritus in Black Skin: Unique Molecular Characteristics and Clinical Features.
McColl M, Boozalis E, Aguh C, Eseonu AC, Okoye GA, Kwatra SG · 2021 · Journal of the National Medical Association 113:30-38
C31-10
African American skin is characterized by low ceramide levels and high protein cohesion in the uppermost stratum corneum, interpreted in relation to the high prevalence of xerosis.
VerifiedOne source behind this claim
The record
Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin.
Muizzuddin N, Hellemans L, Van Overloop L, Corstjens H, Declercq L, Maes D · 2010 · Journal of dermatological science 59:123-8
Concern6 claims · 6 studies

fine lines

C1-1
L-ascorbic acid is the most-studied vitamin C form (direct tyrosinase inhibition); requires pH 2.5-3.5 to penetrate, which can itself trigger PIH on reactive Fitzpatrick IV-VI skin.
C15-1
Fitzpatrick VI skin has a natural SPF equivalent of approximately 13.
VerifiedOne source behind this claim
The record
A Comprehensive Review of the Role of UV Radiation in Photoaging Processes Between Different Types of Skin.
Brar G, Dhaliwal A, Brar AS, Sreedevi M, Ahmadi Y, Irfan M, Golbari R, Zumárraga D, Yateem D, Lysak Y, Abarca-Pineda YA · 2025 · Cureus 17:e81109
C21-2
Topical retinoids increase collagen and normalize keratinocytes/melanocytes, improving wrinkles, texture, and tone.
VerifiedOne of 2 sources behind this claim · see the other
The record
Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials.
Sitohang IBS, Makes WI, Sandora N, Suryanegara J · 2022 · International journal of women's dermatology 8:e003
C22-1
Thicker/more compact dermis on skin of color makes facial lines less noticeable; higher epidermal melanin makes darker skin more vulnerable to dyspigmentation with age.
VerifiedOne source behind this claim
The record
Aging Differences in Ethnic Skin.
Vashi NA, de Castro Maymone MB, Kundu RV · 2016 · The Journal of clinical and aesthetic dermatology 9:31-8
C22-3
Topical retinoids build collagen; on skin of color the gentlest effective strength avoids irritation-triggered PIH.
VerifiedOne of 4 sources behind this claim · see the others
The record
Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials.
Sitohang IBS, Makes WI, Sandora N, Suryanegara J · 2022 · International journal of women's dermatology 8:e003
VerifiedOne of 4 sources behind this claim · see the others
The record
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E · 2022 · American journal of clinical dermatology 23:69-81
Concern1 claim · 3 studies

fitzpatrick

CFITZ-1
The Fitzpatrick scale (developed 1975 by Thomas Fitzpatrick) classifies UV response, not appearance; Types I-VI run from always-burns/never-tans to never-burns/tans-deeply; higher melanin density means higher PIH risk, not more protection; product concentrations formulated/tested on Fitzpatrick I-III can inflame IV-VI skin.
VerifiedOne of 3 sources behind this claim · see the others
The record
Are the Fitzpatrick Skin Phototypes Valid for Cancer Risk Assessment in a Racially and Ethnically Diverse Sample of Women?
Sommers MS, Fargo JD, Regueira Y, Brown KM, Beacham BL, Perfetti AR, Everett JS, Margolis DJ · 2019 · Ethnicity & disease 29:505-512
Concern4 claims · 7 studies

hair breakage

C17-1
Curl arises from asymmetric cell differentiation in the hair root, producing an elliptical cortex; mechanism structurally the same across ethnic origin, more pronounced in coily hair.
VerifiedOne source behind this claim
The record
Human hair keratin network and curvature.
Thibaut S, Barbarat P, Leroy F, Bernard BA · 2007 · International journal of dermatology 46 Suppl 1:7-10
C17-2
African/African-diaspora scalp hair is significantly more curled on average than European or East Asian hair.
VerifiedOne source behind this claim
The record
Quantifying variation in human scalp hair fiber shape and pigmentation.
Lasisi T, Ito S, Wakamatsu K, Shaw CN · 2016 · American journal of physical anthropology 160:341-52
C17-4
Coily/African-type hair shows lower water sorption and distinct cuticle lipid structure vs straighter hair; fragility best attributed to knotting/crack formation rather than cross-sectional shape alone.
VerifiedOne of 3 sources behind this claim · see the others
The record
How different is human hair? A critical appraisal of the reported differences in global hair fibre characteristics and properties towards defining a more relevant framework for hair type classification.
Daniels G, Fraser A, Westgate GE · 2023 · International journal of cosmetic science 45:50-61
VerifiedOne of 3 sources behind this claim · see the others
The record
Ethnic hair: Thermoanalytical and spectroscopic differences.
Oliver MA, Coderch L, Carrer V, Barba C, Marti M · 2020 · Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 26:617-626
VerifiedOne of 3 sources behind this claim · see the others
The record
External lipid function in ethnic hairs.
Coderch L, Oliver MA, Carrer V, Manich AM, Martí M · 2019 · Journal of cosmetic dermatology 18:1912-1920
C17-5
Coconut oil (unlike mineral or sunflower oil) penetrates the hair shaft, measurably reduces protein loss from grooming, correlates with lower Hair Breakage Index.
VerifiedOne of 2 sources behind this claim · see the other
The record
Effect of mineral oil, sunflower oil, and coconut oil on prevention of hair damage.
Rele AS, Mohile RB · 2003 · Journal of cosmetic science 54:175-92
VerifiedOne of 2 sources behind this claim · see the other
The record
Hair breakage index: an alternative tool for damage assessment of human hair.
Mhaskar S, Kalghatgi B, Chavan M, Rout S, Gode V · 2011 · Journal of cosmetic science 62:203-7
Concern26 claims · 38 studies

hyperpigmentation

C1-1
L-ascorbic acid is the most-studied vitamin C form (direct tyrosinase inhibition); requires pH 2.5-3.5 to penetrate, which can itself trigger PIH on reactive Fitzpatrick IV-VI skin.
C2-1
Oral tranexamic acid 250mg twice daily for 3 months produced a 49% mMASI reduction vs 18% placebo.
VerifiedOne source behind this claim
The record
Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
Del Rosario E, Florez-Pollack S, Zapata L, Hernandez K, Tovar-Garza A, Rodrigues M, Hynan LS, Pandya AG · 2018 · Journal of the American Academy of Dermatology 78:363-369
C2-6
Tranexamic acid is an antifibrinolytic lysine analogue that binds the lysine-binding sites of plasminogen and so reduces plasmin generation. In guinea pigs, topical tranexamic acid applied after UV exposure reduced UV-induced pigmentation and arachidonic-acid-induced pigmentation; the authors propose that UV raises epidermal plasmin activity, plasmin promotes arachidonic acid release and prostaglandin production, and these arachidonic-acid metabolites stimulate melanocyte tyrosinase (arachidonic-acid metabolites do stimulate tyrosinase in cultured human melanocytes). This chain rests on animal and cell-culture data and is not established in humans.
VerifiedOne of 6 sources behind this claim · see the others
The record
Maeda K, Naganuma M. J Photochem Photobiol B 1998;47(2-3):136-41. PMID 10093913
VerifiedOne of 6 sources behind this claim · see the others
The record
Tomita Y, Maeda K, Tagami H. Pigment Cell Res 1992;5(5 Pt 2):357-61. PMID 1292020
VerifiedOne of 6 sources behind this claim · see the others
The record
Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA. J Med Chem 2019;63(4):1445-1472. PMID 31658420
VerifiedOne of 6 sources behind this claim · see the others
The record
Silva MMCG, Thelwell C, Williams SC, Longstaff C. J Thromb Haemost 2012;10(11):2354-60. PMID 22974122
VerifiedOne of 6 sources behind this claim · see the others
The record
Hushcha Y, Giuliani AL, Fernanda M, Bononi I, Mazziotta C, Rotondo JC, De Mattei M (author names as listed in PubMed). Cell Biol Int 2025;50(1):e70097. PMID 41147757
VerifiedOne of 6 sources behind this claim · see the others
The record
Perper M, Eber AE, Fayne R, Verne SH, Magno RJ, Cervantes J, ALharbi M, ALOmair I, Alfuraih A, Nouri K. Am J Clin Dermatol 2017 Jun;18(3):373-381. PMID 28283893
C2-7
In cultured melanocytes and keratinocyte-melanocyte models, tranexamic acid reduces melanin content, tyrosinase activity and tyrosinase protein by acting on signalling upstream of the enzyme, rather than being characterised as a direct tyrosinase-enzyme inhibitor. It does so both through a keratinocyte paracrine route (tranexamic acid raised keratinocyte TGF-beta1, which suppressed melanogenesis in melanocytes) and directly on melanocytes (ERK-MITF degradation; cAMP-PKA-CREB-MITF; VEGF-receptor signalling). The evidence is in vitro; in a 30-patient refractory-melasma series, oral tranexamic acid was followed by lower epidermal pigmentation and Melan-A staining.
VerifiedOne of 5 sources behind this claim · see the others
The record
Xing X, Xu Z, Chen L, Jin S, Zhang C, Xiang L. Exp Dermatol 2021 Dec 17;31(4):633-640. PMID 34862827
VerifiedOne of 5 sources behind this claim · see the others
The record
Bae YJ, Lee EJ, Kim JY, Park S, Hwang S, Kwon IJ, Alqahtani JM, Oh SH. Exp Dermatol 2025;34(12):e70194. PMID 41392597
VerifiedOne of 5 sources behind this claim · see the others
The record
Nagaraju D, Bhattacharjee R, Vinay K, Saikia UN, Parsad D, Kumaran MS. Dermatol Ther 2018;31(5):e12704. PMID 30253023
C11-1
Chronic friction induces hyperpigmentation (frictional melanosis).
VerifiedOne of 2 sources behind this claim · see the other
The record
Current understanding of frictional dermatoses: A review.
Arora G, Khandpur S, Bansal A, Shetty B, Aggarwal S, Saha S, Sachdeva S, Gupta M, Sharma A, Monalisa K, Bhandari M, Bagrodia A · 2023 · Indian journal of dermatology, venereology and leprology 89:170-188
C11-5
PIH is often chronic; improves only partially and slowly.
C12-1
Iron-oxide sunscreen protects against visible-light-induced pigmentation in Fitzpatrick III-VI, including melasma, where SPF alone did not.
VerifiedOne source behind this claim
The record
Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage.
Grimes PE, Paturi J, Chen Y, Wangari-Olivero J, Dumbuya H, Yan X, Lynch S, Zheng Q · 2025 · Journal of drugs in dermatology : JDD 24:662-667
C12-2
Visible light is ~45% of solar spectrum and can induce persistent darkening, especially in skin of color.
VerifiedOne of 2 sources behind this claim · see the other
The record
Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage.
Grimes PE, Paturi J, Chen Y, Wangari-Olivero J, Dumbuya H, Yan X, Lynch S, Zheng Q · 2025 · Journal of drugs in dermatology : JDD 24:662-667
VerifiedOne of 2 sources behind this claim · see the other
The record
Enhancing Photoprotection: Assessing Visible Light Photoprotection in Tinted Inorganic Sunscreens.
Ruvolo E, Mortillo S, Yousefian O · 2026 · Photodermatology, photoimmunology & photomedicine 42:e70104
C12-3
Tranexamic acid produced significantly greater melasma improvement (MASI) than ascorbic acid mesotherapy in skin-of-color patients.
VerifiedOne source behind this claim
The record
Comparison of the Efficacy of Intralesional Ascorbic Acid Mesotherapy and Intralesional Tranexamic Acid in Treating Melasma in the Skin of Colour Population.
Aslam H, Muhammad A, Ullah A, Aziz N, Lakhiar JA, Ahmad B, Shahzadi A, Ahmad A, Chandni, Virdi G · 2025 · Cureus 17:e87851
C16-1
Visible light induces pigmentation in darker skin; iron-oxide tints block it, plain nanoparticle mineral filters do not.
VerifiedOne source behind this claim
The record
Photoprotection beyond ultraviolet radiation: A review of tinted sunscreens
Alexis B. Lyons, Carles Trullas, Indermeet Kohli, Iltefat H. Hamzavi, Henry W. Lim · 2021 · Journal of the American Academy of Dermatology 84:1393-1397
C16-2
Iron-oxide/tinted photoprotection corroboration for skin of color.
VerifiedOne source behind this claim
The record
Sunscreens part 1: Mechanisms and efficacy
Sara Abdel Azim, Liat Bainvoll, Natalia Vecerek, Vincent A. DeLeo, Brandon L. Adler · 2025 · Journal of the American Academy of Dermatology 92:677-686
C16-3
Physical sunscreens with iron oxide and silicones give a photoprotective + camouflage effect in melasma.
VerifiedOne source behind this claim
The record
Medical therapies for melasma
Vikram K. Mahajan, Anant Patil, Leszek Blicharz, Martin Kassir, Nellie Konnikov, Michael H. Gold, Mitchel P. Goldman, Hassan Galadari, Mohamad Goldust · 2022 · Journal of Cosmetic Dermatology 21:3707-3728
C16-6
Visible light's role in melasma is established; its role in PIH specifically remains to be demonstrated.
VerifiedOne source behind this claim
The record
L’hyperpigmentation post-inflammatoire
T. Passeron · 2016 · Annales de Dermatologie et de Vénéréologie 143:S15-S19
C18-1
L-ascorbic acid penetrates skin only below pH 3.5, optimal absorption ~20%; several derivatives did not raise skin vitamin C levels in the same study.
VerifiedOne source behind this claim
The record
Topical L-ascorbic acid: percutaneous absorption studies.
Pinnell SR, Yang H, Omar M, Monteiro-Riviere N, DeBuys HV, Walker LC, Wang Y, Levine M · 2001 · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 27:137-42
C18-5
Citrus-induced phytophotodermatitis can present as hyperpigmentation without preceding inflammation, especially in dark-skinned people.
VerifiedOne source behind this claim
The record
Asymptomatic Hyperpigmentation without Preceding Inflammation as a Clinical Feature of Citrus Fruits-Induced Phytophotodermatitis.
Choi JY, Hwang S, Lee SH, Oh SH · 2018 · Annals of dermatology 30:75-78
C21-6
On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up.
C21-7
Topical retinoids reduce hyperpigmentation in patients with skin of color and should be started early.
C21-8
All-Black-patient RCT: 0.1% tretinoin improved melasma (MASI) 32% vs 10% vehicle over 40 weeks; side effects limited to mild retinoid dermatitis in 67%.
VerifiedOne source behind this claim
The record
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial.
Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ · 1994 · Archives of dermatology 130:727-33
C23-2
Frictional melanosis is an acquired pigmentary disorder — brown pigmentation from repeated rubbing — recognized among frictional dermatoses, prevalent in more pigmented skin.
VerifiedOne of 2 sources behind this claim · see the other
The record
Orphan rocker tracks: a variant of friction melanosis in an institutionalized child.
Diamond G, Ben Amitai D · 2013 · Pediatric dermatology 30:e198-9
VerifiedOne of 2 sources behind this claim · see the other
The record
Current understanding of frictional dermatoses: A review.
Arora G, Khandpur S, Bansal A, Shetty B, Aggarwal S, Saha S, Sachdeva S, Gupta M, Sharma A, Monalisa K, Bhandari M, Bagrodia A · 2023 · Indian journal of dermatology, venereology and leprology 89:170-188
C23-3
In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment.
VerifiedOne of 2 sources behind this claim · see the other
The record
Facial Melanosis: A Comprehensive Review of Uncommon and Common Presentations with Personal Experience.
Sarkar R, Verma D · 2026 · Indian journal of dermatology 71:171-184
VerifiedOne of 2 sources behind this claim · see the other
The record
Atopic dirty neck or acquired atopic hyperpigmentation? An epidemiological and clinical study from the National Skin Centre in Singapore.
Seghers AC, Lee JS, Tan CS, Koh YP, Ho MS, Lim YL, Giam YC, Tang MB · 2014 · Dermatology (Basel, Switzerland) 229:174-82
CFITZ-1
The Fitzpatrick scale (developed 1975 by Thomas Fitzpatrick) classifies UV response, not appearance; Types I-VI run from always-burns/never-tans to never-burns/tans-deeply; higher melanin density means higher PIH risk, not more protection; product concentrations formulated/tested on Fitzpatrick I-III can inflame IV-VI skin.
VerifiedOne of 3 sources behind this claim · see the others
The record
Are the Fitzpatrick Skin Phototypes Valid for Cancer Risk Assessment in a Racially and Ethnically Diverse Sample of Women?
Sommers MS, Fargo JD, Regueira Y, Brown KM, Beacham BL, Perfetti AR, Everett JS, Margolis DJ · 2019 · Ethnicity & disease 29:505-512
Concern9 claims · 11 studies · 1 reference

intimate area

C11-1
Chronic friction induces hyperpigmentation (frictional melanosis).
VerifiedOne of 2 sources behind this claim · see the other
The record
Current understanding of frictional dermatoses: A review.
Arora G, Khandpur S, Bansal A, Shetty B, Aggarwal S, Saha S, Sachdeva S, Gupta M, Sharma A, Monalisa K, Bhandari M, Bagrodia A · 2023 · Indian journal of dermatology, venereology and leprology 89:170-188
C11-2
Occlusion and hydration increase how deeply/quickly topical actives penetrate skin.
VerifiedOne of 2 sources behind this claim · see the other
The record
Methodology to measure the transient effect of occlusion on skin penetration and stratum corneum hydration in vivo
K. S. RYATT, M. MOBAYEN, J. M. STEVENSON, H. I. MAIBACH, R. H. GUY · 1988 · British Journal of Dermatology 119:307-312
C11-4
Pregnancy-related hyperpigmentation is common and usually eases postpartum.
VerifiedOne source behind this claim
The record
Physiological Skin Changes During Pregnancy
KELLY H. TYLER · 2015 · Clinical Obstetrics & Gynecology 58:119-124
C11-5
PIH is often chronic; improves only partially and slowly.
C20-3
Hypo-oestrogenism lowers water retention and impairs barrier function, raising irritant-dermatitis risk.
VerifiedOne source behind this claim
The record
Menopause, skin and common dermatosis. Part 3: genital disorders.
Esra Musbahi, Erin Kamp, Mariha Ashraf, Claudia DeGiovanni · 2022 · Clinical and experimental dermatology 47:2123-2129
C20-4
General management of vulvar dermatoses is gentle cleansing, avoidance of irritants, optimized skincare, patch testing where contact allergy is suspected.
VerifiedOne source behind this claim
The record
Update vulval dermatology - diagnostics and therapy.
Christine Brägelmann, Linn Wölber, Laura Susok, Waltraud Anemüller, Wiebke Prüßmann, Irina Ivanova, Dennis Niebel · 2025 · Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 23:65-86
C20-5
Lichen simplex chronicus produces hyperpigmented lichenified plaques from rubbing; PIH/hypopigmentation varies with natural skin color.
VerifiedOne source behind this claim
The record
Vulvar Dermatoses: A Review and Update.
Cassandra Simonetta, Erin K Burns, Mary A Guo · 2015 · Missouri medicine 112:301-7
C20-6
Few studies focus on vulvar disease in skin of color; lichen sclerosus, vitiligo, and inflammatory vulvitis are frequently misdiagnosed as one another; mean delay to LS diagnosis 16.43 months.
VerifiedOne source behind this claim
The record
Insights from a joint pediatric dermatology‐gynecology vulvar clinic: A retrospective study
Nikita Menta, Dillon Nussbaum, Aneka Khilnani, Tazim Dowlut‐McElroy, Kaiane A. Habeshian · 2024 · Pediatric Dermatology 41:41-45
C20-7
Lichen sclerosus is often misdiagnosed as vitiligo on darker skin due to hypopigmentation contrast; scarring and thickening are the distinguishing signs vitiligo does not produce.
Patient organizationVerifiedSource record for this claim
The record
Lichen Sclerosus Support Network
Lichen Sclerosus Support Network
Concern4 claims · 4 studies

makeup

C16-1
Visible light induces pigmentation in darker skin; iron-oxide tints block it, plain nanoparticle mineral filters do not.
VerifiedOne source behind this claim
The record
Photoprotection beyond ultraviolet radiation: A review of tinted sunscreens
Alexis B. Lyons, Carles Trullas, Indermeet Kohli, Iltefat H. Hamzavi, Henry W. Lim · 2021 · Journal of the American Academy of Dermatology 84:1393-1397
C16-2
Iron-oxide/tinted photoprotection corroboration for skin of color.
VerifiedOne source behind this claim
The record
Sunscreens part 1: Mechanisms and efficacy
Sara Abdel Azim, Liat Bainvoll, Natalia Vecerek, Vincent A. DeLeo, Brandon L. Adler · 2025 · Journal of the American Academy of Dermatology 92:677-686
C16-3
Physical sunscreens with iron oxide and silicones give a photoprotective + camouflage effect in melasma.
VerifiedOne source behind this claim
The record
Medical therapies for melasma
Vikram K. Mahajan, Anant Patil, Leszek Blicharz, Martin Kassir, Nellie Konnikov, Michael H. Gold, Mitchel P. Goldman, Hassan Galadari, Mohamad Goldust · 2022 · Journal of Cosmetic Dermatology 21:3707-3728
C16-6
Visible light's role in melasma is established; its role in PIH specifically remains to be demonstrated.
VerifiedOne source behind this claim
The record
L’hyperpigmentation post-inflammatoire
T. Passeron · 2016 · Annales de Dermatologie et de Vénéréologie 143:S15-S19
Concern9 claims · 15 studies

post acne

C1-1
L-ascorbic acid is the most-studied vitamin C form (direct tyrosinase inhibition); requires pH 2.5-3.5 to penetrate, which can itself trigger PIH on reactive Fitzpatrick IV-VI skin.
C2-6
Tranexamic acid is an antifibrinolytic lysine analogue that binds the lysine-binding sites of plasminogen and so reduces plasmin generation. In guinea pigs, topical tranexamic acid applied after UV exposure reduced UV-induced pigmentation and arachidonic-acid-induced pigmentation; the authors propose that UV raises epidermal plasmin activity, plasmin promotes arachidonic acid release and prostaglandin production, and these arachidonic-acid metabolites stimulate melanocyte tyrosinase (arachidonic-acid metabolites do stimulate tyrosinase in cultured human melanocytes). This chain rests on animal and cell-culture data and is not established in humans.
VerifiedOne of 6 sources behind this claim · see the others
The record
Maeda K, Naganuma M. J Photochem Photobiol B 1998;47(2-3):136-41. PMID 10093913
VerifiedOne of 6 sources behind this claim · see the others
The record
Tomita Y, Maeda K, Tagami H. Pigment Cell Res 1992;5(5 Pt 2):357-61. PMID 1292020
VerifiedOne of 6 sources behind this claim · see the others
The record
Steinmetzer T, Pilgram O, Wenzel BM, Wiedemeyer SJA. J Med Chem 2019;63(4):1445-1472. PMID 31658420
VerifiedOne of 6 sources behind this claim · see the others
The record
Silva MMCG, Thelwell C, Williams SC, Longstaff C. J Thromb Haemost 2012;10(11):2354-60. PMID 22974122
VerifiedOne of 6 sources behind this claim · see the others
The record
Hushcha Y, Giuliani AL, Fernanda M, Bononi I, Mazziotta C, Rotondo JC, De Mattei M (author names as listed in PubMed). Cell Biol Int 2025;50(1):e70097. PMID 41147757
VerifiedOne of 6 sources behind this claim · see the others
The record
Perper M, Eber AE, Fayne R, Verne SH, Magno RJ, Cervantes J, ALharbi M, ALOmair I, Alfuraih A, Nouri K. Am J Clin Dermatol 2017 Jun;18(3):373-381. PMID 28283893
C2-7
In cultured melanocytes and keratinocyte-melanocyte models, tranexamic acid reduces melanin content, tyrosinase activity and tyrosinase protein by acting on signalling upstream of the enzyme, rather than being characterised as a direct tyrosinase-enzyme inhibitor. It does so both through a keratinocyte paracrine route (tranexamic acid raised keratinocyte TGF-beta1, which suppressed melanogenesis in melanocytes) and directly on melanocytes (ERK-MITF degradation; cAMP-PKA-CREB-MITF; VEGF-receptor signalling). The evidence is in vitro; in a 30-patient refractory-melasma series, oral tranexamic acid was followed by lower epidermal pigmentation and Melan-A staining.
VerifiedOne of 5 sources behind this claim · see the others
The record
Kim MS, Bang SH, Kim JH, Shin HJ, Choi JH, Chang SE. Ann Dermatol 2015;27(3):250-6. PMID 26082580
VerifiedOne of 5 sources behind this claim · see the others
The record
Xing X, Xu Z, Chen L, Jin S, Zhang C, Xiang L. Exp Dermatol 2021 Dec 17;31(4):633-640. PMID 34862827
VerifiedOne of 5 sources behind this claim · see the others
The record
Bae YJ, Lee EJ, Kim JY, Park S, Hwang S, Kwon IJ, Alqahtani JM, Oh SH. Exp Dermatol 2025;34(12):e70194. PMID 41392597
VerifiedOne of 5 sources behind this claim · see the others
The record
Zhu JW, Ni YJ, Tong XY, Guo X, Wu XP, Lu ZF. Int J Med Sci 2020;17(7):903-911. PMID 32308543
VerifiedOne of 5 sources behind this claim · see the others
The record
Nagaraju D, Bhattacharjee R, Vinay K, Saikia UN, Parsad D, Kumaran MS. Dermatol Ther 2018;31(5):e12704. PMID 30253023
C10-1
HOCl is produced endogenously by neutrophils as part of the innate immune response.
C10-3
Sodium hypochlorite solution pH is 11-12; disrupts skin acid mantle on contact.
C13-3
A brief benzoyl peroxide contact suppresses S. aureus without the full-spectrum damage of longer-contact antibacterial washes.
VerifiedOne source behind this claim
The record
A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne.
Gold MH · 2009 · The Journal of clinical and aesthetic dermatology 2:44-8
C24-1
Acne is a common cause of PIH, particularly in skin of color; resulting marks are often more distressing to patients than the acne itself.
VerifiedOne source behind this claim
The record
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E · 2022 · American journal of clinical dermatology 23:69-81
C24-2
In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently.
C24-3
Topical retinoids and azelaic acid treat acne and reduce post-acne hyperpigmentation in skin of color.
VerifiedOne of 2 sources behind this claim · see the other
The record
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E · 2022 · American journal of clinical dermatology 23:69-81
Concern5 claims · 5 studies

razor bumps

C7-1
Nd:YAG laser is safe and effective for PFB on Fitzpatrick IV-VI skin; other wavelengths risk burns or paradoxical pigmentation.
They asked
Whether a long-pulse Nd:YAG laser reduces razor bumps on dark skin without harming it.
How
26 people with skin types IV–VI whose bumps hadn't responded to treatment. One side of the neck was lasered, the other left alone; bumps were counted a month later.
They found
About 12 bumps on the treated side against about 30 on the untreated side, one month on. The authors call it safe and effective.
Small, one month, one clinic, and a side-by-side design — good evidence that it works in the short term, on 26 people. No one has told us what it looks like a year later.
VerifiedIndependent studies existOne of 2 sources behind this claim · see the other
The record
Treatment of pseudofolliculitis barbae in very dark skin with a long pulse Nd:YAG laser.
Ross EV, Cooke LM, Overstreet KA, Buttolph GD, Blair MA · 2002 · Journal of the National Medical Association 94:888-93
They asked
Which lasers can remove hair on darker skin safely, now that longer wavelengths and better cooling exist.
How
A review of the laser types and settings, by a dermatologist at Howard.
They found
Long-pulsed diode and Nd:YAG lasers, used with conservative settings and more sessions, are the ones suited to darker skin — including for razor bumps.
A review, so it gathers rather than tests. It agrees with Ross on the wavelength, which is why the two sit together.
VerifiedIndependent studies existOne of 2 sources behind this claim · see the other
The record
Laser-assisted hair removal for darker skin types.
Battle EF, Hobbs LM · 2004 · Dermatologic therapy 17:177-83
C7-2
With-the-grain shaving and single-blade/foil razors are the standard mechanism-based recommendation for PFB; direct comparative clinical evidence is limited and partly mixed — a consistent regimen with pre/post-shave care may matter as much as blade count.
They asked
Whether the usual advice for razor bumps — shave less, use one blade — actually holds up.
How
A review: the authors read the existing studies rather than running a new one.
They found
There isn't robust evidence that one blade beats many, or that shaving less helps. One recent study found daily shaving with a multi-blade razor didn't make it worse when it was part of a routine, and early evidence says wetting before and moisturizing after may help.
This is a review, not a trial, and it says plainly that the trials needed haven't been done. Our one-blade advice is mechanism, not settled evidence; the routine around the shave is the better-supported part.
VerifiedOne source behind this claim
The record
Pseudofolliculitis barbae: understanding the condition and the role of facial grooming.
Gray J, McMichael AJ · 2016 · International journal of cosmetic science 38 Suppl 1:24-7
C9-5
Keloid formation is significantly more prevalent in Fitzpatrick IV-VI populations.
VerifiedOne of 2 sources behind this claim · see the other
The record
Multi-ancestry meta-analysis of keloids uncovers novel susceptibility loci in diverse populations.
Greene CA, Hampton G, Jaworski J, Shuey MM, Khan A, Luo Y, Jarvik GP, Namjou-Khales B, Edwards TL, Velez Edwards DR, Hellwege JN · 2025 · Nature communications 16:7770
VerifiedOne of 2 sources behind this claim · see the other
The record
Keloid disease: Review with clinical atlas. Part I: Definitions, history, epidemiology, clinics and diagnosis.
Delaleu J, Charvet E, Petit A · 2023 · Annales de dermatologie et de venereologie 150:3-15
C10-1
HOCl is produced endogenously by neutrophils as part of the innate immune response.
C10-3
Sodium hypochlorite solution pH is 11-12; disrupts skin acid mantle on contact.
Concern2 claims · 2 studies

skin of color

C8-2
Erythema-based severity scales are validated on Fitzpatrick I-III; skin-of-color patients are systematically underdiagnosed or misclassified by tools not designed for their presentations.
VerifiedOne source behind this claim
The record
Diagnostic Disparities in Erythema Visibility: A Call to Redefine Inflammatory Assessment in Diverse Skin Tones.
Forsyth A, Prajapati S, Frasier KM, Kriebel C, Jackson T, Batista R, Jean F, Ezekwe U · 2025 · Cureus 17:e94930
Concern2 claims · 2 studies

squeaky clean

C5-1
Hard water dramatically increases barrier damage from surfactant cleansers — calcium/magnesium ions bind to surfactants and remain on skin after rinsing.
VerifiedOne source behind this claim
The record
The Effect of Water Hardness on Surfactant Deposition after Washing and Subsequent Skin Irritation in Atopic Dermatitis Patients and Healthy Control Subjects.
Danby SG, Brown K, Wigley AM, Chittock J, Pyae PK, Flohr C, Cork MJ · 2018 · The Journal of investigative dermatology 138:68-77
C5-2
Skin surface pH averages ~4.7-5.5; acidic pH keeps resident flora attached, alkaline disperses it; below-5 skin is in better barrier condition.
VerifiedOne source behind this claim
The record
Natural skin surface pH is on average below 5, which is beneficial for its resident flora.
Lambers H, Piessens S, Bloem A, Pronk H, Finkel P · 2006 · International journal of cosmetic science 28:359-70
Concern5 claims · 3 studies · 3 references

sun protection

C12-1
Iron-oxide sunscreen protects against visible-light-induced pigmentation in Fitzpatrick III-VI, including melasma, where SPF alone did not.
VerifiedOne source behind this claim
The record
Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage.
Grimes PE, Paturi J, Chen Y, Wangari-Olivero J, Dumbuya H, Yan X, Lynch S, Zheng Q · 2025 · Journal of drugs in dermatology : JDD 24:662-667
C12-2
Visible light is ~45% of solar spectrum and can induce persistent darkening, especially in skin of color.
VerifiedOne of 2 sources behind this claim · see the other
The record
Photoprotection Efficacy of Sun Protection Factor and Iron Oxide Formulations in Diverse Skin With Melasma and Photodamage.
Grimes PE, Paturi J, Chen Y, Wangari-Olivero J, Dumbuya H, Yan X, Lynch S, Zheng Q · 2025 · Journal of drugs in dermatology : JDD 24:662-667
VerifiedOne of 2 sources behind this claim · see the other
The record
Enhancing Photoprotection: Assessing Visible Light Photoprotection in Tinted Inorganic Sunscreens.
Ruvolo E, Mortillo S, Yousefian O · 2026 · Photodermatology, photoimmunology & photomedicine 42:e70104
C15-1
Fitzpatrick VI skin has a natural SPF equivalent of approximately 13.
VerifiedOne source behind this claim
The record
A Comprehensive Review of the Role of UV Radiation in Photoaging Processes Between Different Types of Skin.
Brar G, Dhaliwal A, Brar AS, Sreedevi M, Ahmadi Y, Irfan M, Golbari R, Zumárraga D, Yateem D, Lysak Y, Abarca-Pineda YA · 2025 · Cureus 17:e81109
C26-2
The FDA approved bemotrizinol (Tinosorb S) as a sunscreen active on June 9, 2026, effective August 9, 2026 — the first new UV filter approved for US use in 20 years.
Regulatory recordVerifiedSource record for this claim
The record
FDA announcement: expands sunscreen options for first time in 20 years
U.S. Food and Drug Administration
Regulatory recordVerifiedSource record for this claim
The record
FDA Q&A on OTC sunscreen regulatory actions
U.S. Food and Drug Administration
C26-5
Waterproof,' 'sunblock,' and 'sweatproof' are prohibited on US sunscreen labels; only 'water resistant 40/80 minutes' is permitted.
Concern10 claims · 10 studies · 1 reference

sweat

C10-1
HOCl is produced endogenously by neutrophils as part of the innate immune response.
C10-3
Sodium hypochlorite solution pH is 11-12; disrupts skin acid mantle on contact.
C13-1
Antiperspirant/deodorant products can compromise the axillary microbiome balance.
VerifiedOne source behind this claim
The record
The potential prebiotic effect of 2-Butyloctanol on the human axillary microbiome.
Li M, Truong K, Pillai S, Boyd T, Fan A · 2021 · International journal of cosmetic science 43:627-635
C13-2
Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis.
VerifiedOne of 2 sources behind this claim · see the other
The record
Allergic contact dermatitis from essential oil in consumer products: Mode of uses and value of patch tests with an essential oil series. Results of a French study of the DAG (Dermato-Allergology group of the French Society of Dermatology).
Barbaud A, Kurihara F, Raison-Peyron N, Milpied B, Valois A, Assier H, Morice C, Manciet JR, Gener G, Giordano-Labadie F, Marcant P, Bernier C, Amsler E, Crepy MN, Tetart F, Soria A, le Bouëdec MF, Dermato-Allergology Group of the French Society of Dermatology (DAG) · 2023 · Contact dermatitis 89:190-197
C13-3
A brief benzoyl peroxide contact suppresses S. aureus without the full-spectrum damage of longer-contact antibacterial washes.
VerifiedOne source behind this claim
The record
A New, Once-daily, Optimized, Fixed Combination of Clindamycin Phosphate 1.2% and Low-concentration Benzoyl Peroxide 2.5% Gel for the Treatment of Moderate-to-Severe Acne.
Gold MH · 2009 · The Journal of clinical and aesthetic dermatology 2:44-8
C14-2
One small study found no aluminum detected in apocrine glands after antiperspirant use; concluded absorption-risk concerns look unfounded on that data.
VerifiedOne source behind this claim
The record
Are Antiperspirants Safe? Shedding Light on the Distribution of Aluminum Compounds in Sweat Glands.
Ho WT · 2023 · Plastic and aesthetic nursing 43:217-218
C14-3
Essential oils (lavender, tea tree) are a documented cause of allergic contact dermatitis.
VerifiedOne of 2 sources behind this claim · see the other
The record
Allergic contact dermatitis from essential oil in consumer products: Mode of uses and value of patch tests with an essential oil series. Results of a French study of the DAG (Dermato-Allergology group of the French Society of Dermatology).
Barbaud A, Kurihara F, Raison-Peyron N, Milpied B, Valois A, Assier H, Morice C, Manciet JR, Gener G, Giordano-Labadie F, Marcant P, Bernier C, Amsler E, Crepy MN, Tetart F, Soria A, le Bouëdec MF, Dermato-Allergology Group of the French Society of Dermatology (DAG) · 2023 · Contact dermatitis 89:190-197
C23-1
Intertrigo is a superficial inflammatory condition of skin folds triggered by friction/moisture/heat/poor ventilation; can become secondarily infected (often Candida).
C23-2
Frictional melanosis is an acquired pigmentary disorder — brown pigmentation from repeated rubbing — recognized among frictional dermatoses, prevalent in more pigmented skin.
VerifiedOne of 2 sources behind this claim · see the other
The record
Orphan rocker tracks: a variant of friction melanosis in an institutionalized child.
Diamond G, Ben Amitai D · 2013 · Pediatric dermatology 30:e198-9
VerifiedOne of 2 sources behind this claim · see the other
The record
Current understanding of frictional dermatoses: A review.
Arora G, Khandpur S, Bansal A, Shetty B, Aggarwal S, Saha S, Sachdeva S, Gupta M, Sharma A, Monalisa K, Bhandari M, Bagrodia A · 2023 · Indian journal of dermatology, venereology and leprology 89:170-188
C23-3
In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment.
VerifiedOne of 2 sources behind this claim · see the other
The record
Facial Melanosis: A Comprehensive Review of Uncommon and Common Presentations with Personal Experience.
Sarkar R, Verma D · 2026 · Indian journal of dermatology 71:171-184
VerifiedOne of 2 sources behind this claim · see the other
The record
Atopic dirty neck or acquired atopic hyperpigmentation? An epidemiological and clinical study from the National Skin Centre in Singapore.
Seghers AC, Lee JS, Tan CS, Koh YP, Ho MS, Lim YL, Giam YC, Tang MB · 2014 · Dermatology (Basel, Switzerland) 229:174-82
Concern5 claims · 8 studies

wound care

C9-1
Moist wound healing accelerates re-epithelialization by approximately 50% vs air-drying (seminal study: ~2x faster).
VerifiedOne of 2 sources behind this claim · see the other
The record
Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig.
WINTER GD · 1962 · Nature 193:293-4
VerifiedOne of 2 sources behind this claim · see the other
The record
Comparison of skin graft donor site management using oxidised regenerated cellulose (ORC)/collagen/silver-ORC with absorptive silicone adhesive border and transparent film dressing vs semi-occlusive dressings.
Chowdhry SA · 2023 · International wound journal 20:1112-1117
C9-2
Silicone gel/sheeting is the internationally recommended first-line OTC scar-prevention intervention (occlusion + hydration normalizes scar-cell overactivity); underlying RCT evidence for scar therapies generally carries some uncertainty per Cochrane, but silicone remains first-line consensus.
VerifiedOne source behind this claim
The record
The Use of Silicone Adhesives for Scar Reduction.
Bleasdale B, Finnegan S, Murray K, Kelly S, Percival SL · 2015 · Advances in wound care 4:422-430
C9-3
Neomycin is among the most common contact allergens identified in patch testing (pooled prevalence 3.2% adults, 6.4% North America); ACDS Allergen of the Year 2010.
VerifiedOne source behind this claim
The record
Prevalence of Contact Allergy to Neomycin in Dermatitis Patients: A Systematic Review and Meta-Analysis.
Jensen MB, Isufi D, Larsen CK, Schwensen JFB, Alinaghi F, Johansen JD · 2025 · Contact dermatitis 93:1-15
C9-4
Topical vitamin E does not improve scar appearance (no effect or worsened in 90% of a split-scar trial) and causes contact dermatitis in ~33% of users.
VerifiedOne of 2 sources behind this claim · see the other
The record
The effects of topical vitamin E on the cosmetic appearance of scars.
Baumann LS, Spencer J · 1999 · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 25:311-5
VerifiedOne of 2 sources behind this claim · see the other
The record
The Role of Topical Vitamin E in Scar Management: A Systematic Review.
Tanaydin V, Conings J, Malyar M, van der Hulst R, van der Lei B · 2016 · Aesthetic surgery journal 36:959-65
C9-5
Keloid formation is significantly more prevalent in Fitzpatrick IV-VI populations.
VerifiedOne of 2 sources behind this claim · see the other
The record
Multi-ancestry meta-analysis of keloids uncovers novel susceptibility loci in diverse populations.
Greene CA, Hampton G, Jaworski J, Shuey MM, Khan A, Luo Y, Jarvik GP, Namjou-Khales B, Edwards TL, Velez Edwards DR, Hellwege JN · 2025 · Nature communications 16:7770
VerifiedOne of 2 sources behind this claim · see the other
The record
Keloid disease: Review with clinical atlas. Part I: Definitions, history, epidemiology, clinics and diagnosis.
Delaleu J, Charvet E, Petit A · 2023 · Annales de dermatologie et de venereologie 150:3-15
Ingredient8 claims · 12 studies · 2 references

azelaic acid

C4-1
Azelaic acid 15-20% produced brightening comparable to 4% hydroquinone for melasma over 24 weeks, with better tolerability and no ochronosis or sensitization, replicated across Fitzpatrick III-V comparative studies.
VerifiedOne of 5 sources behind this claim · see the others
The record
Interventions for melasma.
Rajaratnam R, Halpern J, Salim A, Emmett C · 2010 · The Cochrane database of systematic reviews 2010:CD003583
VerifiedOne of 5 sources behind this claim · see the others
The record
Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.
Farshi S · 2011 · Journal of cosmetic dermatology 10:282-7
VerifiedOne of 5 sources behind this claim · see the others
The record
A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations.
Petrovici AG, Spennato M, Bîtcan I, Péter F, Cotarcă L, Todea A, Ordodi VL · 2025 · Pharmaceuticals (Basel, Switzerland) 18
VerifiedOne of 5 sources behind this claim · see the others
The record
Topical and Systemic Therapies in Melasma: A Systematic Review.
Sarkar R, Handog EB, Das A, Bansal A, Macarayo MJ, Keshavmurthy V, Narayan V, Jagadeesan S, Pipo E, Ibaviosa GM, Podder I, Bansal S · 2023 · Indian dermatology online journal 14:769-781
C4-2
Azelex (20% cream) FDA-approved ~Sept 1995 for acne; Finacea (15% gel) FDA-approved Dec 2002 for rosacea — 'over 30 years' framing accurate.
Regulatory recordVerifiedSource record for this claim
The record
Drugs@FDA — NDA 020428 (Azelex 20%)
U.S. Food and Drug Administration
Regulatory recordVerifiedSource record for this claim
The record
Drugs@FDA — NDA 021470 (Finacea 15%)
U.S. Food and Drug Administration
C11-7
Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase.
C18-6
Commercial azelaic acid is produced almost entirely by ozonolysis of oleic acid; occurs in grains but is not extracted from them at usable scale.
VerifiedOne of 2 sources behind this claim · see the other
The record
Extraction and Quantification of Azelaic Acid from Different Wheat Samples (Triticum durum Desf.) and Evaluation of Their Antimicrobial and Antioxidant Activities.
Chiara Spaggiari, Giannamaria Annunziato, Costanza Spadini, Sabrina Lucia Montanaro, Mattia Iannarelli, Clotilde Silvia Cabassi, Gabriele Costantino · 2023 · Molecules (Basel, Switzerland) 28
VerifiedOne of 2 sources behind this claim · see the other
The record
Characterizing the Potential for Sustainable Azelaic Acid Production from High-Oleic Vegetable Oil Using Two-Step Oxidative Cleavage.
Kudli LP, Cortés-Peña YR, Bhagwat SS, Guest JS · 2026 · ACS ES T Eng 6:391-403
C24-3
Topical retinoids and azelaic acid treat acne and reduce post-acne hyperpigmentation in skin of color.
VerifiedOne of 2 sources behind this claim · see the other
The record
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E · 2022 · American journal of clinical dermatology 23:69-81
C35-9
Azelaic acid — 4 mechanisms (antimicrobial, tyrosinase inhibition, free-radical scavenging, reduced neutrophil ROS).
VerifiedOne source behind this claim
The record
The multiple uses of azelaic acid in dermatology: mechanism of action, preparations, and potential therapeutic applications.
Sauer N, Oślizło M, Brzostek M, Wolska J, Lubaszka K, Karłowicz-Bodalska K · 2023 · Postepy dermatologii i alergologii 40:716-724
C35-10
Azelaic acid also keratolytic.
VerifiedOne source behind this claim
The record
Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.
Del Rosso JQ, Baum EW, Draelos ZD, Elewski BE, Fleischer AB, Kakita LS, Thiboutot D · 2006 · Cutis 78:6-19
Ingredient5 claims · 6 studies

ceramides

C29-1
African American skin was characterized by low ceramide levels in the uppermost layers of the stratum corneum, interpretable alongside the high prevalence of xerosis in Black skin.
VerifiedOne source behind this claim
The record
Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin
Neelam Muizzuddin, Lieveke Hellemans, Luc Van Overloop, Hugo Corstjens, Lieve Declercq, Daniel Maes · 2010 · Journal of Dermatological Science 59:123-128
C29-3
Ceramide subclass composition is tightly linked to barrier function; a skewed or altered ceramide profile correlates with barrier dysfunction.
VerifiedOne source behind this claim
The record
Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide composition
Jannik Rousel, Andreea Nădăban, Mahdi Saghari, Lisa Pagan, Ahnjili Zhuparris, Bart Theelen, Tom Gambrah, Hein E. C. van der Wall, Rob J. Vreeken, Gary L. Feiss, Tessa Niemeyer‐van der Kolk, Jacobus Burggraaf, Martijn B. A. van Doorn, Joke A. Bouwstra, Robert Rissmann · 2024 · Experimental Dermatology 33
C29-4
There are 12+ distinct ceramide subclasses in human skin; a well-built barrier product leads with a few, commonly Ceramide NP/AP/EOP.
VerifiedOne of 3 sources behind this claim · see the others
The record
Ceramide composition of the psoriatic scale.
Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R · 1993 · Biochimica et biophysica acta 1182:147-51
VerifiedOne of 3 sources behind this claim · see the others
The record
Characterization of overall ceramide species in human stratum corneum.
Masukawa Y, Narita H, Shimizu E, Kondo N, Sugai Y, Oba T, Homma R, Ishikawa J, Takagi Y, Kitahara T, Takema Y, Kita K · 2008 · Journal of lipid research 49:1466-76
VerifiedOne of 3 sources behind this claim · see the others
The record
Profiling and characterizing skin ceramides using reversed-phase liquid chromatography-quadrupole time-of-flight mass spectrometry.
t'Kindt R, Jorge L, Dumont E, Couturon P, David F, Sandra P, Sandra K · 2012 · Analytical chemistry 84:403-11
C31-9
Black skin shows increased transepidermal water loss, decreased ceramide levels, and lower stratum corneum pH; management emphasizes low-pH products and emollients.
VerifiedOne source behind this claim
The record
Pruritus in Black Skin: Unique Molecular Characteristics and Clinical Features.
McColl M, Boozalis E, Aguh C, Eseonu AC, Okoye GA, Kwatra SG · 2021 · Journal of the National Medical Association 113:30-38
C31-10
African American skin is characterized by low ceramide levels and high protein cohesion in the uppermost stratum corneum, interpreted in relation to the high prevalence of xerosis.
VerifiedOne source behind this claim
The record
Structural and functional differences in barrier properties of African American, Caucasian and East Asian skin.
Muizzuddin N, Hellemans L, Van Overloop L, Corstjens H, Declercq L, Maes D · 2010 · Journal of dermatological science 59:123-8
Ingredient2 claims · 3 studies

hocl

C10-2
Bleach kills bacteria (textbook); bleach-bath clinical benefit in AD not established as superior to plain water; HOCl reduces bacterial load on its own merits.
VerifiedOne of 2 sources behind this claim · see the other
The record
Efficacy of bleach baths in reducing severity of atopic dermatitis: A systematic review and meta-analysis.
Chopra R, Vakharia PP, Sacotte R, Silverberg JI · 2017 · Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 119:435-440
VerifiedOne of 2 sources behind this claim · see the other
The record
Therapeutic Indices of Topical Antiseptics in Wound Care: A Systematic Review.
Geng RSQ, Sibbald RG, Slomovic J, Toksarka O, Schultz G · 2025 · Advances in skin & wound care 38:10-18
C10-4
HOCl is anti-inflammatory (scoping review).
VerifiedOne source behind this claim
The record
Past, Present, and Future of Sodium Hypochlorite in Dermatology: A Scoping Review.
Chang CH, Devine M, Woo D, Hopkins T, Torres T, Chovatiya R · 2026 · American journal of clinical dermatology 27:415-463
Ingredient6 claims · 14 studies

hydroquinone

C2-3
A 3% topical TXA formulation produced no detectable systemic absorption and efficacy comparable to 3% hydroquinone + dexamethasone.
VerifiedOne of 3 sources behind this claim · see the others
The record
Efficacy and safety of topical agents in the treatment of melasma: What's evidence? A systematic review and meta-analysis.
Chang YF, Lee TL, Oyerinde O, Desai SR, Aljabban A, Bay CP, Bain PA, Chung HJ · 2023 · Journal of cosmetic dermatology 22:1168-1176
VerifiedOne of 3 sources behind this claim · see the others
The record
Topical application of tranexamic acid for the reduction of bleeding.
Ker K, Beecher D, Roberts I · 2013 · The Cochrane database of systematic reviews 2013:CD010562
VerifiedOne of 3 sources behind this claim · see the others
The record
Pilot Clinical Safety and Efficacy Evaluation of a Topical 3% Tranexamic Acid Cream and Serum Protocol for Managing Facial Hyperpigmentation in Caucasian Patients
Sarah Hsin, Kelly Lourenço, Alexandre Porcello, Cíntia Marques, Clara Rodriguez, Wassim Raffoul, Corinne Scaletta, Philippe Abdel-Sayed, Basste Hadjab, Lee Ann Applegate, Alexis Laurent · 2024 · Cosmetics 11:168
C3-2
4% niacinamide showed comparable efficacy to 4% hydroquinone for melasma, with fewer reported side effects (18% vs 29%, not statistically tested).
VerifiedOne source behind this claim
The record
A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma.
Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, Oros-Ovalle C, Fuentes-Ahumada C, González FJ, Martínez-Ramírez JD, Moncada B · 2011 · Dermatology research and practice 2011:379173
C4-1
Azelaic acid 15-20% produced brightening comparable to 4% hydroquinone for melasma over 24 weeks, with better tolerability and no ochronosis or sensitization, replicated across Fitzpatrick III-V comparative studies.
VerifiedOne of 5 sources behind this claim · see the others
The record
Interventions for melasma.
Rajaratnam R, Halpern J, Salim A, Emmett C · 2010 · The Cochrane database of systematic reviews 2010:CD003583
VerifiedOne of 5 sources behind this claim · see the others
The record
Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma.
Farshi S · 2011 · Journal of cosmetic dermatology 10:282-7
VerifiedOne of 5 sources behind this claim · see the others
The record
A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations.
Petrovici AG, Spennato M, Bîtcan I, Péter F, Cotarcă L, Todea A, Ordodi VL · 2025 · Pharmaceuticals (Basel, Switzerland) 18
VerifiedOne of 5 sources behind this claim · see the others
The record
Topical and Systemic Therapies in Melasma: A Systematic Review.
Sarkar R, Handog EB, Das A, Bansal A, Macarayo MJ, Keshavmurthy V, Narayan V, Jagadeesan S, Pipo E, Ibaviosa GM, Podder I, Bansal S · 2023 · Indian dermatology online journal 14:769-781
C6-1
4% hydroquinone cream at 12-24 weeks produces meaningful MASI reduction, outperforming most OTC brighteners for melasma (gold-standard comparator).
VerifiedOne of 2 sources behind this claim · see the other
The record
A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma.
Grimes PE, Dias S, Oparaugo NC, Tatarinova T, McCraw T · 2026 · Journal of drugs in dermatology : JDD 25:25-29
VerifiedOne of 2 sources behind this claim · see the other
The record
Safety and efficacy of niosomal and conventional tranexamic acid/niacinamide vs. hydroquinone creams in melasma: A randomized, double-blind, case-controlled clinical trial.
Ghasemiyeh P, Haghighi NF, Dastgheib L, Ranjbar S, Mohammadi-Samani S · 2025 · Scientific reports 15:42739
C6-2
Exogenous ochronosis (blue-black-gray discoloration) is associated with prolonged HQ use (often years), disproportionately affects Fitzpatrick IV-VI skin, and is documented even at 2-4% OTC concentrations — no safe concentration threshold.
VerifiedOne of 2 sources behind this claim · see the other
The record
Exogenous Ochronosis: Characterizing a Rare Disorder in Skin of Color.
Lazar M, De La Garza H, Vashi NA · 2023 · Journal of clinical medicine 12
VerifiedOne of 2 sources behind this claim · see the other
The record
Clinical and dermoscopic characteristics of exogenous ochronosis: results of a multicentre study by the International Dermoscopy Society Dermoscopy in Skin of Color Task Force.
Vinay K, Mehta H, Bhat YJ, Khare S, Enechukwu NA, Chauhan P, Ankad BS, Awatef K, Rani S, Kaliyadan F, Errichetti E · 2025 · Clinical and experimental dermatology 50:1777-1785
C6-3
The Kligman formula (HQ-tretinoin-corticosteroid) originated in 1975 at 5% hydroquinone / 0.1% tretinoin / 0.1% dexamethasone.
VerifiedOne source behind this claim
The record
A new formula for depigmenting human skin.
Kligman AM, Willis I · 1975 · Archives of dermatology 111:40-8
Ingredient4 claims · 3 studies

niacinamide

C3-2
4% niacinamide showed comparable efficacy to 4% hydroquinone for melasma, with fewer reported side effects (18% vs 29%, not statistically tested).
VerifiedOne source behind this claim
The record
A Double-Blind, Randomized Clinical Trial of Niacinamide 4% versus Hydroquinone 4% in the Treatment of Melasma.
Navarrete-Solís J, Castanedo-Cázares JP, Torres-Álvarez B, Oros-Ovalle C, Fuentes-Ahumada C, González FJ, Martínez-Ramírez JD, Moncada B · 2011 · Dermatology research and practice 2011:379173
C11-7
Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase.
Ingredient11 claims · 9 studies · 1 reference

retinoids

C21-1
All retinoids act through the retinoic acid receptor; later generations bind it more selectively.
ReferenceVerifiedSource record for this claim
The record
Adapalene
Tolaymat L, Dearborn H, Zito PM · 2023 · StatPearls
VerifiedOne source behind this claim
The record
Vitamins and the skin: Vitamin A and retinoids in dermatology.
Dessinioti C, Katsambas A · 2026 · Clin Dermatol 44:212-222
C21-2
Topical retinoids increase collagen and normalize keratinocytes/melanocytes, improving wrinkles, texture, and tone.
VerifiedOne of 2 sources behind this claim · see the other
The record
Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials.
Sitohang IBS, Makes WI, Sandora N, Suryanegara J · 2022 · International journal of women's dermatology 8:e003
C21-4
Adapalene at 0.1% improved wrinkles and pigmentation over six months and was well tolerated.
VerifiedOne source behind this claim
The record
Effectiveness and tolerability of adapalene cream 0.1% in the treatment of female skin ageing: A randomised controlled trial.
Tran QT, Le DV, Vu YH, Le MH, Vu LH, Le DH, Vu MN · 2025 · Indian journal of dermatology, venereology and leprology 91:571-576
C21-5
A retinol-precursor formula matched tretinoin 0.02% on photodamage with erythema six times less frequent (11% vs 64%).
VerifiedOne source behind this claim
The record
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage: A Randomized Clinical Trial.
Chien AL, Kim DJ, Cheng N, Shin J, Leung SG, Nelson AM, Zang J, Suh H, Rainer B, Wallis L, Okoye GA, Loss M, Kang S · 2022 · JAMA dermatology 158:879-886
C21-6
On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up.
C21-7
Topical retinoids reduce hyperpigmentation in patients with skin of color and should be started early.
C21-8
All-Black-patient RCT: 0.1% tretinoin improved melasma (MASI) 32% vs 10% vehicle over 40 weeks; side effects limited to mild retinoid dermatitis in 67%.
VerifiedOne source behind this claim
The record
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial.
Kimbrough-Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo-Ransby SM, Ellis CN, Voorhees JJ · 1994 · Archives of dermatology 130:727-33
C21-9
Major photoaging efficacy RCTs have largely been conducted on lighter (Fitzpatrick I-III) skin — the research-population gap named once in the body.
VerifiedOne source behind this claim
The record
Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage: A Randomized Clinical Trial.
Chien AL, Kim DJ, Cheng N, Shin J, Leung SG, Nelson AM, Zang J, Suh H, Rainer B, Wallis L, Okoye GA, Loss M, Kang S · 2022 · JAMA dermatology 158:879-886
C22-3
Topical retinoids build collagen; on skin of color the gentlest effective strength avoids irritation-triggered PIH.
VerifiedOne of 4 sources behind this claim · see the others
The record
Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials.
Sitohang IBS, Makes WI, Sandora N, Suryanegara J · 2022 · International journal of women's dermatology 8:e003
VerifiedOne of 4 sources behind this claim · see the others
The record
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E · 2022 · American journal of clinical dermatology 23:69-81
C24-3
Topical retinoids and azelaic acid treat acne and reduce post-acne hyperpigmentation in skin of color.
VerifiedOne of 2 sources behind this claim · see the other
The record
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD, Baldwin H, Cook-Bolden FE, Alexis AF, Stein Gold L, Guenin E · 2022 · American journal of clinical dermatology 23:69-81
Ingredient6 claims · 9 studies

tranexamic

C2-1
Oral tranexamic acid 250mg twice daily for 3 months produced a 49% mMASI reduction vs 18% placebo.
VerifiedOne source behind this claim
The record
Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
Del Rosario E, Florez-Pollack S, Zapata L, Hernandez K, Tovar-Garza A, Rodrigues M, Hynan LS, Pandya AG · 2018 · Journal of the American Academy of Dermatology 78:363-369
C2-2
10% topical TXA delivered via microneedling produced 65.92% mMASI improvement at 8 weeks vs 20.75% with microneedling alone.
VerifiedOne source behind this claim
The record
Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.
Kaur A, Bhalla M, Pal Thami G, Sandhu J · 2020 · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 46:e96-e101
C2-3
A 3% topical TXA formulation produced no detectable systemic absorption and efficacy comparable to 3% hydroquinone + dexamethasone.
VerifiedOne of 3 sources behind this claim · see the others
The record
Efficacy and safety of topical agents in the treatment of melasma: What's evidence? A systematic review and meta-analysis.
Chang YF, Lee TL, Oyerinde O, Desai SR, Aljabban A, Bay CP, Bain PA, Chung HJ · 2023 · Journal of cosmetic dermatology 22:1168-1176
VerifiedOne of 3 sources behind this claim · see the others
The record
Topical application of tranexamic acid for the reduction of bleeding.
Ker K, Beecher D, Roberts I · 2013 · The Cochrane database of systematic reviews 2013:CD010562
VerifiedOne of 3 sources behind this claim · see the others
The record
Pilot Clinical Safety and Efficacy Evaluation of a Topical 3% Tranexamic Acid Cream and Serum Protocol for Managing Facial Hyperpigmentation in Caucasian Patients
Sarah Hsin, Kelly Lourenço, Alexandre Porcello, Cíntia Marques, Clara Rodriguez, Wassim Raffoul, Corinne Scaletta, Philippe Abdel-Sayed, Basste Hadjab, Lee Ann Applegate, Alexis Laurent · 2024 · Cosmetics 11:168
C2-4
No increased venous or arterial thromboembolic risk in non-surgical patients without underlying risk factors taking systemic TXA.
VerifiedOne source behind this claim
The record
Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis.
Chornenki NLJ, Um KJ, Mendoza PA, Samienezhad A, Swarup V, Chai-Adisaksopha C, Siegal DM · 2019 · Thrombosis research 179:81-86
C2-5
Oral TXA given around a laser procedure did not reliably prevent post-procedure PIH; the higher-dose trial sped clearance of pigment rather than preventing it.
VerifiedOne of 2 sources behind this claim · see the other
The record
A Prospective Randomized Controlled Study of Oral Tranexamic Acid for Preventing Postinflammatory Hyperpigmentation After Q-Switched Ruby Laser
Harunosuke Kato, Jun Araki, Hitomi Eto, Kentaro Doi, Rintaro Hirai, Shinichiro Kuno, Takuya Higashino, Kotaro Yoshimura · 2011 · Dermatologic Surgery 37:605-610
VerifiedOne of 2 sources behind this claim · see the other
The record
A Prospective Randomized Controlled Study of Oral Tranexamic Acid for the Prevention of Postinflammatory Hyperpigmentation After Q‐Switched 532‐nm Nd:YAG Laser for Solar Lentigines
Suthinee Rutnin, Duangrat Pruettivorawongse, Kunlawat Thadanipon, Vasanop Vachiramon · 2019 · Lasers in Surgery and Medicine 51:850-858
C12-3
Tranexamic acid produced significantly greater melasma improvement (MASI) than ascorbic acid mesotherapy in skin-of-color patients.
VerifiedOne source behind this claim
The record
Comparison of the Efficacy of Intralesional Ascorbic Acid Mesotherapy and Intralesional Tranexamic Acid in Treating Melasma in the Skin of Colour Population.
Aslam H, Muhammad A, Ullah A, Aziz N, Lakhiar JA, Ahmad B, Shahzadi A, Ahmad A, Chandni, Virdi G · 2025 · Cureus 17:e87851
Ingredient4 claims · 11 studies

vitamin c

C1-2
SAP (sodium ascorbyl phosphate) was effective and well tolerated in a controlled trial — for acne, not hyperpigmentation; SAP's pigmentation role rests on shared vitamin C mechanism, not direct pigmentation RCTs (those exist mostly for the magnesium form MAP; sodium AP alone showed only a weak effect at 6%).
VerifiedOne of 4 sources behind this claim · see the others
The record
Sodium L-ascorbyl-2-phosphate 5% lotion for the treatment of acne vulgaris: a randomized, double-blind, controlled trial.
Woolery-Lloyd H, Baumann L, Ikeno H · 2010 · Journal of cosmetic dermatology 9:22-7
VerifiedOne of 4 sources behind this claim · see the others
The record
Treatment of refractory melasma with combination of topical 5% magnesium ascorbyl phosphate and fluorescent pulsed light in Asian patients.
Shaikh ZI, Mashood AA · 2014 · International journal of dermatology 53:93-9
VerifiedOne of 4 sources behind this claim · see the others
The record
Utilization of a high-resolution digital imaging system for the objective and quantitative assessment of hyperpigmented spots on the face.
Miyamoto K, Takiwaki H, Hillebrand GG, Arase S · 2002 · Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) 8:73-7
VerifiedOne of 4 sources behind this claim · see the others
The record
Whitening effect of L-ascorbate-2-phosphate trisodium salt on solar lentigos.
Ishikawa Y, Niwano T, Hirano S, Numano K, Takasima K, Imokawa G · 2019 · Archives of dermatological research 311:183-191
C1-3
SAP 1% showed strong antimicrobial and skin-clarifying activity.
VerifiedOne source behind this claim
The record
Sodium ascorbyl phosphate shows in vitro and in vivo efficacy in the prevention and treatment of acne vulgaris.
Klock J, Ikeno H, Ohmori K, Nishikawa T, Vollhardt J, Schehlmann V · 2005 · International journal of cosmetic science 27:171-6
C1-5
AA-2G suppresses keratinocyte-derived GM-CSF, an inflammatory factor that drives pigmentation.
VerifiedOne source behind this claim
The record
Sage extract and ascorbic acid derivative inhibit melanogenesis via downregulating keratinocyte-derived GM-CSF.
Kubo H, Moriyama M, Goto S, Miyake Y, Nakamura M, Ozeki Y, Nakamura Y, Moriyama H · 2025 · PloS one 20:e0325242
C1-6
THD ascorbate and EAA mechanism/delivery: anti-melanogenic in cell and zebrafish models; EAA stable near neutral pH; THD shows better transdermal absorption in tissue-model imaging via a nanocarrier-enhanced formulation (not plain THD).
VerifiedOne of 5 sources behind this claim · see the others
The record
The anti-melanogenic effects of 3-O-ethyl ascorbic acid via Nrf2-mediated α-MSH inhibition in UVA-irradiated keratinocytes and autophagy induction in melanocytes.
Chen SJ, Hseu YC, Gowrisankar YV, Chung YT, Zhang YZ, Way TD, Yang HL · 2021 · Free radical biology & medicine 173:151-169
VerifiedOne of 5 sources behind this claim · see the others
The record
3-O-ethyl-l-ascorbic acid: Characterisation and investigation of single solvent systems for delivery to the skin.
Iliopoulos F, Sil BC, Moore DJ, Lucas RA, Lane ME · 2019 · International journal of pharmaceutics: X 1:100025
VerifiedOne of 5 sources behind this claim · see the others
The record
Proteomic analysis of the combined effects of cannabigerol and 3-O-ethyl ascorbic acid on kinase-dependent signalling in UVB-irradiated human keratinocytes.
Gęgotek A, Jarocka-Karpowicz I, Ryšavá A, Žarković N, Skrzydlewska E · 2024 · Scientific reports 14:27799
VerifiedOne of 5 sources behind this claim · see the others
The record
Enhanced wound healing via ROS-triggered release of ascorbyl tetraisopalmitate loaded in ferrocene-based polymer nanoparticles.
Yu S, Lee M, Seo D, Kim H, Park CS, Sung D · 2025 · Redox biology 84:103659
VerifiedOne of 5 sources behind this claim · see the others
The record
Biocompatible Lyotropic Nanocarriers for Improved Delivery of Ascorbyl Tetraisopalmitate in Skincare.
Han X, Yan Q, Gao N, Kang Y, Li N, Zou A · 2025 · Langmuir : the ACS journal of surfaces and colloids 41:3278-3290
Library pages109 claims · 67 studies · 60 synthesized

library pages

C10-8
In 15 patients with epidermolysis bullosa, daily acid-oxidising HOCl spray on chronic wounds for 8 weeks reduced S. aureus relative abundance from 34% to about 10% and INCREASED overall bacterial diversity, with the effect persisting 4 weeks after stopping.
VerifiedOne source behind this claim
The record
Zhou XA, Burns MB, Ren Z, Stagaman E, Green SJ, Wu LYA, Yang L, Rangel S, Rabbaa L, Paller AS. Exp Dermatol 2025 Aug;34(8):e70147. PMID 40803690
C10-9
In a 10-day field exercise of 39 adult soldiers, repeated stabilised-HOCl hand antisepsis showed minimal within-treatment microbiome diversity divergence and a significant post-treatment increase in alpha diversity (faster recolonisation) compared with alcohol-based standard hand hygiene; environment explained more microbiome variation than antiseptic choice.
VerifiedOne source behind this claim
The record
Glenna S, Birkeland EE, Orr RJS, Gilfillan GD, Dalland M, Økstad OA, Voie ØA, Rounge TB. Microbiol Spectr 2026 Jul;14(8):e0377125. PMID 42446227
C10-10
A single application of HOCl hygiene solution to the periocular skin of 36 adults produced a greater than 99% reduction in staphylococcal load at 20 minutes with no reduction in bacterial species diversity.
VerifiedOne source behind this claim
The record
Stroman DW, Mintun K, Epstein AB, Brimer CM, Patel CR, Branch JD, Najafi-Tagol K. Clin Ophthalmol 2017 Apr;11:707-714. PMID 28458509
C15-2
Daily sunscreen use (Queensland RCT, ~900 adults, 4.5 years, ~SPF 15) measurably slowed visible skin aging.
VerifiedOne source behind this claim
The record
Hughes MC et al. Ann Intern Med 2013;158(11):781-90. PMID 23732711
C16-4
Comedogenic cosmetics cause 'acne cosmetica'; non-comedogenic reformulation cut incidence from ~25% to under 5%.
C16-5
Cocoa butter induces microcomedones (confocal-microscopy confirmed).
VerifiedOne source behind this claim
The record
Baek et al., J Cosmet Dermatol 2021, DOI 10.1111/jocd.14522
C18-7
Squalene is concentrated in shark liver; plant sources are low-yield; hydrogenated squalane is the stable skincare-ready form.
C19-1
Urushiol (poison ivy) causes contact dermatitis; a natural compound that is highly irritating.
C19-2
Aristolochic acid (found in several traditional-medicine plants) is nephrotoxic.
C19-3
Essential oils are among the most common contact sensitizers in cosmetic dermatology.
C19-4
Tea tree oil is genuinely antimicrobial in vitro, but efficacy is concentration-dependent and the same concentration that works often irritates; potency varies batch to batch as a botanical extract.
C26-1
The US regulates sunscreen as an OTC drug and the EU/Korea/Japan as cosmetics; the US permits ~16 filters vs the EU's ~34, with no new US filter from the late 1990s until 2026.
C26-4
PA++++ corresponds to PPD 16 or higher with no upper limit, so two PA++++ products can differ substantially in UVA protection.
C27-1
Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect.
C34-3
Soap produces the greatest barrier change and greatest pH rise among cleansers.
C34-6
A pH 4.0 emulsion increased stratum corneum ceramide levels despite containing none.
VerifiedOne source behind this claim
The record
Blaak 2016, DOI 10.1111/ics.12374 (no PMID in-doc)
CAMIST-4
Anua's Niacinamide Tranexamic Acid Brightening Booster Toner discloses tranexamic acid at 1,000ppm (0.1%), below every published topical tranexamic acid RCT concentration identified (2-10% range) and below the Ingredient Canon's 2-5% effective-concentration threshold. Niacinamide in the same product is disclosed at 5%, within Canon range.
CAMIST-8
No published topical tranexamic acid RCT tests a concentration below 2%; identified trials and reviews cluster at 2-10%, with most positive melasma outcomes reported at 3-5%. A 0.1% commercial toner concentration sits below the floor of tested literature -- this is untested territory, not a concentration shown ineffective.
CAUS-1
In Australia, sunscreens with SPF 15 or higher that make therapeutic claims are therapeutic goods regulated by the TGA under the joint Australian/New Zealand standard AS/NZS 2604:2021; cosmetic sunscreens with no SPF claim above 14 fall outside TGA jurisdiction.
CAUS-2
Under AS/NZS 2604:2021 Australian sunscreen water-resistance claims are 2-hour and 4-hour (not the US/EU 40- and 80-minute tiers); a 4-hour claim on an SPF 50+ product must pass the full 4-hour immersion protocol, so an Australian "4 hours water resistant" claim is a tested, regulated claim.
CAUS-3
Australia caps SPF claims at 50+ (higher numbers are deemed misleading), whereas SPF 100+ products are sold in the US.
CAUS-4
US FDA water-resistance testing (21 CFR 201.327; Federal Register 2011 Final Rule) measures SPF after immersion only and labels that post-immersion value; EU/UK ISO 16217 requires the product to retain at least 50% of its labeled SPF after immersion (before/after comparison). No regulatory SPF/PA test method requires Fitzpatrick IV-VI test subjects.
CBAKE-1
Alkaline soap applied to forearm skin at least four times a day for seven days was followed by a significant increase in transepidermal water loss after the first wash in all four cleanser groups in a nonblinded comparative in-use study (alkaline, creamy and glycerin soaps and a syndet, 15 healthy subjects per group); the study tests soap, not baking soda. Baking soda is alkaline, but a specific pH figure for baking soda applied to skin is not pinned (CBAKE-4).
CBAKE-3
Citric acid is a recognized alpha-hydroxy acid used in dermatology and cosmetics as a controlled-concentration chemical exfoliant/peeling agent; its effect on skin (beneficial vs. damaging) depends on concentration.
CBAN-2
SLS is used as the standard positive irritant control in patch-test research — what researchers apply when they want to irritate skin on purpose.
VerifiedOne source behind this claim
The record
Lee 2013, DOI 10.1111/srt.12111
CBHF-1
A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
CBITE-2
PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
CBLEACH-5
Niacinamide reduces melanosome transfer (Hakozaki 2002, PMID 12100180) and azelaic acid inhibits tyrosinase (Balina & Graupe 1991, PMID 1816137). Tranexamic acid lowers tyrosinase activity indirectly, through signalling upstream of the enzyme (see C2-7), and is not characterised as a direct tyrosinase-enzyme inhibitor. Hydroquinone is a different route: human tyrosinase itself oxidises it, which is the in vitro basis for the ochronosis concern (Ito et al. 2025, PMID 40662524).
CCAST-1
No controlled clinical trial was located in which castor oil regrew eyelashes, eyebrows or scalp hair, and eyelash-serum evidence reviews grade castor oil at the lowest evidence tier (Grade D, reflecting absence of adequate evidence, not disproof by trial). The only related trial found was in blepharitis (twice-daily castor oil reduced dry-eye symptom scores and eyelid margin thickening over four weeks) and did not measure lash growth. There is no evidence that castor oil increases anagen-phase hair count or follicle activity in humans; the perceived effect is most likely shine and reduced breakage.
CCAST-2
Castor oil is about 90% ricinoleic acid (a hydroxylated monounsaturated fatty acid), which gives it high viscosity and strong occlusive/emollient properties. Jamaican Black Castor Oil is the traditional roasted-then-pressed "black" form (roasting gives the colour, ash and a higher pH per the Lipid Library); ricinoleic content is quoted as about 85-90%.
CCAST-3
Ricinoleic acid shows topical anti-inflammatory/analgesic activity in animal inflammation models (PMID 11200362); the same study found the acute application phase could initially worsen inflammation before repeated dosing produced net benefit. Preclinical only, unrelated to hair growth; no human trial of castor oil for scalp conditions was located.
VerifiedOne source behind this claim
The record
Vieira C, Evangelista S, Cirillo R, Lippi A, Maggi CA, Manzini S. Mediators Inflamm 2000;9(5):223-8. PMID 11200362
CCAST-4
Castor oil is a recognised contact allergen and irritant: published case reports document allergic contact dermatitis and angioedema-like reactions, including cheilitis from lip balm and periocular reactions; it is not hypoallergenic. In melanin-rich skin a reaction in thin periorbital or lip skin carries a higher risk of resolving as PIH (general PIH mechanism; extrapolation, PMID 42234395).
VerifiedOne of 5 sources behind this claim · see the others
The record
Sánchez-Herrero A, Mateos-Mayo A, Rodríguez-Lomba E, Molina-López I, Campos-Domínguez M, Suárez Fernández R. Contact Dermatitis 2018 May;79(3):176-178. PMID 29749619
VerifiedOne of 5 sources behind this claim · see the others
The record
Samaran Q, Dereure O, Raison-Peyron N. Contact Dermatitis 2024 Mar;91(1):76-78. PMID 38553652
VerifiedOne of 5 sources behind this claim · see the others
The record
Sasseville D, Desjardins M, Almutawa F. Contact Dermatitis 2011 Mar;64(3):168-9. PMID 21272025
VerifiedOne of 5 sources behind this claim · see the others
The record
Sánchez-Guerrero IM, Huertas AJ, López MP, Carreño A, Ramírez M, Pajarón M. Contact Dermatitis 2010 May;62(5):318-9. PMID 20536483
VerifiedOne of 5 sources behind this claim · see the others
The record
Lopez-Estebaranz JL, Lopez-Pando M, Mitsunaga K. Am J Clin Dermatol 2026 Jun;27(4):697-707. PMID 42234395
CCAST-5
Castor oil has a recognised oral use as a stimulant laxative in limited, guided doses; oral use outside laxative dosing can cause cramping, diarrhoea and dehydration.
CCITRUS-1
Lemon essential oil's phototoxicity is driven primarily by two furocoumarins, bergapten and oxypeucedanin. Regional lemon-oil samples vary more than 20-fold in furocoumarin content (bergapten 4-87 ppm; oxypeucedanin 26-728 ppm), and oxypeucedanin -- despite being roughly one-quarter as potent per molecule as bergapten -- accounts for most of the oil's phototoxic activity because of its much higher concentration.
CCITRUS-3
Lime oil and bitter-orange oil, in addition to lemon oil, contain substantial oxypeucedanin and share lemon oil's furocoumarin-driven phototoxic/pigmentation risk profile.
CCITRUS-4
Coumarins, furocoumarins and polymethoxyflavones (oxygen heterocyclic compounds) are mainly present in the non-volatile fraction of cold-pressed citrus essential oils (PMIDs 35536412, 40435718), and furocoumarins show phototoxic activity (PMID 40435718). Cold-pressed bergamot oil contains 0.21% bergapten (PMID 28762330), whereas an oil made by vacuum distillation of bergamot peels was bergapten-free (PMID 17696485). In one pomelo study, 13 oxygen heterocyclic compounds were identified in the cold-pressed oil and eight were detected only at trace amounts in the distilled oil (PMID 33688168). This row makes no claim that steam-distilled oils of other citrus fruits contain less furocoumarin; the furocoumarin content of any specific product must be checked on its label or certificate of analysis.
CCITRUS-5
Furocoumarin (psoralen)-class compounds combined with UVA are an established, potent stimulator of melanogenesis, acting through upregulation of tyrosinase and downstream melanogenic-enzyme activity in melanocytes (established in the PUVA-therapy literature). This is the general mechanism class by which citrus-oil furocoumarins are understood to drive photopigmentation after topical exposure and subsequent UV, though these particular studies were not conducted with citrus essential oil itself.
CCITRUS-6
Phytophotodermatitis, including from furocoumarin-containing plant/fruit sources, can leave hyperpigmentation persisting for many weeks and has been clinically mistaken for child abuse when unrecognized. Perfumes and grocery/food products are specifically flagged in the clinical literature as causes to be aware of.
CCITRUS-7
Limonene and linalool -- common terpenes present in citrus essential oils regardless of extraction method -- autoxidize on exposure to air and light into hydroperoxides that are documented human contact-allergy sensitizers. This allergic-sensitization risk pathway is chemically distinct from, and additive to, furocoumarin-driven phototoxicity/pigmentation: an oxidized ('aged,' improperly stored) citrus essential oil carries rising irritancy/allergy risk independent of its furocoumarin content.
CCOCOA-1
Cocoa butter does not prevent or fade stretch marks: a randomized controlled trial of cocoa butter for striae found stretch marks in 45% of the cocoa butter group versus 49% of the comparison group (PMID 18715434), and reviews of topical stretch-mark prevention report no effect for cocoa butter (PMIDs 26486318, 25255817, 23313995).
VerifiedOne of 4 sources behind this claim · see the others
The record
Osman H, Usta IM, Rubeiz N, Abu-Rustum R, Charara I, Nassar AH. BJOG 2008 Aug;115(9):1138-42. PMID 18715434
VerifiedOne of 4 sources behind this claim · see the others
The record
Ud-Din S, McGeorge D, Bayat A. J Eur Acad Dermatol Venereol 2015 Oct;30(2):211-22. PMID 26486318
VerifiedOne of 4 sources behind this claim · see the others
The record
Korgavkar K, Wang F. Br J Dermatol 2015 Feb;172(3):606-15. PMID 25255817
VerifiedOne of 4 sources behind this claim · see the others
The record
Moore J, Kelsberg G, Safranek S. J Fam Pract 2012 Dec;61(12):757-8. PMID 23313995
CCOCOA-2
Cocoa butter is a fat pressed from cocoa beans, hard at room temperature, made mostly of stearic, oleic and palmitic fatty acids (saturated-heavy), which is why it is hard and strongly sealing; it has few unique bioactives, so its value is the seal (an occlusive and emollient, not a treatment).
CFILT-1
In FDA-conducted sunscreen absorption trials, oxybenzone showed the highest measured systemic absorption of the filters tested (200+ ng/mL) and avobenzone was absorbed at roughly 4-7 ng/mL; homosalate and octisalate were also absorbed. Both trials conclude the results do not indicate that individuals should refrain from sunscreen use.
VerifiedOne of 2 sources behind this claim · see the other
The record
Matta MK, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Florian J, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong LA, Ganley C, Michele T, Strauss DG. JAMA 2019 Jun;321(21):2082-2091. PMID 31058986
VerifiedOne of 2 sources behind this claim · see the other
The record
Matta MK, Florian J, Zusterzeel R, Pilli NR, Patel V, Volpe DA, Yang Y, Oh L, Bashaw E, Zineh I, Sanabria C, Kemp S, Godfrey A, Adah S, Coelho S, Wang J, Furlong LA, Ganley C, Michele T, Strauss DG. JAMA 2020 Jan;323(3):256-267. PMID 31961417
CFILT-2
No US-approved sunscreen filter currently on the shelf carries valid human-harm evidence at cosmetic exposure; for octinoxate and homosalate the harm signals are experimental (in vitro/animal), with no human harm outcome. FDA's 'insufficient data' classification means insufficient data, not unsafe.
VerifiedOne of 3 sources behind this claim · see the others
The record
Krause M, Klit A, Blomberg Jensen M, Søeborg T, Frederiksen H, Schlumpf M, Lichtensteiger W, Skakkebaek NE, Drzewiecki KT. Int J Androl 2012 Jun;35(3):424-36. PMID 22612478
VerifiedOne of 3 sources behind this claim · see the others
The record
Kwon B, Choi K. Integr Environ Assess Manag 2021 Jun;17(5):940-950. PMID 33991024
VerifiedOne of 3 sources behind this claim · see the others
The record
Mahajan VK, Sharma N, Sharma V, Verma R, Chandel M, Singh R. Indian Dermatol Online J 2024 Oct;15(6):920-929. PMID 39640469
CFILT-3
The FDA's 2011 sunscreen rule classifies only zinc oxide and titanium dioxide as Generally Recognized As Safe and Effective (GRASE); 12 chemical filters remain 'insufficient data' (still sold, safety unconfirmed); PABA and trolamine salicylate are not GRASE.
CFILT-4
Mexoryl XL (drometrizole trisiloxane) is permitted in the EU/UK and in Korea/Japan but is not FDA-approved; Tinosorb M, Uvinul A Plus, Uvinul T 150, iscotrizinol and (except one legacy La Roche-Posay formula) Mexoryl SX likewise are not FDA-approved.
CFILT-5
For the filters still pending in the US (2003-2010 NDAs), FDA requested blood-absorption, long-term-toxicity and endocrine data that the manufacturers have not satisfied; bemotrizinol cleared via the 2020 streamlined OTC process, the others have not.
CHFN-24
The physiological pH of the stratum corneum is 4.1-5.8 (PMID 29863755), and natural skin surface pH averages about 4.7 (PMID 18489300). The same multicentre-study paper reports that plain tap water at about pH 8 raises skin pH for up to 6 hours after application, that skin with pH below 5.0 is in better condition on barrier function, moisturization and scaling measures than skin above 5.0, and that an alkaline pH (8-9) promotes dispersal of resident bacterial flora from the skin whereas an acid pH (4-4.5) keeps it attached (PMID 18489300). This row makes no claim about the pH of baking soda or its effect on skin; see CBAKE-1.
CHFN-25
Tea tree oil (Melaleuca alternifolia) demonstrates real antibacterial activity against Staphylococcus aureus and related skin bacteria, incl. in a hand-hygiene RCT.
CHOCL-13
US wound-care HOCl products cleared for the US market typically contain 100-200 ppm available (titrable) chlorine as HOCl at pH roughly 3.5-5.5; a comparable EU Class III medical-device HOCl product for wound management contains no more than 200 ppm Cl.
CHOCL-16
FDA Food Contact Notification (FCN) 1811 clears electrolytically-generated hypochlorous acid as a food-contact antimicrobial agent at up to 60 ppm available free chlorine for whole/cut meat and poultry, processed/preformed meat and poultry, fish and seafood, fruits and vegetables, and shell eggs -- but this is NOT a blanket no-rinse clearance: the primary FCN text requires that, when used on ready-to-eat meats, fish/seafood, or produce intended to be consumed raw, treatment be followed by EITHER a 10-minute drain step OR a potable water rinse to remove residues. Separately, EPA (40 CFR 180.940(a), primary text) allows hypochlorous acid in antimicrobial formulations applied to food-contact surfaces in public eating places, dairy-processing equipment, and food-processing equipment/utensils at an end-use concentration not to exceed 200 ppm total available chlorine, applied 'with adequate draining before contact with food' -- the regulation's own language is 'adequate draining,' not an explicit 'no rinse required' phrase, though no mandatory rinse step is imposed at or under 200 ppm. These are two different primary rules for two different contact types (direct food vs. food-contact surface), and the direct-food rule is conditionally rinse/drain-required for RTE and raw-consumed items, not unconditionally rinse-free.
CJOJ-1
Jojoba oil (Simmondsia chinensis seed oil) has documented anti-inflammatory and wound-healing activity and functions as a wax-ester sebum-mimetic rather than a true triglyceride oil.
VerifiedOne of 2 sources behind this claim · see the other
The record
PMID 24442052
VerifiedOne of 2 sources behind this claim · see the other
The record
PMID 29280987
CKOJIC-1
Kojic acid is a PubMed-studied topical melasma treatment among 35 RCT agents reviewed in a 2019 systematic review, but sits in the "more research needed on optimal concentration/formulation" evidence tier rather than the "strong clinical recommendation" tier earned by cysteamine, triple combination therapy, and tranexamic acid.
CKOJIC-2
Plain topical kojic acid applied alone shows only modest melasma improvement in trials; laser-assisted delivery (Q-switched 1064nm Nd:YAG, fractional Er:YAG) produced significantly greater improvement than kojic acid applied alone in split-face RCTs.
CLIPID-6
Topical virgin coconut oil improved pediatric atopic dermatitis more than mineral oil (SCORAD -68% vs -38%).
VerifiedOne source behind this claim
The record
Evangelista MT, Abad-Casintahan F, Lopez-Villafuerte L. Int J Dermatol 2013 Dec;53(1):100-8. PMID 24320105
CLIPID-7
Topical coconut oil cleared Staphylococcus aureus colonization in atopic dermatitis, and a review supports topical coconut oil use in AD.
VerifiedOne of 2 sources behind this claim · see the other
The record
Verallo-Rowell VM, Dillague KM, Syah-Tjundawan BS. Dermatitis 2008;19(6):308-15. PMID 19134433
VerifiedOne of 2 sources behind this claim · see the other
The record
Wallace TC. J Am Coll Nutr 2018 Nov;38(2):97-107. PMID 30395784
CLIPID-8
Tamanu (Calophyllum inophyllum) oil has anti-inflammatory, antimicrobial and wound-healing activity in a review, anti-scarring activity via calophyllolide/TGF-beta, and wound-healing effects in rats; the evidence is preclinical.
VerifiedOne of 3 sources behind this claim · see the others
The record
Pribowo A, Girish J, Gustiananda M, Nandhira RG, Hartrianti P. Evid Based Complement Alternat Med 2021 Dec;2021:6332867. PMID 35069754
VerifiedOne of 3 sources behind this claim · see the others
The record
Krishnappa M, Abraham S, Furtado SC, Krishnamurthy S, Rifaya A, Asiri YI, Chidambaram K, Pavadai P. Pharmaceuticals (Basel) 2024 Jan;17(1). PMID 38256935
VerifiedOne of 3 sources behind this claim · see the others
The record
Erdogan SS, Gur TF, Terzi NK, Dogan B. J Wound Care 2021 Sep;30(Sup9a):Vi-Vx. PMID 34597168
CLIPID-9
Topical Nigella sativa (black seed) oil was comparable to betamethasone for hand eczema in a randomized controlled trial.
VerifiedOne source behind this claim
The record
Yousefi M, Barikbin B, Kamalinejad M, Abolhasani E, Ebadi A, Younespour S, Manouchehrian M, Hejazi S. J Eur Acad Dermatol Venereol 2012 Dec;27(12):1498-504. PMID 23198836
CLIPID-10
Rosehip seed oil is among plant oils reviewed for anti-inflammatory, barrier and wound-repair activity (as an adjunct).
VerifiedOne source behind this claim
The record
PMID 29280987
CLIPID-11
A review of wound-healing and dermal-active vegetable oils covers argan, avocado, grape-seed and sea-buckthorn oils (emollient, antioxidant and barrier activity).
VerifiedOne source behind this claim
The record
Poljšak N, Kreft S, Kočevar Glavač N. Phytother Res 2019 Oct;34(2):254-269. PMID 31657094
CLIPID-12
Vegetable oils higher in linoleic acid show positive barrier effects, while high-oleic, low-linoleic oils can damage an inflamed stratum corneum (review).
VerifiedOne source behind this claim
The record
Poljšak N, Kočevar Glavač N. Front Pharmacol 2022 Apr;13:868461. PMID 35548366
CLIPID-13
An avocado-oil emulsion improved wound healing in vitro.
VerifiedOne source behind this claim
The record
Trindade GAM, Alves LA, Lazo REL, Dallabrida KG, Reolon JB, Bonini JS, Nunes KC, Garcia FP, Nakamura CV, Rego FGM, Pontarolo R, Sari MHM, Ferreira LM. Pharmaceutics 2024 Nov;16(11). PMID 39598549
CLIPID-14
Camellia-seed oil reduced TEWL and improved skin water content in a mouse atopic-dermatitis emollient model with no irritation; human data are limited.
VerifiedOne source behind this claim
The record
Huang SG, Yang XX, Mo LQ, Zhou XY. Nan Fang Yi Ke Da Xue Xue Bao 2017 Jul;37(7):967-974. PMID 28736378
CLIPID-15
Evening primrose (and borage) oil, taken by mouth, is no better than placebo for atopic eczema and is not recommended (systematic reviews).
VerifiedOne of 2 sources behind this claim · see the other
The record
Madhok V, Futamura M, Thomas KS, Barbarot S. Clin Exp Dermatol 2015 Jan;40(4):349-54; quiz 354-5. PMID 25622761
VerifiedOne of 2 sources behind this claim · see the other
The record
Schlichte MJ, Vandersall A, Katta R. Dermatol Pract Concept 2016 Jul;6(3):23-9. PMID 27648380
CLIPID-16
Topical evening primrose oil showed positive hydration and barrier effects in healthy volunteers (review).
VerifiedOne source behind this claim
The record
Sharifi M, Nourani N, Sanaie S, Hamedeyazdan S. BMC Complement Med Ther 2024 Feb;24(1):89. PMID 38360611
CLIPID-17
In a randomized trial, olive oil applied twice daily for 4 weeks significantly reduced stratum corneum integrity and induced erythema (with or without atopic-dermatitis history), while sunflower oil preserved the barrier and improved hydration.
VerifiedOne source behind this claim
The record
Danby SG, AlEnezi T, Sultan A, Lavender T, Chittock J, Brown K, Cork MJ. Pediatr Dermatol 2012 Sep;30(1):42-50. PMID 22995032
CLIPID-18
An omega-6:omega-3 ratio of about 7:1 in olive oil disrupts the skin barrier.
VerifiedOne source behind this claim
The record
Verallo-Rowell VM, Katalbas SS, Pangasinan JP. Curr Allergy Asthma Rep 2016 Jul;16(7):51. PMID 27373890
CLIPID-19
On healthy skin, extra-virgin olive oil improved hydration and turnover.
VerifiedOne source behind this claim
The record
Rubio-Santoyo A, Sanabria-de la Torre R, Montero-Vílchez T, Girón-Prieto MS, Gómez-Farto A, Arias-Santiago S. J Clin Med 2025 Jul;14(13). PMID 40649050
CLIPID-20
Sea-buckthorn oil reduced radiation-induced skin injury (anti-inflammatory, M2 macrophage, VEGF repair) in a rat model.
VerifiedOne source behind this claim
The record
Wang Q, Cao B, Zhan J, Hu X, Yu Y, Li X, Liu Y. Radiat Res 2024 Nov;202(5):785-794. PMID 39343736
CLIPID-21
Sea-buckthorn oil acted as an antioxidant and SPF booster in a formulation study.
VerifiedOne source behind this claim
The record
Murugesan P, Thangarathinam K, Balasubramanian N. Appl Biochem Biotechnol 2026 Jan;198(2):1316-1336. PMID 41484732
CLIPID-22
A narrative review reports that sunflower-seed oil restores lipid-bilayer organization, modulates ceramide synthesis, activates PPAR-alpha, and has clinical TEWL-reduction, hydration and wound-healing effects in xerosis and atopic dermatitis.
VerifiedOne source behind this claim
The record
Lim HC, Lee SK, Keng JW, Lee EQ, Tan ESS, Liew KB, Mai CW, Lee SK, Chen L, Low ML, Chew YL. Drug Deliv Transl Res 2025 Aug;15(11):4260-4276. PMID 40783675
CMAD-1
Madecassoside (from Centella asiatica) has documented anti-inflammatory activity (NF-κB inhibition; reduced TNF-α, IL-6, IL-1β), antioxidant activity, and stimulates type I/III collagen synthesis via the TGF-β1 pathway; wound-healing benefit is well-established for oral/systemic use, but topical clinical evidence specifically is comparatively sparse versus the abundant in vivo/animal evidence.
CMELDISP-11
The belief that skin of color is inherently protected from all photodamage by its melanin is described in a 2026 literature review as a misconception that serves as a barrier to proper photoprotection, and the same review states that skin of color remains susceptible to UV-related pigmentation disorders, photodermatoses and skin cancer (PMID 42668981). This row makes no claim about specific social media platforms or posts: the earlier social-listening observation (Instagram and Reddit, Tavily search 2026-08-17) recorded no URLs and is withdrawn until URLs are recorded.
CNAT-ALOE-1
Clear inner-leaf aloe vera gel is a reasonably gentle topical soother with mixed clinical evidence: a Cochrane review of aloe for wounds found poor-quality evidence and no improvement in burn healing versus silver sulfadiazine (PMID 22336851); an RCT on skin-graft donor sites found faster epithelialisation (11.5 vs 13.67 days, PMID 29649056); topical aloe gives no sunburn or radiation-injury protection (PMID 19218914). Contact allergy to aloe is uncommon but documented.
VerifiedOne of 3 sources behind this claim · see the others
The record
Dat AD, Poon F, Pham KB, Doust J. Cochrane Database Syst Rev 2012 Feb;2012(2):CD008762. PMID 22336851
VerifiedOne of 3 sources behind this claim · see the others
The record
Burusapat C, Supawan M, Pruksapong C, Pitiseree A, Suwantemee C. Plast Reconstr Surg 2018 Jul;142(1):217-226. PMID 29649056
VerifiedOne of 3 sources behind this claim · see the others
The record
Feily A, Namazi MR. G Ital Dermatol Venereol 2009 Feb;144(1):85-91. PMID 19218914
CNAT-OAT-1
Colloidal oatmeal (finely milled, formulated) is an FDA-recognised OTC skin protectant: a randomised investigator-blinded trial of a 1% colloidal oat eczema cream reduced EASI and ADSI by 51% and 54% at 14 days with improved skin pH, barrier function and microbiome diversity versus a standard moisturiser; colloidal oat extracts upregulate epidermal-differentiation, tight-junction and lipid genes and improved dryness and barrier function in a 50-subject blinded study. Evidence is for colloidal products, not raw kitchen oats; it is a barrier/itch ingredient, not a pigment one; no skin-of-color-specific trial.
VerifiedOne of 2 sources behind this claim · see the other
The record
Capone K, Kirchner F, Klein SL, Tierney NK. J Drugs Dermatol 2020 May;19(5):524-531. PMID 32484623
VerifiedOne of 2 sources behind this claim · see the other
The record
Ilnytska O, Kaur S, Chon S, Reynertson KA, Nebus J, Garay M, Mahmood K, Southall MD. J Drugs Dermatol 2016 Jun;15(6):684-90. PMID 27272074
CNAT-WITCHHAZEL-1
Topical alcohol (ethanol, and isopropyl alcohol in some products) is a well-established skin irritant and barrier disruptor at repeated-use concentrations, causing dryness and increased transepidermal water loss. No skin-of-color-specific clinical study located.
CNAT-WITCHHAZEL-2
Many classic US drugstore witch hazel astringents are steam-distilled and contain meaningful alcohol (commonly about 14% ethanol, some isopropyl); alcohol-free witch hazel lines use water maceration instead. Witch hazel is an FDA-recognised OTC astringent skin-protectant active (OTC Monograph M016).
CNAT-WITCHHAZEL-4
Water-macerated alcohol-free witch hazel lines (Thayers is the Natural Ingredient Index example) are made specifically to avoid the alcohol in classic steam-distilled witch hazel astringents; a classic alcohol-based astringent and an alcohol-free toner are meaningfully different products despite both being labelled "witch hazel".
CPEEL-4
Serial in-office glycolic acid peels (68% max concentration, 6 sessions) added a modest additional lightening benefit over topical hydroquinone/tretinoin alone for PIH, with minimal adverse effects.
CPEEL-5
Sequential in-office high-concentration glycolic acid + TCA peels produced significant melasma improvement at 12 weeks in Fitzpatrick IV-VI skin, but with irritation in 77.5%, post-peel cracking in 62.5%, transient hyperpigmentation in 12.5%, and 70% melasma recurrence by 12 weeks post-treatment; no scarring.
CPEEL-7
30% mandelic acid and 30% lactic acid peels were both effective and safe for periorbital hyperpigmentation; lactic acid produced significantly greater pigment reduction and satisfaction; exfoliation more common with lactic, irritation more common with mandelic.
CPEEL-9
Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
CPEEL-10
In an investigator-masked, randomized, intra-individual study of 20 participants with Fitzpatrick skin types IV-V, pigmentation was induced by controlled UV and visible-light exposure with or without tape stripping (mild barrier disruption), and a daily broad-spectrum sunscreen containing sclareolide and niacinamide applied for 20 days significantly prevented pigmentation: in stripped, exposed zones protected skin changed by +5.96 delta-ITA versus -9.88 delta-ITA in unprotected skin (P < 0.001), and no adverse events were reported.
CPEEL-11
In an experimental model using TCA to create standardized PIH lesions, pigmentation severity increased dose-dependently as TCA concentration rose from 20% to 30%; 30% reliably matched natural acne-PIH without causing necrosis.
CPEEL-12
Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
CPEEL-13
Superficial salicylic acid peels (20-30%, five sessions at two-week intervals) after two weeks of 4% hydroquinone pre-treatment produced moderate-to-significant improvement in 88% of 25 patients with Fitzpatrick V-VI skin (acne, PIH, melasma, oily skin); minimal-to-mild side effects in 16%. Pilot, uncontrolled.
CPEEL-14
Systematic review of 48 studies (1,356 skin-of-colour PIH patients; 20% FST III, 40% IV, 34% V, 6% VI; 70% Black): topical retinoids most used (22%) with partial improvement in 85%; laser (17%) partial improvement 66% and the only intervention with complete resolution in a subgroup (26%) but with reported PIH exacerbation; chemical peels (9%) and hydroquinone (7%) among treatments with less effective outcomes; overall lack of robust efficacy across modalities.
CPFB-1
The core lesion of pseudofolliculitis barbae (PFB) is a foreign-body inflammatory reaction around an ingrown hair; the African hair follicle is curved, and shaving causes the hair to re-enter skin by extrafollicular (hair tip grows into skin beside its follicle) or transfollicular (cut tip retracts and pierces the follicle wall) penetration.
CPFB-2
Shaving against the grain is the largest quantified behavioural risk factor for PFB (OR 6.3, 95% CI 4.33-9.08); pre-shave product use (OR 0.4), clipper use (OR 0.5) and a movable/pivoting razor head (OR 0.2) were protective; single-blade and fixed-head razors were associated with higher PFB in the same cross-sectional study (655 Dakar police students, all of African descent, weekly shaving).
VerifiedOne source behind this claim
The record
Seck B, Diallo M, Ndiaye MT, Bouidida B, Diatta BA, Ndiaye M, Diop A, Diadie S, Seck NB, Ly F, Niang SO. Med Trop Sante Int 2024 Apr;4(2). PMID 39099716
CPFB-3
Where a close shave is required, adjustable clipper guards that leave at least about 1 mm of hair are associated with fewer PFB lesions (Ogunbiyi 2019 review; Seck 2024 clipper OR 0.5). No source located specifies 0.5 mm.
VerifiedOne of 2 sources behind this claim · see the other
The record
Seck B, Diallo M, Ndiaye MT, Bouidida B, Diatta BA, Ndiaye M, Diop A, Diadie S, Seck NB, Ly F, Niang SO. Med Trop Sante Int 2024 Apr;4(2). PMID 39099716
CPFB-4
A 2026 JAMA Dermatology three-round Delphi consensus of board-certified US dermatologists (40 statements) reached consensus that behavioural modification of hair-removal practice is first-line PFB therapy, alongside targeted topical/systemic treatment and laser hair removal, and reached NO agreement on multiblade razors, superficial chemical peels, oral isotretinoin or a grading scale.
VerifiedOne source behind this claim
The record
Alomary SA, Baker NJ, Ugwueke G, Alkiswani H, Adotama P, Awosika O, Burgess C, Callender V, Cho S, Downie J, Ibrahimi O, Ludzik J, Mayo T, Mitchell H, Ogunleye T, Ritchie S, Yu J, Lyford WH, Elbuluk N, Taylor SC. JAMA Dermatol 2026 Sep. PMID 42776558
CPFB-5
Dry shaving tends to leave sharp, beveled hair tips that favour extrafollicular penetration; pre-shave hydration (warm water or pre-shave regimen) swells the hair and gives a blunter cut tip. Dull blades and stretching the skin before shaving increase PFB risk. Aftershave/post-shave care is reported as useful but unquantified.
CPIHM-1
Post-inflammatory hyperpigmentation follows any inflammatory trigger, including physical or mechanical injury: tissue injury releases prostaglandins, leukotrienes and reactive oxygen species that activate melanocytes (Nordlund & Abdel-Malek 1988). In Fitzpatrick IV-VI skin melanocytes are more reactive, so the same inflammatory signal produces more pigment.
VerifiedOne source behind this claim
The record
Nordlund JJ, Abdel-Malek ZA. Prog Clin Biol Res 1988;256:219-36. PMID 2835778
CRICE-4
Kojic acid is a secondary metabolite primarily synthesized by Aspergillus oryzae (PMID 41084052) and is described as primarily a fermentation metabolite of A. oryzae (PMID 42727430); a fungal isolate from rice husk accumulated 8.63 to 12.87 g/L of kojic acid over 12 days of static fermentation (PMID 35928501; the species is not named in the retrieved abstract). No PubMed study was located that measures the kojic acid content of home-prepared rice water (PubMed 'kojic acid rice water', run 2026-09-30, 1 result, PMID 37799972, a black soldier fly larvae oil study that does not measure rice water), so a statement that home rice water contains kojic acid has no source located.
CSHEA-1
Shea butter is a barrier-supporting occlusive (mostly oleic ~40-55% and stearic ~35-45% fatty acids) with a triterpene-rich unsaponifiable fraction that has anti-inflammatory activity; it is a component of evidence-backed eczema barrier formulations, with traditional wound-healing use. Comedogenicity low.
VerifiedOne of 3 sources behind this claim · see the others
The record
Akihisa T, Kojima N, Kikuchi T, Yasukawa K, Tokuda H, T Masters E, Manosroi A, Manosroi J. J Oleo Sci 2010;59(6):273-80. PMID 20484832
VerifiedOne of 3 sources behind this claim · see the others
The record
Micali G, Paternò V, Cannarella R, Dinotta F, Lacarrubba F. G Ital Dermatol Venereol 2018 Jan;153(3):396-402. PMID 29368843
VerifiedOne of 3 sources behind this claim · see the others
The record
Anyanwu EG, Onuchukwu CL, Ojukwu CP, Anyanwu CN. J Ethnopharmacol 2026 Jan;361:121293. PMID 41619863
CSILK-1
No PubMed or Europe PMC study was located that tests silk or satin against cotton, or a bonnet against a pillowcase, for hair breakage in any population. The only quantitative hair-friction figure located (silk about 34 percent lower than cotton in an unnamed lab test) is an unpublished vendor blog post that measured friction, not breakage, and is not cited here.
CSILK-3
A 2026 narrative review states that silk scarves and pillowcases are recommended for textured (ethnic) hair, on clinician primers and expert opinion rather than trials.
CSOCS-1
ROOT & REIGN's /find-a-derm page is a static outbound referral to the Skin of Color Society's own directory of dermatologists (live, HTTP 200 on 2026-09-12); the Practitioner Directory is a separate door and does not list dermatologists.
CSQ-1
Traditional soap bars (saponified fatty-acid bases) are alkaline, roughly pH 9-10, well above the skin surface pH of about 4.5-5.5; textbook surfactant chemistry.
CSQ-2
Ceramide and lipid-lamellae stability, and the activity of the pH-dependent stratum corneum enzymes that hold the barrier together, are favoured at acidic pH; sustained alkaline exposure disturbs both; textbook barrier physiology.
CSUNL-1
In the UK/EU, sunscreens are regulated as cosmetics; SPF is tested to ISO 24444:2019, and a voluntary industry recommendation is that UVA protection be at least one-third of the labeled SPF (the UVA-in-a-circle mark).
CSUNL-2
The PA system is a voluntary JCIA (Japan Cosmetic Industry Association) UVA grade, de facto across Asia, based on Persistent Pigment Darkening: PA+ = PPD 2-4 (low), PA++ = PPD 4-8 (moderate), PA+++ = PPD 8-16 (high), PA++++ = PPD 16 or higher (very high, no upper limit); PA++++ was added in 2013.
CTA-1
Traction alopecia occurs more commonly in African American individuals than in other ethnicities (Raffi 2019, PMID 31909150). Tension from tight styling (braids, ponytails, extensions) damages the follicle; early-stage traction alopecia (follicular inflammation, no scarring) is reversible once the offending style stops, while late-stage disease with follicular scarring is permanent. "Lower baseline follicular density and repeated traction force over time can lead to irreversible follicular loss." The point at which reversible becomes permanent is not quantified in the literature and is judged clinically (whether follicular openings remain visible).
VerifiedOne of 2 sources behind this claim · see the other
The record
Raffi J, Suresh R, Agbai O. Int J Womens Dermatol 2019 Aug;5(5):314-319. PMID 31909150
VerifiedOne of 2 sources behind this claim · see the other
The record
Rucker Wright D, Gathers R, Kapke A, Johnson D, Joseph CL. J Am Acad Dermatol 2010 Aug;64(2):253-62. PMID 20728245
CTHIA-1
Most tyrosinase inhibitors were identified using mushroom tyrosinase; against recombinant human tyrosinase, hydroquinone and arbutin inhibit only weakly (IC50 millimolar range), kojic acid weakly (IC50 >500 umol/L); thiamidol (isobutylamido thiazolyl resorcinol) IC50 1.1 umol/L on human tyrosinase and 108 umol/L on mushroom. In melanocyte culture thiamidol inhibited melanin production reversibly (IC50 0.9 umol/L); hydroquinone irreversibly (IC50 16.3 umol/L).
CTHIA-7
Systematic review of topical PIH treatments (47 studies, 1,853 subjects, GRADE-assessed): thiamidol among the topical agents supported by high-quality studies, alongside retinoids, hydroxy acids, corticosteroids, niacinamide.
CTINO-1
Tinosorb M (INCI: Methylene Bis-Benzotriazolyl Tetramethylbutylphenol) is a broad-spectrum organic UV filter approved for use in the EU and parts of Asia (up to 10%) but is not on the US FDA sunscreen monograph, so US-formulated products cannot use it.
CTONER-1
Skin surface pH rises transiently after cleansing (with water alone or with a cleanser/soap); recovery to baseline physiological pH (roughly 4.0-5.0) can take up to several hours.
CTOOTH-2
Toothpaste is a well-documented cause of allergic and irritant contact dermatitis/cheilitis via its flavoring and active agents (stannous fluoride, carvone, d-limonene, anethole, triclosan, SLS), independent of any skin-lightening or acne-treatment use.
CTOOTH-6
Petrolatum is a well-tolerated occlusive emollient with an established safety profile, including in pediatric atopic dermatitis and neonatal skin care; it carries no comparable harm signal to toothpaste in this DIY combination and has no plausible brightening mechanism either.
CBAKE-6
Our reasoning, not a study result: repeated baking soda on skin could unsettle the barrier, raise oil production and set off small inflammatory responses that add to post-inflammatory hyperpigmentation on Fitzpatrick IV to VI skin, with a delay between cause and visible result.
SYNTHESIZED

Synthesized by us. No study is claimed for this.

CBHF-REASON1
Professional bald-head facial (a scalp treatment: cleanse and steam, professional microdermabrasion, manual extraction of embedded ingrown hairs, anti-inflammatory mask, red light) as the step past the ceiling of the home scalp routine for severe or persistent scalp razor bumps and the PIH they leave.
SYNTHESIZED
Synthesized from:
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
CBITE-9
Scratching an itchy bite (excoriation) is not directly tested in a bite-specific PIH trial, but is consistent with the general principle already verified in this canon — irritation/inflammation intensity is a documented PIH trigger in skin of color — applied here by extension rather than by dedicated bite research.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
  • C31-2 Eczema in skin of color may appear psoriasiform, lichenoid, scaly or papular with a violaceous color, with higher prevalence of PIH than White patients. PMID 37119261 DOI
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
CPWO-2
Our reasoning, not a study result: after a workout, rinse or cleanse, apply a light barrier-supportive product while skin is damp, and wait until skin has cooled before retinoids, exfoliating acids or strong niacinamide, because flushed skin may absorb and be irritated by them more.
SYNTHESIZED

Synthesized by us. No study is claimed for this.

CSCALP-1
Our reasoning, not a study result: a thick balm or butter could hold sweat and bacteria against a shaved scalp that sweats, sits under hats and meets clipper blades weekly, so a serum or light lotion is the safer post-shave layer.
SYNTHESIZED

Synthesized by us. No study is claimed for this.

CSILK-2
Our reasoning, not a study result: a bonnet is fixed to the head and moves with it, while a pillowcase stays on the pillow when a sleeper turns, so a bonnet is more likely to stay in place all night; we therefore keep the bonnet and treat a silk pillowcase as an add-on.
SYNTHESIZED
Synthesized from:
  • CSILK-1 No PubMed or Europe PMC study was located that tests silk or satin against cotton, or a bonnet against a pillowcase, for hair breakage in any population. The only quantitative hair-friction figure located (silk about 34 percent lower than cotton in an unnamed lab test) is an unpublished vendor blog post that measured friction, not breakage, and is not cited here.
CTOOTH-5
Toothpaste's documented irritant/allergenic action (CTOOTH-2) plausibly connects to the verified finding that barrier disruption followed by UV exposure worsens pigmentation in Fitzpatrick III-IV skin (CPEEL-9), suggesting toothpaste use on the face is more likely to cause or worsen dark spots than fade them, but no study has directly tested toothpaste-induced PIH, so this is inference bridging two separate findings, not a single-study result.
SYNTHESIZED
Synthesized from:
  • CTOOTH-2 Toothpaste is a well-documented cause of allergic and irritant contact dermatitis/cheilitis via its flavoring and active agents (stannous fluoride, carvone, d-limonene, anethole, triclosan, SLS), independent of any skin-lightening or acne-treatment use.
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
RAUS-1
A sunscreen film that wears off faster leaves more unprotected skin, so more UV (and visible light) reaches existing dark marks and can drive new pigment on Fitzpatrick IV-VI skin.
SYNTHESIZED
Synthesized from:
  • CPEEL-10 In an investigator-masked, randomized, intra-individual study of 20 participants with Fitzpatrick skin types IV-V, pigmentation was induced by controlled UV and visible-light exposure with or without tape stripping (mild barrier disruption), and a daily broad-spectrum sunscreen containing sclareolide and niacinamide applied for 20 days significantly prevented pigmentation: in stripped, exposed zones protected skin changed by +5.96 delta-ITA versus -9.88 delta-ITA in unprotected skin (P < 0.001), and no adverse events were reported.
  • CTOOTH-4 In Fitzpatrick IV-V skin, a daily broad-spectrum sunscreen containing sclareolide and niacinamide significantly prevented pigmentation induced by controlled UV and visible-light exposure with or without tape stripping (investigator-masked randomized intra-individual study, n=20). The trial tests a sunscreen, not toothpaste, and does not itself establish that irritation from any product worsens PIH.
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CAUS-2 Under AS/NZS 2604:2021 Australian sunscreen water-resistance claims are 2-hour and 4-hour (not the US/EU 40- and 80-minute tiers); a 4-hour claim on an SPF 50+ product must pass the full 4-hour immersion protocol, so an Australian "4 hours water resistant" claim is a tested, regulated claim.
RAUS-2
Apply the full correct amount; if a heavier-feeling sunscreen leads you to apply less, a lighter formulation applied correctly protects you better.
SYNTHESIZED
Synthesized from:
  • C26-3 Measured sunscreen products delivered on average ~42-59% of labeled SPF and ~24% of labeled UVA protection. PMC12332967 Open source
  • CSUN-1 In a predominantly skin-of-color patient survey, the most common reported barrier to daily sunscreen use was forgetting to apply it, followed by the perception that sunscreen is unnecessary when spending most of the day indoors; non-Hispanic Black patients were less likely than other groups to prioritize how the product feels/looks; Hispanic/Latino patients were less likely to prioritize broad-spectrum protection.
RAUS-3
If you are unlikely to reapply, a long-tested water-resistant (Australian 2h/4h-tier) sunscreen is the more realistic choice than a formula expected to wear off sooner; this is harm reduction, not a substitute for reapplication.
SYNTHESIZED
Synthesized from:
  • CAUS-2 Under AS/NZS 2604:2021 Australian sunscreen water-resistance claims are 2-hour and 4-hour (not the US/EU 40- and 80-minute tiers); a 4-hour claim on an SPF 50+ product must pass the full 4-hour immersion protocol, so an Australian "4 hours water resistant" claim is a tested, regulated claim.
  • CSUN-1 In a predominantly skin-of-color patient survey, the most common reported barrier to daily sunscreen use was forgetting to apply it, followed by the perception that sunscreen is unnecessary when spending most of the day indoors; non-Hispanic Black patients were less likely than other groups to prioritize how the product feels/looks; Hispanic/Latino patients were less likely to prioritize broad-spectrum protection.
  • C26-3 Measured sunscreen products delivered on average ~42-59% of labeled SPF and ~24% of labeled UVA protection. PMC12332967 Open source
  • C26-5 Waterproof,' 'sunblock,' and 'sweatproof' are prohibited on US sunscreen labels; only 'water resistant 40/80 minutes' is permitted. Open source
RBAKE-1
Baking soda (alkaline) applied to skin raises the surface pH and disrupts the acid mantle, which impairs pH-dependent barrier enzymes and weakens antimicrobial defence.
SYNTHESIZED
Synthesized from:
  • CHFN-24 The physiological pH of the stratum corneum is 4.1-5.8 (PMID 29863755), and natural skin surface pH averages about 4.7 (PMID 18489300). The same multicentre-study paper reports that plain tap water at about pH 8 raises skin pH for up to 6 hours after application, that skin with pH below 5.0 is in better condition on barrier function, moisturization and scaling measures than skin above 5.0, and that an alkaline pH (8-9) promotes dispersal of resident bacterial flora from the skin whereas an acid pH (4-4.5) keeps it attached (PMID 18489300). This row makes no claim about the pH of baking soda or its effect on skin; see CBAKE-1.
  • CBAKE-1 Alkaline soap applied to forearm skin at least four times a day for seven days was followed by a significant increase in transepidermal water loss after the first wash in all four cleanser groups in a nonblinded comparative in-use study (alkaline, creamy and glycerin soaps and a syndet, 15 healthy subjects per group); the study tests soap, not baking soda. Baking soda is alkaline, but a specific pH figure for baking soda applied to skin is not pinned (CBAKE-4).
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
  • C34-3 Soap produces the greatest barrier change and greatest pH rise among cleansers. PMID 12858234
  • C34-9 pH regulates the enzymes holding the stratum corneum together; infant mantle is mid-construction. DOI
  • C27-2 Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash. DOI
  • C5-2 Skin surface pH averages ~4.7-5.5; acidic pH keeps resident flora attached, alkaline disperses it; below-5 skin is in better barrier condition. PMID 18489300 DOI
RBAKE-2
By raising skin pH, repeated baking soda use may disperse resident skin flora and shift the surface toward conditions less favourable for the community that helps keep acne bacteria in check.
SYNTHESIZED
Synthesized from:
  • CHFN-24 The physiological pH of the stratum corneum is 4.1-5.8 (PMID 29863755), and natural skin surface pH averages about 4.7 (PMID 18489300). The same multicentre-study paper reports that plain tap water at about pH 8 raises skin pH for up to 6 hours after application, that skin with pH below 5.0 is in better condition on barrier function, moisturization and scaling measures than skin above 5.0, and that an alkaline pH (8-9) promotes dispersal of resident bacterial flora from the skin whereas an acid pH (4-4.5) keeps it attached (PMID 18489300). This row makes no claim about the pH of baking soda or its effect on skin; see CBAKE-1.
  • C5-2 Skin surface pH averages ~4.7-5.5; acidic pH keeps resident flora attached, alkaline disperses it; below-5 skin is in better barrier condition. PMID 18489300 DOI
  • CBAKE-1 Alkaline soap applied to forearm skin at least four times a day for seven days was followed by a significant increase in transepidermal water loss after the first wash in all four cleanser groups in a nonblinded comparative in-use study (alkaline, creamy and glycerin soaps and a syndet, 15 healthy subjects per group); the study tests soap, not baking soda. Baking soda is alkaline, but a specific pH figure for baking soda applied to skin is not pinned (CBAKE-4).
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
  • C34-3 Soap produces the greatest barrier change and greatest pH rise among cleansers. PMID 12858234
  • C34-9 pH regulates the enzymes holding the stratum corneum together; infant mantle is mid-construction. DOI
  • C27-2 Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash. DOI
RBAKE-3
Repeated baking soda use on Fitzpatrick IV-VI skin may repeatedly irritate the barrier and add to post-inflammatory hyperpigmentation and, over time, to breakouts, with a delay between cause and visible result.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • C18-2 PIH affects darker skin with greater frequency/severity; azelaic acid, niacinamide, ascorbic acid are recognized topical depigmenting agents in skin of color. PMID 20725554 PMC2921758
  • CHFN-24 The physiological pH of the stratum corneum is 4.1-5.8 (PMID 29863755), and natural skin surface pH averages about 4.7 (PMID 18489300). The same multicentre-study paper reports that plain tap water at about pH 8 raises skin pH for up to 6 hours after application, that skin with pH below 5.0 is in better condition on barrier function, moisturization and scaling measures than skin above 5.0, and that an alkaline pH (8-9) promotes dispersal of resident bacterial flora from the skin whereas an acid pH (4-4.5) keeps it attached (PMID 18489300). This row makes no claim about the pH of baking soda or its effect on skin; see CBAKE-1.
  • CBAKE-1 Alkaline soap applied to forearm skin at least four times a day for seven days was followed by a significant increase in transepidermal water loss after the first wash in all four cleanser groups in a nonblinded comparative in-use study (alkaline, creamy and glycerin soaps and a syndet, 15 healthy subjects per group); the study tests soap, not baking soda. Baking soda is alkaline, but a specific pH figure for baking soda applied to skin is not pinned (CBAKE-4).
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
  • C34-3 Soap produces the greatest barrier change and greatest pH rise among cleansers. PMID 12858234
  • C34-9 pH regulates the enzymes holding the stratum corneum together; infant mantle is mid-construction. DOI
  • C27-2 Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash. DOI
  • C5-2 Skin surface pH averages ~4.7-5.5; acidic pH keeps resident flora attached, alkaline disperses it; below-5 skin is in better barrier condition. PMID 18489300 DOI
RBAKE-4
Instead of baking soda: use chemical exfoliants (lactic, salicylic, azelaic acid) formulated at skin-appropriate pH, a gentle pH-appropriate cleanser, niacinamide and a fragrance-free routine.
SYNTHESIZED
Synthesized from:
  • CBAKE-3 Citric acid is a recognized alpha-hydroxy acid used in dermatology and cosmetics as a controlled-concentration chemical exfoliant/peeling agent; its effect on skin (beneficial vs. damaging) depends on concentration.
  • C35-10 Azelaic acid also keratolytic. PMID 17354468
  • C28-2 Evidence-based skin repair rests on gentle pH-balanced cleansing, ceramide- or urea-based moisturizers, and photoprotection. DOI
  • C34-4 A soap-free, mildly acidic washing emulsion produces barrier disruption comparable to washing with water (the ceiling). PMID 15691260
  • C11-7 Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase. PMID 12100180 DOI PMID 1816137 DOI
  • CPEEL-6 A single-session 30% salicylic acid peel performed equally to Jessner's solution for acne and post-acne hyperpigmentation; complications were burning/stinging/exfoliation; PIH occurred in 1 of 36 subjects.
RBARB-1
Navigating alcohol aftershave at the barbershop: say "I have sensitive skin" or "can you skip the aftershave", or bring your own post-shave product; read how the barber responds as information about the shop.
SYNTHESIZED
Synthesized from:
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • C27-3 Surfactants remove not just grease and dirt but also corneocytes, lipids, and proteins; repeated over-exposure causes irritant dermatitis. DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CNAT-WITCHHAZEL-1 Topical alcohol (ethanol, and isopropyl alcohol in some products) is a well-established skin irritant and barrier disruptor at repeated-use concentrations, causing dryness and increased transepidermal water loss. No skin-of-color-specific clinical study located.
  • CPFB-5 Dry shaving tends to leave sharp, beveled hair tips that favour extrafollicular penetration; pre-shave hydration (warm water or pre-shave regimen) swells the hair and gives a blunter cut tip. Dull blades and stretching the skin before shaving increase PFB risk. Aftershave/post-shave care is reported as useful but unquantified. PMID 31354326
RBARB-2
If something must be applied at the shop, an alcohol-free aloe gel (aloe first, no alcohol in the first three ingredients), a genuinely alcohol-free witch hazel, or a light fragrance-free alcohol-free moisturiser is better than an alcohol aftershave, and applying nothing is also acceptable.
SYNTHESIZED
Synthesized from:
  • CNAT-ALOE-1 Clear inner-leaf aloe vera gel is a reasonably gentle topical soother with mixed clinical evidence: a Cochrane review of aloe for wounds found poor-quality evidence and no improvement in burn healing versus silver sulfadiazine (PMID 22336851); an RCT on skin-graft donor sites found faster epithelialisation (11.5 vs 13.67 days, PMID 29649056); topical aloe gives no sunburn or radiation-injury protection (PMID 19218914). Contact allergy to aloe is uncommon but documented. PMID 22336851 PMID 29649056 PMID 19218914
  • CNAT-WITCHHAZEL-1 Topical alcohol (ethanol, and isopropyl alcohol in some products) is a well-established skin irritant and barrier disruptor at repeated-use concentrations, causing dryness and increased transepidermal water loss. No skin-of-color-specific clinical study located.
  • CNAT-WITCHHAZEL-2 Many classic US drugstore witch hazel astringents are steam-distilled and contain meaningful alcohol (commonly about 14% ethanol, some isopropyl); alcohol-free witch hazel lines use water maceration instead. Witch hazel is an FDA-recognised OTC astringent skin-protectant active (OTC Monograph M016).
  • CNAT-WITCHHAZEL-4 Water-macerated alcohol-free witch hazel lines (Thayers is the Natural Ingredient Index example) are made specifically to avoid the alcohol in classic steam-distilled witch hazel astringents; a classic alcohol-based astringent and an alcohol-free toner are meaningfully different products despite both being labelled "witch hazel".
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • C27-3 Surfactants remove not just grease and dirt but also corneocytes, lipids, and proteins; repeated over-exposure causes irritant dermatitis. DOI
  • C27-2 Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash. DOI
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
  • C10-1 HOCl is produced endogenously by neutrophils as part of the innate immune response.
  • C10-2 Bleach kills bacteria (textbook); bleach-bath clinical benefit in AD not established as superior to plain water; HOCl reduces bacterial load on its own merits. PMID 29150071 PMC5726436 DOI PMID 39355996 DOI
  • C10-4 HOCl is anti-inflammatory (scoping review). PMID 41428161 PMC13172020 DOI
  • C10-9 In a 10-day field exercise of 39 adult soldiers, repeated stabilised-HOCl hand antisepsis showed minimal within-treatment microbiome diversity divergence and a significant post-treatment increase in alpha diversity (faster recolonisation) compared with alcohol-based standard hand hygiene; environment explained more microbiome variation than antiseptic choice. PMID 42446227
  • C11-7 Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase. PMID 12100180 DOI PMID 1816137 DOI
  • C12-5 Niacinamide at 10-12% blocks melanosome transfer. PMID 12100180 DOI
  • CMAD-1 Madecassoside (from Centella asiatica) has documented anti-inflammatory activity (NF-κB inhibition; reduced TNF-α, IL-6, IL-1β), antioxidant activity, and stimulates type I/III collagen synthesis via the TGF-β1 pathway; wound-healing benefit is well-established for oral/systemic use, but topical clinical evidence specifically is comparatively sparse versus the abundant in vivo/animal evidence. PMC11510310 Open source PMC8627341 Open source
  • C29-3 Ceramide subclass composition is tightly linked to barrier function; a skewed or altered ceramide profile correlates with barrier dysfunction. DOI
  • C28-2 Evidence-based skin repair rests on gentle pH-balanced cleansing, ceramide- or urea-based moisturizers, and photoprotection. DOI
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
RBHF-1
Our own home scalp routine for shavers (behavioural shaving changes plus anti-inflammatory and pigment-targeting topicals) reduces the frequency and severity of razor bumps and the PIH they leave when followed consistently.
SYNTHESIZED
Synthesized from:
  • CPFB-4 A 2026 JAMA Dermatology three-round Delphi consensus of board-certified US dermatologists (40 statements) reached consensus that behavioural modification of hair-removal practice is first-line PFB therapy, alongside targeted topical/systemic treatment and laser hair removal, and reached NO agreement on multiblade razors, superficial chemical peels, oral isotretinoin or a grading scale. PMID 42776558
  • C7-2 With-the-grain shaving and single-blade/foil razors are the standard mechanism-based recommendation for PFB; direct comparative clinical evidence is limited and partly mixed — a consistent regimen with pre/post-shave care may matter as much as blade count. PMID 27212468 DOI
  • CPFB-5 Dry shaving tends to leave sharp, beveled hair tips that favour extrafollicular penetration; pre-shave hydration (warm water or pre-shave regimen) swells the hair and gives a blunter cut tip. Dull blades and stretching the skin before shaving increase PFB risk. Aftershave/post-shave care is reported as useful but unquantified. PMID 31354326
  • CPFB-1 The core lesion of pseudofolliculitis barbae (PFB) is a foreign-body inflammatory reaction around an ingrown hair; the African hair follicle is curved, and shaving causes the hair to re-enter skin by extrafollicular (hair tip grows into skin beside its follicle) or transfollicular (cut tip retracts and pierces the follicle wall) penetration. PMID 31354326 PMID 6354618 PMID 3048823
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C11-7 Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase. PMID 12100180 DOI PMID 1816137 DOI
  • C12-4 Azelaic acid inhibits tyrosinase and accelerates keratinocyte turnover. PMID 1816137 DOI
RBHF-2
Manually extracting an embedded ingrown hair frees the trapped hair, removes the foreign-body trigger and so prevents the papule (and the PIH that follows it) from forming.
SYNTHESIZED
Synthesized from:
  • CPFB-1 The core lesion of pseudofolliculitis barbae (PFB) is a foreign-body inflammatory reaction around an ingrown hair; the African hair follicle is curved, and shaving causes the hair to re-enter skin by extrafollicular (hair tip grows into skin beside its follicle) or transfollicular (cut tip retracts and pierces the follicle wall) penetration. PMID 31354326 PMID 6354618 PMID 3048823
  • CPFB-6 An entrapped PFB hair left to grow to about 10 mm is pulled back out of the inflammatory papule and the lesion regresses; discontinuing hair removal for about 30 days is the conventional first step. PMID 31354326
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
RBHF-3
Professional microdermabrasion with formulations designed for the scalp clears keratinised buildup around follicle openings with less irritation than a rough physical scrub done at home.
SYNTHESIZED
Synthesized from:
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPFB-4 A 2026 JAMA Dermatology three-round Delphi consensus of board-certified US dermatologists (40 statements) reached consensus that behavioural modification of hair-removal practice is first-line PFB therapy, alongside targeted topical/systemic treatment and laser hair removal, and reached NO agreement on multiblade razors, superficial chemical peels, oral isotretinoin or a grading scale. PMID 42776558
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
RBHF-4
Red light (photobiomodulation) after extraction supports calming inflammation and healing of scalp tissue, and an at-home red-light panel can extend that between professional visits.
SYNTHESIZED
Synthesized from:
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
  • CLED-7 No PubMed-indexed study was located that directly tests a named consumer home LED mask for prevention or clearance of post-inflammatory hyperpigmentation in Fitzpatrick IV-VI skin.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-3 In a single-center human study of melanocompetent Fitzpatrick III-VI subjects, visible LED exposure produced dose-responsive pigment darkening in 80% of subjects beginning at 60 J/cm2.
RBHF-5
How to choose an esthetician and a space for a scalp facial: look for lived or direct experience with shaving, ingrowns and PIH on melanated skin; talk to them first; read the retail shelf for multi-active, fragrance-free, clinical lines; ask what they use for extraction and whether protocols are adapted for melanated skin.
SYNTHESIZED
Synthesized from:
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPFB-1 The core lesion of pseudofolliculitis barbae (PFB) is a foreign-body inflammatory reaction around an ingrown hair; the African hair follicle is curved, and shaving causes the hair to re-enter skin by extrafollicular (hair tip grows into skin beside its follicle) or transfollicular (cut tip retracts and pierces the follicle wall) penetration. PMID 31354326 PMID 6354618 PMID 3048823
  • CFRAG-1 The EU Cosmetics Regulation (EC No 1223/2009, Annex III) requires named fragrance allergens — historically 26, including linalool, limonene, citronellol, geraniol and eugenol — to be individually declared on cosmetic ingredient labels when present above 0.001% in leave-on or 0.01% in rinse-off products; Commission Regulation (EU) 2023/1545 (26 Jul 2023) expands the declarable list to 80+ substances (compliance deadlines Jul 2026 / Jul 2028). A 'fragrance-free' claim does not preclude these compounds appearing on-label under their own names.
RBHF-6
Lines built around botanical extracts and volatile (essential) oils carry an irritation and sensitisation risk that matters more on freshly extracted, sensitised scalp skin, so a spa leaning on them is a reason to ask more questions (not a reason to refuse).
SYNTHESIZED
Synthesized from:
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • CCITRUS-7 Limonene and linalool -- common terpenes present in citrus essential oils regardless of extraction method -- autoxidize on exposure to air and light into hydroperoxides that are documented human contact-allergy sensitizers. This allergic-sensitization risk pathway is chemically distinct from, and additive to, furocoumarin-driven phototoxicity/pigmentation: an oxidized ('aged,' improperly stored) citrus essential oil carries rising irritancy/allergy risk independent of its furocoumarin content.
  • C19-4 Tea tree oil is genuinely antimicrobial in vitro, but efficacy is concentration-dependent and the same concentration that works often irritates; potency varies batch to batch as a botanical extract.
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
RBHF-7
Cadence for professional scalp treatment: monthly while razor bumps are severe or persistent; stretch to every six to eight weeks, or quarterly maintenance, once the home routine is managing daily shaving without significant new bumps.
SYNTHESIZED
Synthesized from:
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
  • CPFB-4 A 2026 JAMA Dermatology three-round Delphi consensus of board-certified US dermatologists (40 statements) reached consensus that behavioural modification of hair-removal practice is first-line PFB therapy, alongside targeted topical/systemic treatment and laser hair removal, and reached NO agreement on multiblade razors, superficial chemical peels, oral isotretinoin or a grading scale. PMID 42776558
  • C7-2 With-the-grain shaving and single-blade/foil razors are the standard mechanism-based recommendation for PFB; direct comparative clinical evidence is limited and partly mixed — a consistent regimen with pre/post-shave care may matter as much as blade count. PMID 27212468 DOI
  • CPFB-5 Dry shaving tends to leave sharp, beveled hair tips that favour extrafollicular penetration; pre-shave hydration (warm water or pre-shave regimen) swells the hair and gives a blunter cut tip. Dull blades and stretching the skin before shaving increase PFB risk. Aftershave/post-shave care is reported as useful but unquantified. PMID 31354326
  • CPFB-1 The core lesion of pseudofolliculitis barbae (PFB) is a foreign-body inflammatory reaction around an ingrown hair; the African hair follicle is curved, and shaving causes the hair to re-enter skin by extrafollicular (hair tip grows into skin beside its follicle) or transfollicular (cut tip retracts and pierces the follicle wall) penetration. PMID 31354326 PMID 6354618 PMID 3048823
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C11-7 Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase. PMID 12100180 DOI PMID 1816137 DOI
  • C12-4 Azelaic acid inhibits tyrosinase and accelerates keratinocyte turnover. PMID 1816137 DOI
RCALC-1
Shaving removes surface skin and temporarily leaves a barrier-compromised, more reactive surface, comparable to the tape-stripping model of barrier disruption.
SYNTHESIZED
Synthesized from:
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • C27-3 Surfactants remove not just grease and dirt but also corneocytes, lipids, and proteins; repeated over-exposure causes irritant dermatitis. DOI
RCALC-2
On freshly shaved Fitzpatrick IV-VI skin, an alcohol aftershave adds a second inflammatory insult to the shave itself, deepening and prolonging post-shave hyperpigmentation.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CNAT-WITCHHAZEL-1 Topical alcohol (ethanol, and isopropyl alcohol in some products) is a well-established skin irritant and barrier disruptor at repeated-use concentrations, causing dryness and increased transepidermal water loss. No skin-of-color-specific clinical study located.
RCALC-3
Stinging, burning or tightness after applying a product to freshly shaved skin is a sign of barrier irritation; stop and move to a gentle recovery routine.
SYNTHESIZED
Synthesized from:
  • CNAT-WITCHHAZEL-1 Topical alcohol (ethanol, and isopropyl alcohol in some products) is a well-established skin irritant and barrier disruptor at repeated-use concentrations, causing dryness and increased transepidermal water loss. No skin-of-color-specific clinical study located.
  • C27-2 Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash. DOI
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
RCALC-4
The tight, cooling feeling after an alcohol aftershave reflects dehydration and mild irritation, not a physical change in pore size; skin hydration and surface texture, not any astringent, determine how pores look.
SYNTHESIZED
Synthesized from:
  • CNAT-WITCHHAZEL-1 Topical alcohol (ethanol, and isopropyl alcohol in some products) is a well-established skin irritant and barrier disruptor at repeated-use concentrations, causing dryness and increased transepidermal water loss. No skin-of-color-specific clinical study located.
RCALC-5
Post-shave protocol in order: HOCl first on any cut or broken skin; then a fragrance-free, alcohol-free niacinamide product on damp skin; centella if irritated; then a ceramide moisturiser to seal.
SYNTHESIZED
Synthesized from:
  • C10-1 HOCl is produced endogenously by neutrophils as part of the innate immune response.
  • C10-2 Bleach kills bacteria (textbook); bleach-bath clinical benefit in AD not established as superior to plain water; HOCl reduces bacterial load on its own merits. PMID 29150071 PMC5726436 DOI PMID 39355996 DOI
  • C10-4 HOCl is anti-inflammatory (scoping review). PMID 41428161 PMC13172020 DOI
  • C10-9 In a 10-day field exercise of 39 adult soldiers, repeated stabilised-HOCl hand antisepsis showed minimal within-treatment microbiome diversity divergence and a significant post-treatment increase in alpha diversity (faster recolonisation) compared with alcohol-based standard hand hygiene; environment explained more microbiome variation than antiseptic choice. PMID 42446227
  • C11-7 Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase. PMID 12100180 DOI PMID 1816137 DOI
  • C12-5 Niacinamide at 10-12% blocks melanosome transfer. PMID 12100180 DOI
  • CMAD-1 Madecassoside (from Centella asiatica) has documented anti-inflammatory activity (NF-κB inhibition; reduced TNF-α, IL-6, IL-1β), antioxidant activity, and stimulates type I/III collagen synthesis via the TGF-β1 pathway; wound-healing benefit is well-established for oral/systemic use, but topical clinical evidence specifically is comparatively sparse versus the abundant in vivo/animal evidence. PMC11510310 Open source PMC8627341 Open source
  • C29-3 Ceramide subclass composition is tightly linked to barrier function; a skewed or altered ceramide profile correlates with barrier dysfunction. DOI
  • C28-2 Evidence-based skin repair rests on gentle pH-balanced cleansing, ceramide- or urea-based moisturizers, and photoprotection. DOI
  • CNAT-WITCHHAZEL-1 Topical alcohol (ethanol, and isopropyl alcohol in some products) is a well-established skin irritant and barrier disruptor at repeated-use concentrations, causing dryness and increased transepidermal water loss. No skin-of-color-specific clinical study located.
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
RCALC-6
Ethanol and other broad-spectrum antimicrobials do not discriminate between pathogenic and commensal skin bacteria; repeated application after every shave therefore disturbs the resident skin microbiome.
SYNTHESIZED
Synthesized from:
  • C10-9 In a 10-day field exercise of 39 adult soldiers, repeated stabilised-HOCl hand antisepsis showed minimal within-treatment microbiome diversity divergence and a significant post-treatment increase in alpha diversity (faster recolonisation) compared with alcohol-based standard hand hygiene; environment explained more microbiome variation than antiseptic choice. PMID 42446227
  • C5-2 Skin surface pH averages ~4.7-5.5; acidic pH keeps resident flora attached, alkaline disperses it; below-5 skin is in better barrier condition. PMID 18489300 DOI
  • C13-1 Antiperspirant/deodorant products can compromise the axillary microbiome balance. PMID 34448215 DOI
RCAST-1
Castor oil is a thick occlusive that coats hair strands and reduces moisture loss from the shaft, so it may reduce breakage; reduced breakage means hair keeps length it would otherwise lose, which can look like growth but is retention.
SYNTHESIZED
Synthesized from:
  • CCAST-1 No controlled clinical trial was located in which castor oil regrew eyelashes, eyebrows or scalp hair, and eyelash-serum evidence reviews grade castor oil at the lowest evidence tier (Grade D, reflecting absence of adequate evidence, not disproof by trial). The only related trial found was in blepharitis (twice-daily castor oil reduced dry-eye symptom scores and eyelid margin thickening over four weeks) and did not measure lash growth. There is no evidence that castor oil increases anagen-phase hair count or follicle activity in humans; the perceived effect is most likely shine and reduced breakage.
  • CCAST-2 Castor oil is about 90% ricinoleic acid (a hydroxylated monounsaturated fatty acid), which gives it high viscosity and strong occlusive/emollient properties. Jamaican Black Castor Oil is the traditional roasted-then-pressed "black" form (roasting gives the colour, ash and a higher pH per the Lipid Library); ricinoleic content is quoted as about 85-90%.
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • C17-4 Coily/African-type hair shows lower water sorption and distinct cuticle lipid structure vs straighter hair; fragility best attributed to knotting/crack formation rather than cross-sectional shape alone. PMID 36374002 DOI PMID 32162430 DOI PMID 30866162 DOI
  • C17-5 Coconut oil (unlike mineral or sunflower oil) penetrates the hair shaft, measurably reduces protein loss from grooming, correlates with lower Hair Breakage Index. PMID 12715094 PMID 21635848
RCAST-2
A thick castor-oil layer on a dry or irritated scalp can act as an occlusive conditioning agent, reducing moisture loss and possibly adding some comfort from ricinoleic acid's anti-inflammatory activity.
SYNTHESIZED
Synthesized from:
  • CCAST-3 Ricinoleic acid shows topical anti-inflammatory/analgesic activity in animal inflammation models (PMID 11200362); the same study found the acute application phase could initially worsen inflammation before repeated dosing produced net benefit. Preclinical only, unrelated to hair growth; no human trial of castor oil for scalp conditions was located. PMID 11200362
RCAST-3
How to use castor oil: small amounts on hair ends or as a seal over a water-based leave-in, a very small amount on existing lash or brow hairs with a clean applicator, small amounts on specific dry scalp patches followed by thorough cleansing, a thick body moisturiser for heels and elbows, blended with lighter oils; not a daily all-over scalp treatment; stop if irritation occurs.
SYNTHESIZED
Synthesized from:
  • CCAST-2 Castor oil is about 90% ricinoleic acid (a hydroxylated monounsaturated fatty acid), which gives it high viscosity and strong occlusive/emollient properties. Jamaican Black Castor Oil is the traditional roasted-then-pressed "black" form (roasting gives the colour, ash and a higher pH per the Lipid Library); ricinoleic content is quoted as about 85-90%.
  • CCAST-4 Castor oil is a recognised contact allergen and irritant: published case reports document allergic contact dermatitis and angioedema-like reactions, including cheilitis from lip balm and periocular reactions; it is not hypoallergenic. In melanin-rich skin a reaction in thin periorbital or lip skin carries a higher risk of resolving as PIH (general PIH mechanism; extrapolation, PMID 42234395). PMID 29749619 PMID 38553652 PMID 21272025 PMID 20536483 PMID 42234395
  • CCAST-1 No controlled clinical trial was located in which castor oil regrew eyelashes, eyebrows or scalp hair, and eyelash-serum evidence reviews grade castor oil at the lowest evidence tier (Grade D, reflecting absence of adequate evidence, not disproof by trial). The only related trial found was in blepharitis (twice-daily castor oil reduced dry-eye symptom scores and eyelid margin thickening over four weeks) and did not measure lash growth. There is no evidence that castor oil increases anagen-phase hair count or follicle activity in humans; the perceived effect is most likely shine and reduced breakage.
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • C17-4 Coily/African-type hair shows lower water sorption and distinct cuticle lipid structure vs straighter hair; fragility best attributed to knotting/crack formation rather than cross-sectional shape alone. PMID 36374002 DOI PMID 32162430 DOI PMID 30866162 DOI
  • C17-5 Coconut oil (unlike mineral or sunflower oil) penetrates the hair shaft, measurably reduces protein loss from grooming, correlates with lower Hair Breakage Index. PMID 12715094 PMID 21635848
  • CCAST-3 Ricinoleic acid shows topical anti-inflammatory/analgesic activity in animal inflammation models (PMID 11200362); the same study found the acute application phase could initially worsen inflammation before repeated dosing produced net benefit. Preclinical only, unrelated to hair growth; no human trial of castor oil for scalp conditions was located. PMID 11200362
RCAST-4
Heavy castor oil left on the scalp or face can build up and contribute to follicular occlusion, so thorough cleansing matters and facial use is usually not advised.
SYNTHESIZED
Synthesized from:
  • C16-4 Comedogenic cosmetics cause 'acne cosmetica'; non-comedogenic reformulation cut incidence from ~25% to under 5%. PMID 138532
  • CCAST-2 Castor oil is about 90% ricinoleic acid (a hydroxylated monounsaturated fatty acid), which gives it high viscosity and strong occlusive/emollient properties. Jamaican Black Castor Oil is the traditional roasted-then-pressed "black" form (roasting gives the colour, ash and a higher pH per the Lipid Library); ricinoleic content is quoted as about 85-90%.
RCAST-6
If edges are thinning, see a dermatologist who works with textured hair early, while follicle damage can still be reversible, rather than increasing castor oil, because a topical oil does not treat traction alopecia or hormonal thinning.
SYNTHESIZED
Synthesized from:
  • CTA-1 Traction alopecia occurs more commonly in African American individuals than in other ethnicities (Raffi 2019, PMID 31909150). Tension from tight styling (braids, ponytails, extensions) damages the follicle; early-stage traction alopecia (follicular inflammation, no scarring) is reversible once the offending style stops, while late-stage disease with follicular scarring is permanent. "Lower baseline follicular density and repeated traction force over time can lead to irreversible follicular loss." The point at which reversible becomes permanent is not quantified in the literature and is judged clinically (whether follicular openings remain visible). PMID 31909150 PMID 20728245
  • CCAST-1 No controlled clinical trial was located in which castor oil regrew eyelashes, eyebrows or scalp hair, and eyelash-serum evidence reviews grade castor oil at the lowest evidence tier (Grade D, reflecting absence of adequate evidence, not disproof by trial). The only related trial found was in blepharitis (twice-daily castor oil reduced dry-eye symptom scores and eyelid margin thickening over four weeks) and did not measure lash growth. There is no evidence that castor oil increases anagen-phase hair count or follicle activity in humans; the perceived effect is most likely shine and reduced breakage.
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
RCOCOA-1
Cocoa butter is a rich occlusive and emollient that softens and seals dry skin, reduces water loss and supports barrier comfort, including on body skin during and after pregnancy.
SYNTHESIZED
Synthesized from:
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • CCOCOA-2 Cocoa butter is a fat pressed from cocoa beans, hard at room temperature, made mostly of stearic, oleic and palmitic fatty acids (saturated-heavy), which is why it is hard and strongly sealing; it has few unique bioactives, so its value is the seal (an occlusive and emollient, not a treatment).
  • CSHEA-1 Shea butter is a barrier-supporting occlusive (mostly oleic ~40-55% and stearic ~35-45% fatty acids) with a triterpene-rich unsaponifiable fraction that has anti-inflammatory activity; it is a component of evidence-backed eczema barrier formulations, with traditional wound-healing use. Comedogenicity low. PMID 20484832 PMID 29368843 PMID 41619863
RCOCOA-2
Topical products cannot prevent stretch marks because the tear occurs in the dermis, below where a surface product can structurally reinforce collagen and elastin.
SYNTHESIZED
Synthesized from:
RCOCOA-3
Use cocoa butter as the last (seal) step over water-based products and actives, on dry body skin (elbows, knees, heels, abdomen), with accurate expectations (moisturising, not preventing stretch marks); keep it off an acne-prone face; for body folds use it after actives, not instead of them.
SYNTHESIZED
Synthesized from:
  • CCOCOA-1 Cocoa butter does not prevent or fade stretch marks: a randomized controlled trial of cocoa butter for striae found stretch marks in 45% of the cocoa butter group versus 49% of the comparison group (PMID 18715434), and reviews of topical stretch-mark prevention report no effect for cocoa butter (PMIDs 26486318, 25255817, 23313995). PMID 18715434 PMID 26486318 PMID 25255817 PMID 23313995
  • CCOCOA-2 Cocoa butter is a fat pressed from cocoa beans, hard at room temperature, made mostly of stearic, oleic and palmitic fatty acids (saturated-heavy), which is why it is hard and strongly sealing; it has few unique bioactives, so its value is the seal (an occlusive and emollient, not a treatment).
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • C11-2 Occlusion and hydration increase how deeply/quickly topical actives penetrate skin. PMID 41610072 DOI DOI
  • C16-5 Cocoa butter induces microcomedones (confocal-microscopy confirmed). DOI
  • C23-1 Intertrigo is a superficial inflammatory condition of skin folds triggered by friction/moisture/heat/poor ventilation; can become secondarily infected (often Candida). PMID 30285384 PMID 21396557 DOI
RCOCOA-4
Cocoa butter versus shea butter: cocoa has more palmitic acid and a firmer texture, so it is a more robust occlusive but more comedogenic for acne-prone skin; shea is more emollient and carries less comedogenic risk, so it is the safer facial choice.
SYNTHESIZED
Synthesized from:
  • C16-5 Cocoa butter induces microcomedones (confocal-microscopy confirmed). DOI
  • CCOCOA-2 Cocoa butter is a fat pressed from cocoa beans, hard at room temperature, made mostly of stearic, oleic and palmitic fatty acids (saturated-heavy), which is why it is hard and strongly sealing; it has few unique bioactives, so its value is the seal (an occlusive and emollient, not a treatment).
  • CSHEA-1 Shea butter is a barrier-supporting occlusive (mostly oleic ~40-55% and stearic ~35-45% fatty acids) with a triterpene-rich unsaponifiable fraction that has anti-inflammatory activity; it is a component of evidence-backed eczema barrier formulations, with traditional wound-healing use. Comedogenicity low. PMID 20484832 PMID 29368843 PMID 41619863
RFOAM-1
Post-wash tightness or "squeak" is a marker of cleanser-induced barrier disruption (raised TEWL, dehydration of the surface), not of cleanliness; skin that feels soft, comfortable and neutral after washing indicates a gentler cleanse.
SYNTHESIZED
Synthesized from:
  • C27-1 Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect. DOI
  • C27-3 Surfactants remove not just grease and dirt but also corneocytes, lipids, and proteins; repeated over-exposure causes irritant dermatitis. DOI
  • C34-3 Soap produces the greatest barrier change and greatest pH rise among cleansers. PMID 12858234
  • CBAKE-1 Alkaline soap applied to forearm skin at least four times a day for seven days was followed by a significant increase in transepidermal water loss after the first wash in all four cleanser groups in a nonblinded comparative in-use study (alkaline, creamy and glycerin soaps and a syndet, 15 healthy subjects per group); the study tests soap, not baking soda. Baking soda is alkaline, but a specific pH figure for baking soda applied to skin is not pinned (CBAKE-4).
  • C13-4 Skin pH rises after a single wash and takes hours to recover; soap causes the greatest pH rise of any cleanser type tested.
  • CSQ-2 Ceramide and lipid-lamellae stability, and the activity of the pH-dependent stratum corneum enzymes that hold the barrier together, are favoured at acidic pH; sustained alkaline exposure disturbs both; textbook barrier physiology.
RFOAM-2
Foam is a property of the surfactant and not a measure of cleaning; low-foam, mild surfactant systems (glucosides, isethionates, sulfosuccinates, amphoterics) are gentler on the barrier than SLS and soap while still cleansing, so they are preferred.
SYNTHESIZED
Synthesized from:
  • C34-2 Syndets are milder than soap via reduced protein denaturation. PMID 29231284
  • C34-4 A soap-free, mildly acidic washing emulsion produces barrier disruption comparable to washing with water (the ceiling). PMID 15691260
  • C27-3 Surfactants remove not just grease and dirt but also corneocytes, lipids, and proteins; repeated over-exposure causes irritant dermatitis. DOI
  • CBAN-2 SLS is used as the standard positive irritant control in patch-test research — what researchers apply when they want to irritate skin on purpose. DOI
  • CBAN-5 SLES ruling: ethoxylation yields a larger molecule that penetrates the barrier far less than SLS; SLS is the standard irritant control, SLES is not; SLES is the workhorse of most gentle market cleansers — allowed, penalized, never preferred, never in a baby product.
RFOAM-3
A cleanser that raises skin pH and TEWL leaves a window, lasting up to several hours for pH recovery, in which the barrier is less intact; products applied in that window (actives, fragrance, occlusives) meet more permeable skin and are more likely to irritate.
SYNTHESIZED
Synthesized from:
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
  • C27-2 Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash. DOI
  • CTONER-1 Skin surface pH rises transiently after cleansing (with water alone or with a cleanser/soap); recovery to baseline physiological pH (roughly 4.0-5.0) can take up to several hours.
  • C27-1 Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect. DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
RFOAM-4
For Fitzpatrick IV-VI skin the consequence of repeated barrier disruption is larger because irritation drives post-inflammatory hyperpigmentation; general barrier and irritation findings are applied to this population.
SYNTHESIZED
Synthesized from:
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-10 In an investigator-masked, randomized, intra-individual study of 20 participants with Fitzpatrick skin types IV-V, pigmentation was induced by controlled UV and visible-light exposure with or without tape stripping (mild barrier disruption), and a daily broad-spectrum sunscreen containing sclareolide and niacinamide applied for 20 days significantly prevented pigmentation: in stripped, exposed zones protected skin changed by +5.96 delta-ITA versus -9.88 delta-ITA in unprotected skin (P < 0.001), and no adverse events were reported.
  • C31-9 Black skin shows increased transepidermal water loss, decreased ceramide levels, and lower stratum corneum pH; management emphasizes low-pH products and emollients. PMID 32747312 DOI
  • C29-1 African American skin was characterized by low ceramide levels in the uppermost layers of the stratum corneum, interpretable alongside the high prevalence of xerosis in Black skin. DOI
RFOAM-5
Changing from a stripping cleanser to a gentle, pH-appropriate one reduces a source of repeated low-grade irritation and is a worthwhile first step when a PIH routine is not working; the cleanser is part of the cause, not only a bystander.
SYNTHESIZED
Synthesized from:
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
  • C27-2 Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash. DOI
  • CTONER-1 Skin surface pH rises transiently after cleansing (with water alone or with a cleanser/soap); recovery to baseline physiological pH (roughly 4.0-5.0) can take up to several hours.
  • C27-1 Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect. DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • CPEEL-10 In an investigator-masked, randomized, intra-individual study of 20 participants with Fitzpatrick skin types IV-V, pigmentation was induced by controlled UV and visible-light exposure with or without tape stripping (mild barrier disruption), and a daily broad-spectrum sunscreen containing sclareolide and niacinamide applied for 20 days significantly prevented pigmentation: in stripped, exposed zones protected skin changed by +5.96 delta-ITA versus -9.88 delta-ITA in unprotected skin (P < 0.001), and no adverse events were reported.
  • C31-9 Black skin shows increased transepidermal water loss, decreased ceramide levels, and lower stratum corneum pH; management emphasizes low-pH products and emollients. PMID 32747312 DOI
  • C29-1 African American skin was characterized by low ceramide levels in the uppermost layers of the stratum corneum, interpretable alongside the high prevalence of xerosis in Black skin. DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
  • C28-2 Evidence-based skin repair rests on gentle pH-balanced cleansing, ceramide- or urea-based moisturizers, and photoprotection. DOI
RFOAM-6
Switching from a stripping cleanser to a gentle one involves a transition: the first washes feel less "clean", barrier comfort returns over days to a few weeks, and some people see a temporary oiliness or congestion; allow about two weeks before judging the product.
SYNTHESIZED
Synthesized from:
  • C27-1 Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect. DOI
  • C27-3 Surfactants remove not just grease and dirt but also corneocytes, lipids, and proteins; repeated over-exposure causes irritant dermatitis. DOI
  • C34-3 Soap produces the greatest barrier change and greatest pH rise among cleansers. PMID 12858234
  • CBAKE-1 Alkaline soap applied to forearm skin at least four times a day for seven days was followed by a significant increase in transepidermal water loss after the first wash in all four cleanser groups in a nonblinded comparative in-use study (alkaline, creamy and glycerin soaps and a syndet, 15 healthy subjects per group); the study tests soap, not baking soda. Baking soda is alkaline, but a specific pH figure for baking soda applied to skin is not pinned (CBAKE-4).
  • C13-4 Skin pH rises after a single wash and takes hours to recover; soap causes the greatest pH rise of any cleanser type tested.
  • CSQ-2 Ceramide and lipid-lamellae stability, and the activity of the pH-dependent stratum corneum enzymes that hold the barrier together, are favoured at acidic pH; sustained alkaline exposure disturbs both; textbook barrier physiology.
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
  • C34-4 A soap-free, mildly acidic washing emulsion produces barrier disruption comparable to washing with water (the ceiling). PMID 15691260
RFOAM-7
Prefer a cleanser close to skin pH (about 4.5-5.5): traditional alkaline soap raises skin pH and barrier disruption more than syndets; liquid and syndet-bar formulations can be pH-controlled, so check the product.
SYNTHESIZED
Synthesized from:
  • C14-4 Skin's optimal surface pH sits around 4.5-5.5; a single alkaline exposure measurably raises pH and recovery takes hours.
  • C5-2 Skin surface pH averages ~4.7-5.5; acidic pH keeps resident flora attached, alkaline disperses it; below-5 skin is in better barrier condition. PMID 18489300 DOI
  • C34-2 Syndets are milder than soap via reduced protein denaturation. PMID 29231284
  • C34-3 Soap produces the greatest barrier change and greatest pH rise among cleansers. PMID 12858234
  • C34-4 A soap-free, mildly acidic washing emulsion produces barrier disruption comparable to washing with water (the ceiling). PMID 15691260
  • C34-6 A pH 4.0 emulsion increased stratum corneum ceramide levels despite containing none. DOI
  • C27-1 Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect. DOI
  • CSQ-1 Traditional soap bars (saponified fatty-acid bases) are alkaline, roughly pH 9-10, well above the skin surface pH of about 4.5-5.5; textbook surfactant chemistry.
  • CSQ-2 Ceramide and lipid-lamellae stability, and the activity of the pH-dependent stratum corneum enzymes that hold the barrier together, are favoured at acidic pH; sustained alkaline exposure disturbs both; textbook barrier physiology.
  • CBAN-4 True soap/high-pH cleansers vetoed for babies — infant acid mantle still forming, pH regulates the enzymes holding the stratum corneum together. DOI
RFOAM-8
Choose a fragrance-free cleanser because fragrance components are common contact sensitisers and irritants, and a PIH-prone person gains nothing from adding that risk to a freshly cleansed surface.
SYNTHESIZED
Synthesized from:
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • CFRAG-1 The EU Cosmetics Regulation (EC No 1223/2009, Annex III) requires named fragrance allergens — historically 26, including linalool, limonene, citronellol, geraniol and eugenol — to be individually declared on cosmetic ingredient labels when present above 0.001% in leave-on or 0.01% in rinse-off products; Commission Regulation (EU) 2023/1545 (26 Jul 2023) expands the declarable list to 80+ substances (compliance deadlines Jul 2026 / Jul 2028). A 'fragrance-free' claim does not preclude these compounds appearing on-label under their own names.
  • C34-1 Skin surface pH rises after a single wash, even water alone; recovery takes up to several hours. PMID 30130782
  • C27-2 Skin's acidic pH supports barrier repair and antimicrobial defense; pH stays raised for hours after even a single wash. DOI
  • CTONER-1 Skin surface pH rises transiently after cleansing (with water alone or with a cleanser/soap); recovery to baseline physiological pH (roughly 4.0-5.0) can take up to several hours.
  • C27-1 Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect. DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
RFRAG-1
Read the ingredient list on the back rather than the front-of-pack claim: look for named essential oils (tea tree, lavender, citrus and others), fragrant plant extracts and the EU-declarable allergens (linalool, limonene, citronellol, geraniol, eugenol); these can appear under their own names in a product labelled fragrance-free.
SYNTHESIZED
Synthesized from:
  • CFRAG-1 The EU Cosmetics Regulation (EC No 1223/2009, Annex III) requires named fragrance allergens — historically 26, including linalool, limonene, citronellol, geraniol and eugenol — to be individually declared on cosmetic ingredient labels when present above 0.001% in leave-on or 0.01% in rinse-off products; Commission Regulation (EU) 2023/1545 (26 Jul 2023) expands the declarable list to 80+ substances (compliance deadlines Jul 2026 / Jul 2028). A 'fragrance-free' claim does not preclude these compounds appearing on-label under their own names.
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • C14-3 Essential oils (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • CCITRUS-7 Limonene and linalool -- common terpenes present in citrus essential oils regardless of extraction method -- autoxidize on exposure to air and light into hydroperoxides that are documented human contact-allergy sensitizers. This allergic-sensitization risk pathway is chemically distinct from, and additive to, furocoumarin-driven phototoxicity/pigmentation: an oxidized ('aged,' improperly stored) citrus essential oil carries rising irritancy/allergy risk independent of its furocoumarin content.
RFRAG-2
Judge a brand's "fragrance-free" claim by whether it publishes a full ingredient list with a reason for each ingredient, defines what fragrance-free means for its own products, and whether its list contains essential oils, citrus extracts or named sensitisers; a claim sitting beside such ingredients is a marketing claim.
SYNTHESIZED
Synthesized from:
  • CFRAG-1 The EU Cosmetics Regulation (EC No 1223/2009, Annex III) requires named fragrance allergens — historically 26, including linalool, limonene, citronellol, geraniol and eugenol — to be individually declared on cosmetic ingredient labels when present above 0.001% in leave-on or 0.01% in rinse-off products; Commission Regulation (EU) 2023/1545 (26 Jul 2023) expands the declarable list to 80+ substances (compliance deadlines Jul 2026 / Jul 2028). A 'fragrance-free' claim does not preclude these compounds appearing on-label under their own names.
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • C14-3 Essential oils (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • CCITRUS-7 Limonene and linalool -- common terpenes present in citrus essential oils regardless of extraction method -- autoxidize on exposure to air and light into hydroperoxides that are documented human contact-allergy sensitizers. This allergic-sensitization risk pathway is chemically distinct from, and additive to, furocoumarin-driven phototoxicity/pigmentation: an oxidized ('aged,' improperly stored) citrus essential oil carries rising irritancy/allergy risk independent of its furocoumarin content.
RFRAG-3
Smell is an imperfect screening cue: a product with very little aromatic content smells of little, and a distinct herb, flower or citrus smell signals aromatic ingredients the front label does not disclose.
SYNTHESIZED
Synthesized from:
  • CFRAG-1 The EU Cosmetics Regulation (EC No 1223/2009, Annex III) requires named fragrance allergens — historically 26, including linalool, limonene, citronellol, geraniol and eugenol — to be individually declared on cosmetic ingredient labels when present above 0.001% in leave-on or 0.01% in rinse-off products; Commission Regulation (EU) 2023/1545 (26 Jul 2023) expands the declarable list to 80+ substances (compliance deadlines Jul 2026 / Jul 2028). A 'fragrance-free' claim does not preclude these compounds appearing on-label under their own names.
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • C14-3 Essential oils (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • CCITRUS-7 Limonene and linalool -- common terpenes present in citrus essential oils regardless of extraction method -- autoxidize on exposure to air and light into hydroperoxides that are documented human contact-allergy sensitizers. This allergic-sensitization risk pathway is chemically distinct from, and additive to, furocoumarin-driven phototoxicity/pigmentation: an oxidized ('aged,' improperly stored) citrus essential oil carries rising irritancy/allergy risk independent of its furocoumarin content.
RFRAG-4
Fragrance and essential-oil exposure on an already inflamed, shaved or otherwise barrier-disrupted surface, on Fitzpatrick IV-VI skin, is a plausible route to an inflammatory event that becomes post-inflammatory hyperpigmentation; fragrance exposure is a variable that carries more risk when the barrier is compromised.
SYNTHESIZED
Synthesized from:
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
RFRAG-5
The warm, moist, occluded environment of a skin fold amplifies irritant and allergic reactions to a leave-on ingredient, so itching or burning in a fold after applying a product is a reason to stop the product; sustained inflammation there is a PIH risk on high-melanin skin.
SYNTHESIZED
Synthesized from:
RFRAG-6
A reaction that appears after long uneventful use of a product is consistent with allergic sensitisation, in which repeated exposure builds immune memory before a threshold is crossed; years of tolerance do not show a product is safe for that skin.
SYNTHESIZED
Synthesized from:
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • CCITRUS-7 Limonene and linalool -- common terpenes present in citrus essential oils regardless of extraction method -- autoxidize on exposure to air and light into hydroperoxides that are documented human contact-allergy sensitizers. This allergic-sensitization risk pathway is chemically distinct from, and additive to, furocoumarin-driven phototoxicity/pigmentation: an oxidized ('aged,' improperly stored) citrus essential oil carries rising irritancy/allergy risk independent of its furocoumarin content.
  • CFRAG-1 The EU Cosmetics Regulation (EC No 1223/2009, Annex III) requires named fragrance allergens — historically 26, including linalool, limonene, citronellol, geraniol and eugenol — to be individually declared on cosmetic ingredient labels when present above 0.001% in leave-on or 0.01% in rinse-off products; Commission Regulation (EU) 2023/1545 (26 Jul 2023) expands the declarable list to 80+ substances (compliance deadlines Jul 2026 / Jul 2028). A 'fragrance-free' claim does not preclude these compounds appearing on-label under their own names.
RNAT-1
Whether an ingredient is natural or synthetic does not predict its safety or efficacy; judge any ingredient by mechanism, concentration, evidence base and consistency of the source material.
SYNTHESIZED
Synthesized from:
  • C19-1 Urushiol (poison ivy) causes contact dermatitis; a natural compound that is highly irritating.
  • C19-2 Aristolochic acid (found in several traditional-medicine plants) is nephrotoxic.
  • C19-3 Essential oils are among the most common contact sensitizers in cosmetic dermatology.
  • C19-4 Tea tree oil is genuinely antimicrobial in vitro, but efficacy is concentration-dependent and the same concentration that works often irritates; potency varies batch to batch as a botanical extract.
  • C13-2 Essential oils marketed as natural (lavender, tea tree) are a documented cause of allergic contact dermatitis. PMID 34222588 PMC8243157 DOI PMID 37403438 DOI
  • CAMIST-4 Anua's Niacinamide Tranexamic Acid Brightening Booster Toner discloses tranexamic acid at 1,000ppm (0.1%), below every published topical tranexamic acid RCT concentration identified (2-10% range) and below the Ingredient Canon's 2-5% effective-concentration threshold. Niacinamide in the same product is disclosed at 5%, within Canon range.
  • CAMIST-8 No published topical tranexamic acid RCT tests a concentration below 2%; identified trials and reviews cluster at 2-10%, with most positive melasma outcomes reported at 3-5%. A 0.1% commercial toner concentration sits below the floor of tested literature -- this is untested territory, not a concentration shown ineffective.
RNAT-2
For PIH on Fitzpatrick IV-VI skin, treat natural oils and butters as seal/barrier support layered over clinically evidenced actives, not as the primary intervention.
SYNTHESIZED
Synthesized from:
  • CSHEA-2 No study located shows shea BUTTER fades hyperpigmentation: the published melanogenesis-inhibition result is for a lab extract of the defatted kernel, not the butter; the Library declines the "shea fades dark spots" claim. PMID 25446237
  • C18-2 PIH affects darker skin with greater frequency/severity; azelaic acid, niacinamide, ascorbic acid are recognized topical depigmenting agents in skin of color. PMID 20725554 PMC2921758
  • C24-3 Topical retinoids and azelaic acid treat acne and reduce post-acne hyperpigmentation in skin of color. PMID 34751927 PMC8776661 DOI PMID 35720053 PMC9165627 DOI
  • C21-7 Topical retinoids reduce hyperpigmentation in patients with skin of color and should be started early. PMID 34751927 PMC8776661 DOI
  • CTHIA-7 Systematic review of topical PIH treatments (47 studies, 1,853 subjects, GRADE-assessed): thiamidol among the topical agents supported by high-quality studies, alongside retinoids, hydroxy acids, corticosteroids, niacinamide.
  • C9-4 Topical vitamin E does not improve scar appearance (no effect or worsened in 90% of a split-scar trial) and causes contact dermatitis in ~33% of users. PMID 10417589 DOI PMID 26977069 DOI
RSUNL-1
Ultraviolet exposure of skin that is healing from inflammation plausibly re-stimulates already-active melanocytes and so deepens or prolongs post-inflammatory hyperpigmentation; this is an extrapolation from experimental barrier-disruption + UV models (Fitzpatrick III-V) and the general PIH mechanism, not a trial of UV re-exposure of an existing PIH mark.
SYNTHESIZED
Synthesized from:
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-10 In an investigator-masked, randomized, intra-individual study of 20 participants with Fitzpatrick skin types IV-V, pigmentation was induced by controlled UV and visible-light exposure with or without tape stripping (mild barrier disruption), and a daily broad-spectrum sunscreen containing sclareolide and niacinamide applied for 20 days significantly prevented pigmentation: in stripped, exposed zones protected skin changed by +5.96 delta-ITA versus -9.88 delta-ITA in unprotected skin (P < 0.001), and no adverse events were reported.
  • CMELDISP-11 The belief that skin of color is inherently protected from all photodamage by its melanin is described in a 2026 literature review as a misconception that serves as a barrier to proper photoprotection, and the same review states that skin of color remains susceptible to UV-related pigmentation disorders, photodermatoses and skin cancer (PMID 42668981). This row makes no claim about specific social media platforms or posts: the earlier social-listening observation (Instagram and Reddit, Tavily search 2026-08-17) recorded no URLs and is withdrawn until URLs are recorded.
RSUNL-2
Freshly shaved skin is a mildly injured, irritated surface; on Fitzpatrick IV-VI skin irritation and injury carry elevated PIH risk. No study of freshly shaved scalp or face sunscreen choice was located.
SYNTHESIZED
Synthesized from:
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
RSUNL-3
Mineral (zinc oxide/titanium dioxide) sunscreen particles dragged across freshly shaved skin could abrade it and add inflammation; chemical filters are suggested instead for that window. The abrasion step has no study (C26-6 is Unconfirmed, flagged SYNTHESIZED); the doc also flags sensitizing chemical filters as a PIH risk.
SYNTHESIZED
Synthesized from:
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
RSUNL-4
PA++++ is a floor (PPD >= 16, no ceiling), so within the top bracket the PPD value, not the plus count, separates products; comparing broad-spectrum products by PA rating gives more UVA information than the US broad-spectrum label alone.
SYNTHESIZED
Synthesized from:
  • C26-4 PA++++ corresponds to PPD 16 or higher with no upper limit, so two PA++++ products can differ substantially in UVA protection.
RTOOTH-1
The short-term drying and tightening of a pimple after toothpaste application is irritant surface drying (documented irritant and allergenic ingredients, CTOOTH-2), not treatment; no clinical study tests toothpaste as an acne or dark-spot treatment (CTOOTH-1).
SYNTHESIZED
Synthesized from:
  • CTOOTH-2 Toothpaste is a well-documented cause of allergic and irritant contact dermatitis/cheilitis via its flavoring and active agents (stannous fluoride, carvone, d-limonene, anethole, triclosan, SLS), independent of any skin-lightening or acne-treatment use.
  • CBAN-2 SLS is used as the standard positive irritant control in patch-test research — what researchers apply when they want to irritate skin on purpose. DOI
RTOOTH-2
Starting benzoyl peroxide at 2.5% rather than higher is a reasonable lower-irritation choice on skin of color, because irritation can itself trigger PIH; no trial compares 2.5% and 5% in Fitzpatrick IV-VI.
SYNTHESIZED
Synthesized from:
Guides11 claims · 3 studies · 12 synthesized

guides

C31-12
Moisturizer use versus none reduced eczema flares (RR 0.40), prolonged time to flare (median 180 vs 30 days), and reduced the amount of topical corticosteroid needed; moisturizer plus active treatment beat active treatment alone; no reliable evidence one moisturizer is better than another.
VerifiedOne source behind this claim
The record
PMID 28166390 (Cochrane, 77 trials)
C36-3
In ordinary daylight exposure, visible light drives long-lasting pigmentation in deeper skin, and this effect is undetectable in lighter skin under the same exposure.
C36-6
Standard in vitro SPF measurements consider only the transmission of ultraviolet light (PMID 42763104). Broad-spectrum sunscreens protect against ultraviolet radiation but do not adequately protect against visible light; tinted sunscreens, which use iron oxides and pigmentary titanium dioxide, are formulated to provide protection against visible light (PMID 32335182).
C36-7
For a sunscreen to protect against visible light it must be visible on the skin: broad-spectrum sunscreens do not adequately protect against visible light, zinc oxide and titanium dioxide nanoparticle filters do not protect against it, and tinted sunscreens (iron oxides plus pigmentary titanium dioxide) are formulated to provide protection against it (PMID 32335182). No PubMed study was located that tests whether any topical product blocks visible light completely (PubMed searches run 2026-09-30, 0 results each: 'visible light transmittance topical sunscreen complete blocking opaque barrier'; 'iron oxide sunscreen visible light transmission percent').
C36-8
In studies on skin of color, an iron-oxide-containing tinted mineral sunscreen provided better protection against visible-light-induced pigmentation than a plain, untinted mineral SPF 50 sunscreen.
CAGE-FEET-2
Xerosis (dry skin) is a common and prominent presentation in Fitzpatrick IV-VI skin. A specific claim that xerosis characteristically appears 'ashy' or grey on darker skin (light scattering off desquamating scale, rather than dirt) is consumer-education/clinical-teaching terminology not located in the indexed primary literature.
CGLUT-1
Glutathione inhibits tyrosinase (direct and indirect) and shifts melanogenesis from eumelanin toward phaeomelanin, a real antimelanogenic mechanism.
CGLUT-2
No randomized controlled trial establishing IV/injectable glutathione's efficacy for skin lightening was located; a 2025 systematic review found only one placebo-controlled study on intravenous glutathione (6/16 [37.5%] versus 3 [18.7%], p 0.054).
CPIHP-1
In Fitzpatrick IV-VI skin, inflammation commonly presents as violet, grey-brown or ashy-darkened rather than red, and erythema is masked by melanin density, so erythema-based severity scoring undercounts disease.
VerifiedOne of 2 sources behind this claim · see the other
The record
Nazarian A, Alexis AF. Curr Allergy Asthma Rep 2024 May;24(6):317-322. PMID 38776041
VerifiedOne of 2 sources behind this claim · see the other
The record
Ben-Gashir MA, Hay RJ. Br J Dermatol 2002 Nov;147(5):920-5. PMID 12410701
CTHIA-2
Evaluator-blinded RCT, 50 Brazilian women with facial melasma (86% phototypes III-IV): 0.2% thiamidol twice daily vs 4% hydroquinone nightly, 90 days, both on tinted SPF60; mMASI reduction 43% (thiamidol) vs 33% (hydroquinone), no significant difference between groups (P>=0.09); allergic contact dermatitis in 2 of the thiamidol group (8%).
CTHIA-6
Systematic review (14 clinical studies, search to June 2022): all 14 found statistically significant improvement with topical thiamidol across facial hyperpigmentation, melasma, PIH, and UV-induced hyperpigmentation; effective dosing 0.1-0.2%, 2-4 times daily, 12-24 weeks; authors note evidence is limited and direct comparison to hydroquinone is needed.
RBODY-1
On skin of color, body skin is exposed to more friction, heat and razor injury than facial skin, and injury or irritation can trigger PIH; extrapolated from the general PIH mechanism and friction-pigmentation rows; no study compares trigger exposure between face and body.
SYNTHESIZED
Synthesized from:
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C23-3 In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment. PMID 42109558 PMC13155718 DOI PMID 25227244 DOI
  • C11-1 Chronic friction induces hyperpigmentation (frictional melanosis). PMID 36461803 DOI DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
RBODY-2
Because azelaic acid also acts on pigment, it is a reasonable choice for body acne on mark-prone skin; extrapolated from azelaic acid evidence in post-acne hyperpigmentation in skin of color; no body-acne PIH trial.
SYNTHESIZED
Synthesized from:
RBODY-3
Harsh scrubbing of keratosis pilaris irritates skin and on skin of color irritation can trigger pigment change; no keratosis-pilaris-specific pigmentation study was located.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
RBODY-4
Reducing friction, trapped sweat and warmth in skin folds (looser, breathable or wicking fabric; letting folds dry) is a reasonable measure because friction, moisture and heat trigger intertrigo and friction darkening; no fabric-comparison study was located.
SYNTHESIZED
Synthesized from:
RBODY-5
In hot, humid conditions a heavy occlusive layer may add to follicular congestion; reasoned from the comedogenic-cosmetics evidence; no heat- or humidity-specific study.
SYNTHESIZED
Synthesized from:
  • C16-4 Comedogenic cosmetics cause 'acne cosmetica'; non-comedogenic reformulation cut incidence from ~25% to under 5%. PMID 138532
  • C16-5 Cocoa butter induces microcomedones (confocal-microscopy confirmed). DOI
  • C25-1 Ambient humidity and temperature strongly affect the stratum corneum; colder/drier regions show markedly higher population-level dry-skin burden than warm/humid ones. PMID 42184334 PMC13200769 DOI PMID 27306376 DOI
RHYP-1
Post-inflammatory hyperpigmentation can be addressed through several distinct mechanisms (tyrosinase inhibition, melanosome transfer, melanin-type shift, cell turnover; plus antioxidant action, for which no row exists); the five-lever grouping is a teaching frame assembled from the individual mechanism rows, not a published classification, and the claim that only turnover clears existing pigment is in tension with rows showing azelaic acid, niacinamide and ascorbic acid reduce existing marks.
SYNTHESIZED
Synthesized from:
  • C12-4 Azelaic acid inhibits tyrosinase and accelerates keratinocyte turnover. PMID 1816137 DOI
  • C11-7 Niacinamide blocks melanosome transfer; Azelaic Acid slows tyrosinase. PMID 12100180 DOI PMID 1816137 DOI
  • C12-5 Niacinamide at 10-12% blocks melanosome transfer. PMID 12100180 DOI
  • C1-1 L-ascorbic acid is the most-studied vitamin C form (direct tyrosinase inhibition); requires pH 2.5-3.5 to penetrate, which can itself trigger PIH on reactive Fitzpatrick IV-VI skin.
  • CGLUT-1 Glutathione inhibits tyrosinase (direct and indirect) and shifts melanogenesis from eumelanin toward phaeomelanin, a real antimelanogenic mechanism.
  • C21-2 Topical retinoids increase collagen and normalize keratinocytes/melanocytes, improving wrinkles, texture, and tone. PMID 37683070 DOI PMID 35620028 PMC9112391 DOI
  • C21-7 Topical retinoids reduce hyperpigmentation in patients with skin of color and should be started early. PMID 34751927 PMC8776661 DOI
  • CPEEL-14 Systematic review of 48 studies (1,356 skin-of-colour PIH patients; 20% FST III, 40% IV, 34% V, 6% VI; 70% Black): topical retinoids most used (22%) with partial improvement in 85%; laser (17%) partial improvement 66% and the only intervention with complete resolution in a subgroup (26%) but with reported PIH exacerbation; chemical peels (9%) and hydroquinone (7%) among treatments with less effective outcomes; overall lack of robust efficacy across modalities.
  • C18-2 PIH affects darker skin with greater frequency/severity; azelaic acid, niacinamide, ascorbic acid are recognized topical depigmenting agents in skin of color. PMID 20725554 PMC2921758
RHYP-2
Daily sunscreen is necessary but not sufficient for pigmentation control on skin of color because SPF is a UV measure and visible light also drives pigmentation (iron-oxide tints protect where untinted SPF does not).
SYNTHESIZED
Synthesized from:
  • CMELDISP-11 The belief that skin of color is inherently protected from all photodamage by its melanin is described in a 2026 literature review as a misconception that serves as a barrier to proper photoprotection, and the same review states that skin of color remains susceptible to UV-related pigmentation disorders, photodermatoses and skin cancer (PMID 42668981). This row makes no claim about specific social media platforms or posts: the earlier social-listening observation (Instagram and Reddit, Tavily search 2026-08-17) recorded no URLs and is withdrawn until URLs are recorded.
  • C36-6 Standard in vitro SPF measurements consider only the transmission of ultraviolet light (PMID 42763104). Broad-spectrum sunscreens protect against ultraviolet radiation but do not adequately protect against visible light; tinted sunscreens, which use iron oxides and pigmentary titanium dioxide, are formulated to provide protection against visible light (PMID 32335182).
  • C36-3 In ordinary daylight exposure, visible light drives long-lasting pigmentation in deeper skin, and this effect is undetectable in lighter skin under the same exposure.
  • C12-1 Iron-oxide sunscreen protects against visible-light-induced pigmentation in Fitzpatrick III-VI, including melasma, where SPF alone did not. PMID 40627587 DOI
  • C16-1 Visible light induces pigmentation in darker skin; iron-oxide tints block it, plain nanoparticle mineral filters do not. DOI
RRB-1
Gentle exfoliation before shaving may lift trapped hair tips so the blade can reach them, while a harsh or sharp-particle scrub risks barrier damage that can lead to PIH; no study of pre-shave exfoliation in PFB. The practice page and the guide disagree on timing (night before vs right before) and on type (chemical vs mechanical).
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
RRB-2
Preventing razor-bump inflammation early is likely easier than clearing the PIH or keloid it can cause, because PIH is often chronic and slow to clear and keloids are more prevalent in Fitzpatrick IV-VI; no study compares early and late intervention.
SYNTHESIZED
Synthesized from:
RRB-3
Shaving against the grain may cut the hair shorter below the skin surface and so raise ingrowth risk; with-the-grain and single-blade/foil shaving are the standard mechanism-based recommendation, with limited and partly mixed comparative evidence.
SYNTHESIZED
Synthesized from:
  • C7-2 With-the-grain shaving and single-blade/foil razors are the standard mechanism-based recommendation for PFB; direct comparative clinical evidence is limited and partly mixed — a consistent regimen with pre/post-shave care may matter as much as blade count. PMID 27212468 DOI
RRB-4
Avoiding alcohol-based aftershave on freshly shaved skin is a precaution because a compromised barrier admits irritants and irritation can trigger PIH on skin of color; no study of alcohol aftershave in PFB was located.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
RRB-5
Picking at razor bumps adds mechanical injury and inflammation, which feeds the injury-to-melanocyte pathway and so raises PIH risk; no study of picking in PFB.
SYNTHESIZED
Synthesized from:
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
  • C31-2 Eczema in skin of color may appear psoriasiform, lichenoid, scaly or papular with a violaceous color, with higher prevalence of PIH than White patients. PMID 37119261 DOI
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
Practices4 synthesized

practices

RPR-1
Exfoliating gently the night before shaving rather than immediately before is a reasoned timing choice meant to lift trapped hair tips without irritating skin that is about to be cut; no study of timing; it conflicts with the guide page, which says right before shaving.
SYNTHESIZED
Synthesized from:
RPR-2
A ceramide-containing shaving product is a reasonable barrier-supportive choice at the time the skin is most exposed to injury; no study of ceramide shaving creams.
SYNTHESIZED
Synthesized from:
  • C28-2 Evidence-based skin repair rests on gentle pH-balanced cleansing, ceramide- or urea-based moisturizers, and photoprotection. DOI
  • C29-3 Ceramide subclass composition is tightly linked to barrier function; a skewed or altered ceramide profile correlates with barrier dysfunction. DOI
RPR-3
Azelaic acid applied once daily to the whole shaved area, starting low, is a reasoned approach to post-shave marks (azelaic acid reduces post-acne hyperpigmentation in skin of color and has antibacterial and tyrosinase-inhibiting actions); no trial in razor-bump PIH; C19-5 is Unconfirmed.
SYNTHESIZED
Synthesized from:
RPR-4
Niacinamide (melanosome-transfer inhibition) followed by a ceramide moisturizer is a reasoned post-shave step to reduce pigment transfer and keep the barrier intact; no trial in razor-bump PIH.
SYNTHESIZED
Synthesized from:
Other cited claims322 claims · 37 studies · 38 synthesized

other cited claims

C5-3
Hard-water exposure is associated with higher odds of AD DEVELOPMENT in children (pooled OR 1.28, GRADE very low); water-softener RCTs did NOT reduce severity in established eczema (GRADE moderate).
VerifiedOne source behind this claim
The record
Jabbar-Lopez et al. 2021, PMID 33259122
C8-1
The definition of skin of color is imprecise and often used simply to mean non-Caucasian-White; clinical trials, publications, and dermatology education still underrepresent these populations relative to global prevalence.
VerifiedOne source behind this claim
The record
Lim et al. 2026, PMID 41195697
C10-6
No PubMed study was located that tests whether overuse of a hypochlorous acid (HOCl) facial spray causes dryness, redness or irritation, by any mechanism (PubMed 'hypochlorous acid spray dryness transepidermal water loss', run 2026-09-30, 0 results; an earlier HOCl dryness/TEWL query also returned 0 results). No cause is asserted here for dryness reported with HOCl spray overuse, and this row does not clear HOCl of causing irritation.
Verified
C11-3
Velvety, thickened darkening in folds (acanthosis nigricans) is associated with insulin resistance.
VerifiedOne source behind this claim
The record
DOI 10.1111/jocd.13544; PMID 41835959
C11-6
Mercury-containing lightening creams cause renal and neurological harm; contaminate the household.
VerifiedOne of 3 sources behind this claim · see the others
The record
DOI 10.3109/15563650.2011.626425; DOI 10.3389/fmed.2024.1511493; DOI 10.1016/j.ijheh.2016.03.002
VerifiedOne of 3 sources behind this claim · see the others
The record
DOI 10.3109/15563650.2011.626425; DOI 10.3389/fmed.2024.1511493; DOI 10.1016/j.ijheh.2016.03.002
VerifiedOne of 3 sources behind this claim · see the others
The record
DOI 10.3109/15563650.2011.626425; DOI 10.3389/fmed.2024.1511493; DOI 10.1016/j.ijheh.2016.03.002
C13-PROC1
Procedural/dosage figures used without individual citation: HOCl 0.002% concentration; BP 4% / 2-minute contact; vaginal pH 3.8-4.5; menstrual blood pH ~7.4; semen pH ~7.2.
C14-1
The aluminum-antiperspirant/breast-cancer question is genuinely contested — a 2023 systematic review found inconsistent results and recommended precautionary avoidance; a 2025 review found no established causal link but called for more research.
VerifiedOne of 2 sources behind this claim · see the other
The record
Moussaron et al. 2023, PMID 37354712
VerifiedOne of 2 sources behind this claim · see the other
The record
Hangan et al. 2025, PMID 38173070
C16-7
Film-former chemistry (acrylates copolymers, silicone resins, volatile carriers) explains why waterproof/silicone makeup resists water and needs oil to remove.
C18-3
Kakadu plum is exceptionally high in vitamin C.
VerifiedOne source behind this claim
The record
PMID 36985798 (Zhou 2023)
C18-8
Hyaluronic acid was traditionally extracted from rooster combs, now produced predominantly by bacterial fermentation.
VerifiedOne source behind this claim
The record
ScienceDirect 2025; PMC10004376 (microbial HA production reviews)
C20-1
The vulva is external skin subject to a range of skin problems; 'itch equals yeast' leads people to self-treat the wrong cause.
C20-2
Less estrogen reduces natural moisture and can dry/irritate the vulva (GSM).
C20-8
Lichen sclerosus diagnosis is clinical and supported by biopsy; treatment is potent topical glucocorticoids; carries increased vulvar SCC risk.
VerifiedOne source behind this claim
The record
Nair PA 2017, DOI 10.4103/jmh.JMH_13_17
C26-3
Measured sunscreen products delivered on average ~42-59% of labeled SPF and ~24% of labeled UVA protection.
C30-1
Dermatology (diagnosis/treatment of skin disease) and cosmetic chemistry (product formulation) are distinct fields with distinct training; expertise in one does not confer expertise in the other.
Verified
C31-8
Psoriasis is a chronic, systemic immune-mediated disease associated with increased risk of psoriatic arthritis, cardiovascular disease, diabetes, obesity, IBD, and NAFLD.
VerifiedOne source behind this claim
The record
PMID 31225638
C31-13
Topical corticosteroid phobia prevalence ranges from 21.0% to 83.7%; patients with it show significantly higher non-adherence (49.4% vs 14.1% in one comparison).
VerifiedOne source behind this claim
The record
PMID 28724128
C34-2
Syndets are milder than soap via reduced protein denaturation.
VerifiedOne source behind this claim
The record
Draelos 2017, PMID 29231284
C34-4
A soap-free, mildly acidic washing emulsion produces barrier disruption comparable to washing with water (the ceiling).
VerifiedOne source behind this claim
The record
Bornkessel et al. 2005, PMID 15691260
C34-8
Aged skin shows elevated surface pH, reduced hydration, compromised barrier.
VerifiedOne source behind this claim
The record
Wang/Man/Li/Elias/Mauro 2020, DOI 10.18632/aging.102946 (no PMID in-doc)
C36-1
Visible light constitutes approximately 44-50% of the sunlight reaching skin, compared to approximately 5% for ultraviolet radiation.
Verified
C36-2
Within the visible light spectrum, the blue-violet (high-energy visible) end is the strongest driver of pigmentation, attributed to its proximity in wavelength/energy to ultraviolet light.
Verified
C36-4
Opsin-3, a photoreceptor present in skin pigment cells (melanocytes), senses blue light and responds by stimulating ongoing melanin production, which is why visible-light-induced pigmentation is more persistent than a UV-induced tan.
Verified
C36-5
Visible light penetrates the skin more deeply than UVA and is not blocked by ordinary window glass.
Verified
C36-9
Screen/device blue light emission is approximately 100-1,000 times weaker than solar blue light; a controlled study exposing melasma patients to a dose equivalent to 8 hours per day of strong screen light for 5 consecutive days did not worsen melasma.
Verified
C36-10
Blue LED light at approximately 415nm reduces C. acnes bacteria and inflammatory acne; combined red and blue LED protocols have been studied for acne treatment.
Verified
C36-11
As of the verification date, no dedicated clinical trial or case report documents that therapeutic blue-LED acne masks cause pigmentation/darkening in Fitzpatrick IV-VI skin; this risk is mechanistic/extrapolated rather than clinically demonstrated. An acne study that tracked pigmentation outcomes across blue-light treatment arms found no statistically significant pigmentation change.
Verified
C36-12
Opsin-3 (OPN3) is the sensor in melanocytes through which shorter-wavelength (blue) visible light induces hyperpigmentation (PMID 28842328), acting downstream through OPN3-TRPV1 signalling (PMID 39241981), and a 2026 narrative review reports that blue-violet light induces dose-dependent hyperpigmentation whereas red light produces none (PMID 42802407). No PubMed study was located on whether red or near-infrared light engages the opsin-3 pathway, or on the mechanism by which red and near-infrared light treat acne (PubMed searches run 2026-09-30, 0 results each: 'opsin 3 OPN3 red light near-infrared melanocytes'; 'red light near-infrared acne mechanism photobiomodulation sebaceous gland').
Verified
CAGE-EYE-1
Periorbital hyperpigmentation (periorbital melanosis) is a common cosmetic concern with multifactorial etiology. Cross-sectional dermoscopic studies classify it into constitutional/pigmentary, vascular, structural (shadow-effect from skin laxity/hollowing), post-inflammatory, and mixed types — mixed type is most common (88.4% in one 250-patient series); dermoscopy is significantly more accurate than the naked eye at distinguishing pigmentary from vascular components. A specific manual 'stretch test' as a clinical differentiation method was not located as directly studied in the indexed literature (pressing/stretching to assess whether darkening reduces is standard clinical teaching but not itself the subject of a primary study found).
Verified
CAGE-EYE-2
A 2026 global consensus (10 pigmentary-disorder experts, Delphi process) includes periorbital hyperpigmentation among melanin hyperpigmentation disorders with treatment algorithms tailored by skin type and pigmentation depth (topical lightening agents, oral tranexamic acid, chemical peels, lasers/IPL). A separate systematic review of under-eye treatments categorizes options (topicals, peels, lasers, microneedling, fillers, neuromodulators, surgery) by which structural/pigmentary/vascular component they address. A 1927nm non-ablative fractional diode laser case series in skin of color (Fitzpatrick III-IV) showed safe, effective pigment improvement with no post-inflammatory hyperpigmentation. Which specific topical agents (retinoids, azelaic acid, vitamin C, sunscreen) have dedicated periorbital-site trials, versus general facial-hyperpigmentation evidence extrapolated to the eye area, was not itemized by agent in a periorbital-specific trial among the sources located.
Verified
CAGE-FEET-1
Heel fissures result from a taut, poorly hydrated stratum corneum unable to withstand shear/pressure at the weight-bearing heel; urea is a hygroscopic component of the skin's natural moisturizing factor that improves stratum corneum hydration, barrier function, and desquamation, and is used across a range of concentrations as a moisturizing/keratolytic dermatologic agent for scaly, dry dermatoses. In an existing indexed RCT (see row C28-1), a fragrance-free barrier-repair cream with hyaluronic acid healed pedal fissures as effectively as urea 40%.
Verified
CAGE-FEET-3
Tinea pedis is diagnosed via KOH microscopy (and/or culture), considered the diagnostic gold standard, which distinguishes fungal infection from plain xerosis (no fungal elements on microscopy). No primary study was located directly comparing the clinical presentations of tinea pedis and plain xerosis on the sole to establish specific distinguishing visual features.
Verified
CAGE-FEET-4
Plantar and heel hyperpigmentation is common as benign, physiologic or frictional pigmentation in skin of color (see existing rows C11-1/C23-2 on frictional melanosis). Acral lentiginous melanoma (ALM) — which disproportionately affects Black, Hispanic, and Asian patients (see existing rows CHFN-1 through CHFN-4, CSUN-2, CMELDISP-2) — is dermoscopically distinguished from benign acral nevi primarily by the parallel ridge pattern (pigmentation on the raised dermatoglyphic ridge rather than the furrow), which is highly sensitive (79.6%) and specific (99.4%) for ALM versus benign nevi in a pooled meta-analysis, versus the parallel furrow pattern that predominates in benign nevi.
Verified
CAGE-HAND-1
Dorsal hand photoaging presents as dyschromia (solar lentigines), soft-tissue atrophy, and volume loss, resulting in visible wrinkles and prominent deep structures (veins/tendons). In darker Fitzpatrick skin types, treatment of solar lentigines on the back of the hands carries a materially higher risk of post-inflammatory hyperpigmentation, and destructive treatments (cryotherapy, trichloroacetic acid) show better lightening results in fairer Fitzpatrick types.
Verified
CAGE-HAND-2
Topical tretinoin 0.1% significantly lightens hyperpigmented photoaging lesions of the face AND hands in a double-blind vehicle-controlled RCT conducted in Chinese and Japanese patients (90% lighter/much lighter vs 33% vehicle, 40 weeks). A mequinol 2%/tretinoin 0.01% combination significantly lightened solar lentigines on the back of the hand in a separate split-hand RCT. No primary study was located specifically testing sunscreen application or compliance on the hands as a distinct site.
Verified
CAGE-JOINT-1
Darkening over the knuckles, elbows or knees should not be assumed to be friction: acanthosis nigricans (AN) is characterized by symmetric, hyperpigmented, velvety plaques typically involving intertriginous areas such as the axilla, neck, inframammary area and groin (PMIDs 36698243, 32516476), can serve as a cutaneous marker of insulin resistance (PMID 36698243), and has been reported at atypical sites such as the scalp (PMID 40414955, a case report). Frictional melanosis is one of the recognized frictional dermatoses, and repetitive trauma to the skin can cause hyperpigmentation (PMID 36461803). No PubMed study was located on the cause of hyperpigmentation specifically at the knuckles, elbows or knees (PubMed 'knuckle elbow knee hyperpigmentation frictional' and 'elbow knee darkening pigmentation dermatology', both run 2026-09-30, 0 results each). Diagnosis is clinical; velvety or thickened darkening should be evaluated by a clinician.
Verified
CAGE-JOINT-2
Topical retinoids and keratolytics have documented efficacy for acanthosis nigricans generally: a randomized trial of topical tretinoin (posterior neck AN) showed ~17-18% improvement at 8 weeks at both 0.025% and 0.05% concentrations, and a sirolimus 0.2% gel pilot study showed ~20% melanin-index reduction at 12 weeks. No study was located testing these treatments specifically at knuckle/elbow/knee sites. A claim that mechanical scrubbing is futile/harmful for this type of pigmentation was not directly tested in a primary study, but is consistent with the general dermatology principle that friction/irritation is itself a cause of this pigmentation (frictional melanosis) and that irritation can trigger further PIH in skin of color (existing row C21-6).
Verified
CAGE-LIP-1
Aging of the upper lip involves statistically significant thinning of the dermis (cutis) and thinning/atrophy of the orbicularis oris muscle, with an increased vermilion-border angle; the aged appearance is better explained by loss of elasticity/ptosis than by total volume loss per se. Reviews describe general age-related lip changes as volume loss, vermilion-border thinning, and philtrum flattening. No Fitzpatrick-stratified or skin-of-color-specific study of lip aging was located.
Verified
CAGE-LIP-2
Chronic dry, cracked, or peeling lips have several distinct clinical causes: lip-licker's dermatitis (irritant contact dermatitis from saliva, a recognized clinical entity, especially in children), exfoliative cheilitis (a chronic scaling condition), and irritant/allergic contact cheilitis from cosmetic ingredients (see CLIP-5). No primary study specifically testing petrolatum/occlusion or sunscreen as a lip treatment was located.
Verified
CAGE-LIP-3
General topical skin-lightening agents (niacinamide, azelaic acid, tranexamic acid, kojic acid) have documented efficacy for facial hyperpigmentation (melasma) in randomized trials and meta-analyses, with azelaic acid, kojic acid, and tranexamic acid showing lower irritation rates than hydroquinone. No study was located testing any of these agents specifically on lip/vermilion tissue, and no study was located analyzing hydroquinone-containing products marketed specifically as lip-lightening treatments (see CLIP-10) or specifically assessing hydroquinone absorption/safety on vermilion tissue.
Verified
CAGE-NECK-1
Neck skin is measurably thinner than mid-facial skin (dermal thickness ~1.2mm at neck vs ~1.75mm mid-face on high-resolution ultrasound); a claim that neck skin also has lower sebaceous gland density than facial skin could not be corroborated by a primary source and is not asserted here.
Verified
CAGE-NECK-2
The platysma muscle underlies the anterior neck; visible vertical neck bands (platysmal bands) are among the most visible signs of cervical aging and become more apparent as overlying skin thins and loosens with age.
Verified
CAGE-NECK-5
The décolleté (chest) shows sun-driven mottled dyspigmentation from chronic UV exposure — vascular proliferation and red-cell extravasation causing hemosiderin and melanin deposition, classically described as poikiloderma of Civatte on the neck, cheeks and chest. Whether this presents predominantly as pigment (rather than the erythema/telangiectasia component) specifically in Fitzpatrick IV-VI skin was not established in the literature located.
Verified
CAGE-NECK-7
Microfocused ultrasound (MFU) and radiofrequency (RF) skin-tightening devices are considered safe in Fitzpatrick IV-VI skin because their mechanism (mechanical/thermal collagen remodeling) is not melanin-targeted, versus a documented higher post-inflammatory hyperpigmentation/scarring risk with many laser modalities (e.g. Q-switched, ablative) in darker skin. A claim that 'topical products do not meaningfully correct established skin laxity' could not be corroborated by a primary source and is not asserted here.
Verified
CAGE-SPINE-1
In skin of color, visible aging presents predominantly as dyspigmentation (mottled hyperpigmentation, solar lentigines, melasma, post-inflammatory hyperpigmentation), with rhytides (wrinkles) often delayed by the partial photoprotection of increased epidermal melanin, versus lighter skin. Long-wavelength UVA1 and visible light are highlighted as key drivers of this pigmentary aging pattern, for which conventional (non-tinted, non-iron-oxide) sunscreens may provide inadequate protection.
Verified
CAMIST-1
Topical tranexamic acid cream at 10% concentration produced a markedly smaller melasma improvement (4.2% MASI-score reduction) than intradermal injection of tranexamic acid (39.1% and 62.7% MASI-score reduction across two injected-dose arms) in a 60-patient randomized clinical trial.
Verified
CAMIST-2
A systematic review of 35 melasma RCTs gives topical tranexamic acid a strong clinical recommendation (alongside cysteamine and triple-combination therapy) but explicitly states that optimal formulation and appropriate concentration for tranexamic acid and other natural-compound actives remains unresolved.
Verified
CAMIST-5
Across a 13-SKU toner/mist sample audited 2026-08-18, all disclosed-percentage niacinamide toners (2%, 5%, 10%) met or exceeded the Ingredient Canon's 2% minimum-effective floor; no niacinamide underdosing pattern was found in the disclosed subset.
Verified
CAMIST-6
In a 13-SKU toner/mist sample audited 2026-08-18, zero of six vitamin-C-marketed toners/mists disclosed the vitamin C percentage or derivative strength; one (Pure Fiji) names no isolated vitamin C ingredient in its INCI at all, relying on Kakadu plum fruit extract to support the product name.
Verified
CAMIST-7
A 2026 in vitro and clinical study found niacinamide inhibited melanin synthesis and melanocyte dendricity, and reduced facial hyperpigmentation, only in low-pH formulations (pH 2.5-4); niacinamide in neutral-pH solutions did not inhibit melanin synthesis. Clinical benefit was shown at 2% niacinamide/pH 2.5 (Caucasian cohort, 4wk) and 5% niacinamide/pH 4 (Chinese cohort, 8wk), both vs neutral-pH controls.
Verified
CAMIST-9
PDRN's mechanism (adenosine A2A receptor agonism, nucleotide salvage-pathway activation, suppression of TNF-alpha/IL-6/IL-1beta) is well-established via preclinical and injectable-clinical evidence.
Verified
CAMIST-10
A 2026 randomized split-face human trial (PMID 42430369) shows a specific engineered PDRN variant (0.1% 'PDRN-850K') topically outperformed 0.1% retinol on periocular wrinkles and dermal thickness over 28 days -- this is real human topical evidence, but for a molecularly-optimized formulation, not plain/marketed PDRN.
Verified
CAMIST-11
Standard/plain PDRN's topical skin penetration is limited by its high molecular weight and anionic charge; molecular engineering (e.g. plasma treatment, size reduction) was required in the located literature to make a topical PDRN 'cosmetically viable.'
Verified
CAMIST-14
Injected polynucleotide or PDRN has been studied in humans in three settings: esthetic medicine (a systematic review of nine low to moderate quality studies, 219 patients, reporting side effects as generally mild and transient), knee osteoarthritis (a meta-analysis of five randomized trials against hyaluronic acid, with no significant difference in adverse events, relative risk 2.15, 95% CI 0.17-26.67), and partial-thickness supraspinatus tear (17 patients, open-label, no significant adverse events leading to hospitalization). These are injected, not topical, studies and do not address topical cosmetic PDRN.
Verified
CAROTONE-1
CAROTONE Brightening Oil (65mL), CAROTONE Clarifying Cream (300mL), and CAROTONE Brightening Body Lotion (350mL) — imported, unapproved products marketed for skin brightening — were laboratory-tested by Australia's Therapeutic Goods Administration and found to contain undeclared hydroquinone at 3.6%, 2.9%, and 3.4% respectively, exceeding the 2% concentration threshold at which hydroquinone is classified as a prescription-only medicine under Australian law.
Verified
CBAN-1
Isothiazolinone preservatives (MI, MCI, BIT) are sensitizers; contact-allergy prevalence rose 2.0%→3.7% (MI) and 1.0%→2.4% (MCI/MI) in two years (authors' own word: 'alarming'); EU regulation of MI reduced cases, high rates persist in North America.
VerifiedOne of 3 sources behind this claim · see the others
The record
Lundov 2013 DOI 10.1111/cod.12149; Lundov 2011 DOI 10.1111/j.1365-2133.2011.10523.x; Johansen 2022 DOI 10.1016/j.jaci.2022.02.002
VerifiedOne of 3 sources behind this claim · see the others
The record
Lundov 2013 DOI 10.1111/cod.12149; Lundov 2011 DOI 10.1111/j.1365-2133.2011.10523.x; Johansen 2022 DOI 10.1016/j.jaci.2022.02.002
VerifiedOne of 3 sources behind this claim · see the others
The record
Lundov 2013 DOI 10.1111/cod.12149; Lundov 2011 DOI 10.1111/j.1365-2133.2011.10523.x; Johansen 2022 DOI 10.1016/j.jaci.2022.02.002
CBAN-3
Camphor causes seizures in young children via skin exposure (repeated rubbing); documented, unrecognized source of pediatric seizures in populations using it as a natural remedy.
VerifiedOne of 2 sources behind this claim · see the other
The record
Khine et al. 2009, DOI 10.1542/peds.2008-2097 (Pediatrics); Kumar 2019 DOI 10.5005/jp-journals-10071-23316
VerifiedOne of 2 sources behind this claim · see the other
The record
Khine et al. 2009, DOI 10.1542/peds.2008-2097 (Pediatrics); Kumar 2019 DOI 10.5005/jp-journals-10071-23316
CBAN-5
SLES ruling: ethoxylation yields a larger molecule that penetrates the barrier far less than SLS; SLS is the standard irritant control, SLES is not; SLES is the workhorse of most gentle market cleansers — allowed, penalized, never preferred, never in a baby product.
Verified
CBAN-6
Parabens are NOT banned — among the least sensitizing preservatives available.
Verified
CBAN-7
Cocamidopropyl betaine is NOT banned but is named as a recognized contact allergen — penalized, not vetoed.
Verified
CBHF-2
No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
Verified
CBITE-1
Insect bite reactions are named as an allergic/immunologic-dysregulation cause of PIH (alongside dermatoses, cutaneous injury, infection); patients with Fitzpatrick III-VI skin have increased PIH risk and more pronounced dyspigmentation.
Verified
CBITE-3
Papular urticaria (the clinical hypersensitivity reaction to arthropod bites) is a Th2-cell-mediated delayed hypersensitivity reaction to bite antigens with unclear IgE role; common in the tropics, disproportionately affects young children.
Verified
CBITE-4
In a Bogotá, Colombia child cohort (n=2437, ages 1-6), papular urticaria was the most frequent dermatologic diagnosis (62.9% of children with skin disease); a companion paper on the same cohort found flea-bite-specific papular urticaria prevalence of 20.3%, with household flea presence and housing conditions as risk factors.
Verified
CBITE-6
Standard symptomatic treatment for arthropod-bite reactions (including papular urticaria and bed bug bites) is oral antihistamines for pruritus and topical corticosteroids for significant eruptions, used to control inflammation/itch and hasten lesion resolution — not tested in the literature as a PIH-prevention intervention specifically.
Verified
CBITE-10
Topical corticosteroid misuse for cosmetic skin-lightening (including of blemishes/marks) is a documented harm pathway: a national simulated-patient study found 70.0% of Jordanian pharmacists dispensed potent steroids for facial whitening without prescription; a Basrah, Iraq case series documented atrophy, telangiectasia, and dermatoses from prolonged unsupervised corticosteroid/counterfeit-cosmetic use for lightening.
Verified
CBITE-11
OTC skin-lightening/hydroquinone-containing product use without prescription is common (35.7%-63.5% in Saudi Arabian cross-sectional surveys) and carries documented adverse effects — irritation, redness, paradoxical darkening — in roughly a third to two-fifths of users.
Verified
CBLEACH-1
Hydroquinone induces exogenous ochronosis via tyrosinase-catalyzed oxidation of hydroquinone into cytotoxic quinone/melanin-adduct intermediates, not via inhibition of homogentisate dioxygenase.
Verified
CBLEACH-2
Mercury absorbed from skin-lightening products causes renal harm (reversible proteinuria, acute tubular necrosis, nephrotic syndrome — mainly minimal-change or membranous nephropathy) and neurotoxicity with prolonged exposure.
Verified
CBLEACH-3
A spectrometric analysis of 549 skin-lightening products purchased across multiple countries found 6.0% contained mercury above 1000ppm (FDA cosmetic limit is 1ppm), including 3.3% of products purchased in the US.
Verified
CBLEACH-4
In two Dakar, Senegal dermatology-clinic studies, 41-53% of women presenting for care were current users of cosmetic bleaching products, dominated by topical corticosteroids (70-78% of users) and hydroquinone (56-89% of users), with mercury iodide in ~10%; documented complications included exogenous ochronosis, striae, and skin atrophy.
Verified
CBLEACH-6
No PubMed-indexed studies directly comparing percutaneous absorption or occlusion characteristics of genital/vulvar/intimate skin versus facial skin for lightening/depigmenting actives were located.
Verified
CBLEACH-8
Citrus juice (lemon/lime) applied to skin followed by UV exposure causes phytophotodermatitis via furocoumarin-photosensitized keratinocyte damage, producing burn-like erythema/blistering within 24-48 hours and subsequent hyperpigmentation; the mechanism requires direct UV exposure after contact.
Verified
CBLEACH-9
Med-spa/dermatologist-administered 'vaginal/intimate lightening' treatments (e.g., Dermamelan Intimate) are marketed at roughly £850-$1,500+ per treatment course (in-clinic chemical peel plus at-home maintenance phase), with marketing claiming visible lightening within 1 week and best results at 3-4 weeks.
Verified
CBLEACH-10
The global 'intimate lightening products' market is estimated at roughly $148-151 million (2024-2025), a small fraction of the broader $32-55 billion global women's intimate care product market.
Verified
CBLEACH-11
The Intimate Area Products Rubric's marketing-register auto-fail (Claims Honesty hard veto) makes R&R's sourcing decision on Channel A (unbranded, bleaching-register-marketed) intimate-lightening SKUs independent of ingredient disclosure. This does not resolve or supersede CBLEACH-7, which tracks whether those specific SKUs actually disclose full INCI — that fact remains separately, genuinely unverified.
Verified
CBLEACH-12
Pediatric mercury poisoning from skin-lightening/lightening-cream household exposure is documented in case reports, presenting as renal and neurological harm (hypertension, tachycardia, neurological/behavioral changes), including via indirect secondhand contact; not reported as carcinogenic in these cases.
Verified
CBLEACH-13
A direct causal link between cosmetic-level topical hydroquinone or mercury exposure and skin cancer in humans has not been established by the literature located. The located evidence is descriptive: case reports and case series of cutaneous squamous cell carcinoma in long-term skin-bleaching users, in which the products were typically hydroquinone combined with highly potent topical corticosteroids (CBLEACH-15).
Verified
CBLEACH-14
In a study of hydrocortisone and testosterone applied to the vulva and ventral forearm of pre- and post-menopausal women, percutaneous absorption of hydrocortisone was significantly greater in vulvar than forearm skin in both groups (P < 0.05), and testosterone absorption was significantly greater on the vulva only in post-menopausal women (P < 0.01). These are a corticosteroid and a hormone, not depigmenting agents.
Verified
CBLEACH-15
Cutaneous squamous cell carcinoma in long-term cosmetic skin-bleaching users is reported in case reports and case series, mostly from sub-Saharan Africa: 8 women in Senegal (mean 20.3 years of whole-body use of topical hydroquinone and highly potent corticosteroids, no pre-neoplastic skin disease found), one woman in Togo after a 30-year history of use, and 19 archived cases in Dakar (mean 20 years of bleaching, 14 using a hydroquinone and clobetasol propionate mixture). A scoping review found reports limited to a small number of case reports in Africa, most patients Fitzpatrick VI. These are descriptive reports; none of the four abstracts reports a controlled comparison.
Verified
CBPEEL-1
No published human clinical trial was located testing raw or solvent-extracted banana peel applied topically for reduction of hyperpigmentation or dark spots. The closest human study located is an uncontrolled single-arm study of a 5% lady finger banana peel extract nanoparticle serum for photoaging in women aged 25-50 (PMID 42657390), which is not a hyperpigmentation trial.
Verified
CBPEEL-2
Solvent-extracted banana peel phenolics, including rosmarinic acid, inhibit tyrosinase activity and melanin content in cultured human and mouse melanoma cell lines in vitro.
Verified
CBPEEL-3
Banana contains cross-reactive allergens (S-adenosyl-L-homocysteine hydrolase; endo-beta-1,3-glucanase) implicated in latex-fruit syndrome, with a documented case of topical contact allergic reaction to a banana-containing product in a latex-allergic patient.
Verified
CBPEEL-4
No Fitzpatrick IV-VI-specific or skin-of-color-specific data was located for topical banana peel use, in either the efficacy or the harm direction.
Verified
CCITRUS-2
Oxypeucedanin from lemon oil produced photopigmentation on pigmented guinea-pig skin with no preceding visible erythema -- furocoumarin-driven skin darkening can occur without a visible burn as a warning sign.
Verified
CDET-1
Laundry detergent patch-tested at 0.1% aqueous dilution is a rare cause of confirmed allergic contact dermatitis in patients already referred for suspected contact dermatitis; only 0.7% (5/738) showed a positive reaction, and follow-up use-testing did not confirm true detergent allergy in most of those.
Verified
CDET-2
"Free and clear" and "free and gentle" detergent labeling does not reliably indicate absence of common contact allergens; ingredient-list analysis of top-selling US laundry products found methylisothiazolinone in 80% of products labeled "baby safe" and 57.1% of products labeled "free and gentle."
Verified
CDET-3
Modern encapsulated protease enzymes in laundry detergent do not produce clinically meaningful skin irritation or contact sensitization at the level of exposure reaching skin via laundered fabric or direct product handling; the documented enzyme safety concern is occupational respiratory sensitization from airborne exposure during manufacturing, a different exposure route than skin contact with laundered fabric.
Verified
CDET-4
In a large historical patch-test study, irritation from enzyme-containing laundry detergent tracked with the base surfactant in the formulation, not with the protease enzyme itself; no contact sensitization to the enzyme developed in any subject.
Verified
CDET-5
Fragrance and essential oils are the most prevalent allergen category identified in commercial laundry products: present in 66.7% of detergents, 90% of fabric softeners, and 75% of dryer sheets in an ingredient-list review of top-selling US products, higher than any other allergen class checked.
Verified
CDET-7
Borax (sodium borate), a common laundry-stripping ingredient, has negligible dermal absorption through intact skin; absorption increases meaningfully only through denuded or already-irritated skin. Its primary hazard in household use is handling/ingestion, not topical residue on worn, rinsed fabric.
Verified
CDET-9
A meaningful share of contact dermatitis clinically attributed by patients to "clothing" or "detergent" is, on patch testing, actually attributable to textile dyes (particularly Disperse Blue 106 and 124) and formaldehyde-based finishing resins built into the fabric during manufacturing — a different allergen source and causal pathway than detergent residue from washing.
Verified
CDET-11
Significant differences were found in the frequency of borderline (doubtful) patch-test reactions between Fitzpatrick skin types I/II and V/VI and across all six types (P < 0.0001) in a retrospective cohort of 1,899 comprehensively patch-tested patients in one US metropolitan area over 4 years, and patients with type V or VI had 43% lower odds of a borderline reaction. The authors' stated background is that patch-test reactions can be difficult to interpret in higher Fitzpatrick types because of limited erythema or vesiculation, and that missed reactions may prolong allergic contact dermatitis.
Verified
CDOUCH-1
Douching disrupts the Lactobacillus-dominant vaginal microbiome that maintains protective acidic pH.
Verified
CDOUCH-2
Hydrogen-peroxide douching used as a bacterial vaginosis treatment shows higher clinical failure and higher adverse-event rates than a single dose of metronidazole.
Verified
CDOUCH-3
Vaginal douching is an independently associated risk factor for bacterial vaginosis in pregnancy, and pregnancy-related BV is associated with PROM, preterm birth, and low birth weight.
Verified
CDOUCH-4
Black women douche at markedly higher rates (47%) than non-Hispanic White (17%), Mexico-born Mexican American (12.5%), and US-born Mexican American (19%) women, independent of socioeconomic status.
Verified
CDOUCH-5
Bacterial vaginosis prevalence is race-stratified in the US in the same direction as the douching-rate disparity: 51.4% among non-Hispanic Black women vs. 31.9% Mexican American vs. 23.2% non-Hispanic White; 84% of women with BV in this sample reported no symptoms.
Verified
CDOUCH-6
Black women have significantly higher measured whole-blood concentrations of a feminine-hygiene-product-associated VOC (1,4-dichlorobenzene), with a dose-response relationship to douching frequency.
Verified
CDOUCH-7
Commercial douche products inhibit the growth of protective vaginal Lactobacillus strains in vitro.
Verified
CDOUCH-8
Prescribed intravaginal boric acid suppositories (typically 600mg, 14-day course) are an effective, clinician-directed second-line treatment for recurrent or azole-resistant vulvovaginal candidiasis, distinct from general 'freshness'/detox marketing use.
Verified
CDOUCH-9
The vagina is a self-cleaning organ; ACOG and other major clinical bodies advise against douching generally.
Verified
CDOUCH-11
Summer's Eve's 2011 'Hail to the V' campaign ran ethnically-coded advertising (including a Black-coded 'talking hand' character analogizing vulvar 'freshness' upkeep to Black women's hair-care time investment) that was publicly criticized as racially stereotyped and partially pulled after backlash, without the company conceding the ads were racist.
Verified
CDOUCH-12
Yoni pearls and vaginal steaming have no supporting evidence of therapeutic benefit and carry documented risks (yeast infection/discomfort for pearls; burn risk for steaming).
Verified
CDYIMASK-1
A challenge-test survey of 32 commercial skin/body-care cosmetic products found most samples contaminated; two products (a foaming gel and a body/face cream) failed to meet pharmacopeial (European Pharmacopeia 7.0) microbiocidal-effect standards against S. aureus. This is the contamination-risk floor for a professionally formulated, preserved product; an unpreserved home-mixed combination of honey, aloe vera, squalane, and turmeric has no equivalent testing and is expected to carry materially higher risk.
Verified
CDYIMASK-2
Raw materials, including natural/plant-derived ingredients, are a documented major reservoir of microbial contamination in daily chemical and cosmetic products; some contaminant bacterial lineages (Burkholderia cepacia complex, Pseudomonas aeruginosa) show tolerance to preservatives even at maximum permitted concentrations. 'Natural' ingredients are not inherently self-preserving or lower-risk.
Verified
CDYIMASK-4
A 2016 randomized trial of 136 participants with facial acne tested medical-grade kanuka honey (90%) plus glycerine (10%) added to antibacterial soap. It did not find evidence of greater effectiveness than soap alone; this does not establish efficacy of raw honey masks.
Verified
CDYIMASK-5
Daily oral (ingested) Aloe sterol supplementation improved skin barrier function (reduced transepidermal water loss), moisture, elasticity, and dermal collagen score over 12 weeks in placebo-controlled trials. This is systemic/oral evidence, not topical, and does not establish that a topical aloe vera gel face mask produces the same or any brightening/hyperpigmentation benefit.
Verified
CDYIMASK-7
A topical ointment combining aloe vera, honey, and peppermint (not the same as, but the closest located study to, this row's four-ingredient combination) was tested against petroleum jelly on split-thickness skin-graft donor-site surgical wounds in a double-blind RCT (n=28): no significant difference in wound-healing rate, pain, pruritus, or discomfort, but the natural ointment was superior in reducing wound erythema and had significantly better patient satisfaction. This is surgical-wound evidence, not intact facial skin, and does not include turmeric or squalane.
Verified
CDYIMASK-8
Two narrative reviews attribute honey's antibacterial activity to low pH, high sugar content, hydrogen peroxide production (medical-grade honey) and methylglyoxal (Manuka honey). The settings reviewed are medical-grade honey for bacterial vaginosis (with in vitro antibacterial data; the authors state more clinical research is required) and Manuka honey in surgical and chronic wound care, not unpreserved multi-ingredient DIY cosmetic mixtures.
Verified
CFHYG-1
Genital/perineal talc powder use shows a modest positive association with ovarian cancer risk in case-control studies (pooled OR 1.24, 95% CI 1.15-1.33, n=8,525 cases/9,859 controls; most recent 2026 meta-analysis RR 1.32, 95% CI 1.25-1.39), but the largest prospective cohort pooled analysis (n=252,745) found a smaller, non-statistically-significant association (HR 1.08, 95% CI 0.99-1.17). The causal relationship is genuinely disputed, not established.
Verified
CFHYG-2
Genital powder use is significantly more prevalent among African-American women than White women (35.8% vs 29.5% ever-use among cases in the largest race-stratified consortium study), but the per-use ovarian cancer odds ratio is similar across race (OR 1.22, 95% CI 0.97-1.53 in African-American women; OR 1.36, 95% CI 1.19-1.57 in White women) and does not materially vary by histotype in either group -- the documented disparity is in exposure prevalence, not differential biological risk per use.
Verified
CFHYG-3
Feminine spray, powder, and wipe/towelette use (distinct from vaginal douching) is reported at significantly higher rates by Black women than White or Mexican-American women (NHANES 2001-2004, n=739); however, in the same dataset, only douching -- not spray, powder, or wipe use -- showed a statistically significant association with urinary phthalate metabolite (MEP) concentration.
Verified
CFHYG-4
In a separate NHANES 2001-2004 analysis of whole-blood volatile organic compounds, use of feminine powder in the past month was significantly associated with 36% higher blood ethylbenzene concentration (95% CI 0.4%-83%) versus non-use -- a powder-specific finding distinct from and additional to the douching/1,4-dichlorobenzene finding already logged as CDOUCH-6, from the same source paper.
Verified
CFHYG-5
Education level, more than race/ethnicity, was the statistically significant predictor of scent-altering (fragranced) menstrual and intimate-care product use in an adjusted multivariate model (n=661); race/ethnicity dropped out of significance once education was controlled for. In unadjusted comparison, Black participants were more likely than White participants to use douches and wipes specifically (p<0.05).
Verified
CFHYG-6
Typical commercial formulations in this category: vulvar wipes = water + mild cleansing agent + preservatives + antimicrobials + fragrance; vulvar sprays = antimicrobial agents + astringents + fragrance + propellants; vulvar powders = typically cornstarch-based for odor/moisture control. Talc is not stated as the default modern powder base; multiple current top-selling feminine-powder brands are explicitly formulated talc-free.
Verified
CFHYG-7
Contact allergens, most commonly fragrances, other scented botanicals and vitamin E, have been reported in best-selling feminine hygiene wipes (CFHYG-9), and a Philippine study chemically tested 65 mixed consumer products, including feminine hygiene washes and wipes, for methylchloroisothiazolinone, methylisothiazolinone and formaldehyde (PMID 35150015; results by product class not extracted). No study was located testing methylisothiazolinone (MIT) or cocamidopropyl betaine specifically within feminine hygiene wipe, spray or powder products in a defined population, or testing these products in a Fitzpatrick IV-VI population. The general isothiazolinone-sensitization mechanism (CBAN-1) and cocamidopropyl-betaine allergen status (CBAN-7) are transferable in principle but are not product-specific data.
Verified
CFHYG-8
The ratified Intimate Area Products Rubric's fragrance absolute veto (a hard cap at NOT LISTED, not the 7.0-ceiling treatment used elsewhere) excludes any fragranced feminine wipe, spray or powder from R&R's shelf on formula grounds alone, independent of the talc/VOC/phthalate findings in CFHYG-1 through 4. The rubric has no dedicated sourcing row for wipes/sprays/powders as a category (its Rows 1-8 cover underwear, detergent, cleanser, azelaic acid and niacinamide actives, an external barrier moisturizer, and a brightening serum only); this is a filing gap, not a scoring gap.
Verified
CFHYG-9
An internet-based survey of best-selling feminine hygiene wipes compared listed ingredients with the North American Contact Dermatitis Group 80 allergens and found contact allergens frequently present, most commonly fragrances, other scented botanicals (essences, oils, fruit juices) and vitamin E. A separate survey of 59 pantiliners and 111 maxi pads identified 139 unique compounds. Both are ingredient-list analyses of products, not studies of people.
Verified
CGLUT-3
A glutathione buccal lozenge produced a statistically significant melanin-index reduction by 2 weeks in 30 Filipino women, Fitzpatrick IV-V, with no serious adverse events.
Verified
CGLUT-5
Philippines FDA states no injectable glutathione product is approved for skin lightening; approved indication is only as a cisplatin-chemotherapy adjunct; no published trials establish safety/efficacy for lightening; cosmetic-use doses (600mg-3,000mg/session, multiple times weekly) can cause serious organ damage.
Verified
CGLUT-6
Documented adverse effects of IV/injectable glutathione include potentially fatal Stevens-Johnson syndrome and toxic epidermal necrolysis, severe abdominal pain, thyroid dysfunction, renal dysfunction, air embolism, and sepsis from unsterile administration; bloodborne-pathogen transmission risk (HIV, hepatitis B/C) where non-medical practitioners or non-sterile settings are involved.
Verified
CGLUT-OUTBREAK-20260919
A CDC/FDA-confirmed multi-state outbreak (Texas, Washington, Florida, New York) of bacterial-endotoxin adverse reactions (fever, chills, myalgia, headache, nausea, vomiting, hypotension) linked to compounded intravenous glutathione products made with dietary-supplement-grade (not injectable-grade) glutathione API sourced from Medisca Inc. As of CDC update 2026-09-11 and FDA safety alert 2026-08-27, at least 30+ patients across 4 states affected, 3+ hospitalized. Centric Compounding (Houston, TX) issued a nationwide recall 2026-09-09 of 6 lots of Glutathione 200mg/mL, Myer's Cocktail, and Tri-Immune Boost. Investigation ongoing as of this check. Glutathione IV/injectable products are not FDA-approved for any indication and are frequently marketed off-label for systemic skin lightening/brightening, a use this canon already covers under claim prefix CGLUT- (Research Queue Priority 25, output doc 1HmktpfqpX-JAlZ8NFt2G5WQX5AASaBWlg2fa0Vyn3ek). This is a new, dated, government-confirmed instance of the endotoxin-contamination harm mechanism that row already flagged generically (citing 2019 precedent) — it is not a new mechanism, it is live, current, ongoing evidence of that exact mechanism causing real hospitalizations right now.
Verified
CGSM-01
Declining estrogen after menopause causes vulvovaginal epithelial thinning and reduced tissue trophism, impairing barrier function (extends C20-2/C20-3).
Verified
CGSM-02
GSM prevalence estimates among postmenopausal women range widely from 13% to 87% depending on symptom definition and study population; commonly summarized as affecting more than half of postmenopausal women.
Verified
CGSM-03
A substantial share of women with GSM symptoms never discuss them with a clinician; in one large US survey, 44% of symptomatic women had never discussed VVA/GSM symptoms with a healthcare provider, and this discussion rate had shown minimal improvement a decade later despite direct-to-consumer marketing.
Verified
CGSM-04
Vaginal moisturizers and lubricants work by different mechanisms: moisturizers increase fluid content in the vaginal epithelium and lower vaginal pH with regular use; lubricants provide short-term friction reduction during sexual activity only and do not treat the underlying tissue change.
Verified
CGSM-05
Vaginal estrogen outperforms non-hormonal moisturizers/lubricants on objective clinical endpoints (vaginal pH, tissue maturation) but not consistently on subjective symptom relief; non-hormonal moisturizers are an evidence-backed option for symptom relief though they do not reverse tissue-level change the way estrogen does.
Verified
CGSM-06
The belief that GSM/vaginal dryness after menopause is 'just normal aging, nothing can be done' is common but false — effective skin-care-slice (moisturizers) and clinical-slice (vaginal estrogen, DHEA, ospemifene) options exist. Unlike vasomotor symptoms, genitourinary symptoms tend to persist rather than spontaneously resolve.
Verified
CGSM-07
Energy-based devices (vaginal CO2 laser, radiofrequency) marketed direct-to-consumer for GSM lack robust efficacy evidence; a systematic evidence review found evidence does not demonstrate efficacy of energy-based therapies for GSM, and a controlled animal-model study found CO2 laser did not improve microcirculatory/epithelial outcomes versus untreated controls while vaginal estrogen did.
Verified
CGSM-08
GSM symptoms overlap with other conditions requiring different treatment (infectious vaginitis, vulvar lichen sclerosus, dermatitis, lichen planus, active UTI, rarely vulvar malignancy); self-attributing new or changing vulvovaginal symptoms to menopause without clinical evaluation risks delayed diagnosis of these other conditions.
Verified
CGSM-09
Black patients' pain and physical symptom reports are documented to be systematically discounted, underestimated, and undertreated relative to white patients across multiple clinical contexts, associated with measurable implicit/perceptual bias and false beliefs about biological differences among clinicians and trainees; this pattern is separately documented specifically within obstetric/gynecologic care as symptom dismissal and credibility discounting.
Verified
CGSM-10
No study was located that reports genitourinary syndrome of menopause (GSM) prevalence, diagnosis rate or treatment rate specifically for Black women (PubMed 'genitourinary syndrome of menopause Black women', run 2026-09-30, 4 results, none reporting GSM prevalence, diagnosis or treatment by race; 'vulvovaginal atrophy race ethnicity prevalence treatment', run 2026-09-30, 0 results; earlier searches listed in the notes). Whether GSM is under-diagnosed or under-treated in Black women is not established by any source located, and no direction or rate is asserted.
Verified
CHFN-1
Acral lentiginous melanoma (ALM) accounts for over 50% of melanomas diagnosed in Black patients, compared to under 3-5% in non-Hispanic White patients.
Verified
CHFN-2
Black patients with acral lentiginous melanoma (ALM) face significantly higher melanoma-specific mortality than White patients with ALM (hazard ratio 2.04, 95% CI 1.31-3.11), despite no significant difference in disease severity at diagnosis between the two groups -- countering the assumption that this disparity is explained by delayed diagnosis and socioeconomic factors alone.
Verified
CHFN-3
Black patients have markedly higher adjusted odds of an acral melanoma diagnosis than non-Hispanic White patients (odds ratio 27.6, 95% CI 24.4-31.2), and Black patients have higher odds of major amputation as surgical management across all melanoma stages even after adjusting for acral histology -- the higher amputation rate is not fully explained by Black patients simply having more acral-subtype melanoma.
Verified
CHFN-4
Socioeconomic status and race both independently associate with survival differences in acral lentiginous melanoma (ALM); Hispanic White and Black patients had higher risk of death vs. non-Hispanic White patients, with hazard ratios attenuating (though not disappearing) after adjusting for SES and stage at diagnosis.
Verified
CHFN-5
A 2024 systematic review of 9 studies (3 case reports, 1 cross-sectional, 5 experimental) on UV nail lamps and skin malignancy rated overall risk-of-bias as high or unclear and concluded prolonged/repeated exposure may pose a low risk of skin cancer, recommending UV-blocking gloves or sunscreen as precautions.
Verified
CHFN-6
A 2025 systematic review of 14 articles on UV nail polish dryer lamps found 5 published SCC cases in patients with a lamp-use history, mixed in-vitro cytotoxicity/mutagenicity results, no melanoma signal in SEER registry data, and 6 of 7 mathematical risk models finding minimal-to-no risk; recommends photoprotection for anticipated long-term use.
Verified
CHFN-7
Direct dosimetry of two UV/LED nail curing lamp types found the UV plus high-energy-visible dose per gel-manicure session is equivalent to roughly 3-6 minutes of midday summer sun exposure at the study's Spanish latitude -- very low carcinogenic potential relative to sunlight, though comparable photoimmunosuppressive potential.
Verified
CHFN-8
The most comprehensive synthesis to date on UV/LED nail lamps (17 studies, PubMed/Scopus/CINAHL through Jan 2024) concludes carcinogenicity remains inconclusive and current evidence is insufficient to mandate gloves or sunscreen, while noting properly-calibrated dosimetry puts non-melanoma skin cancer risk from nail lamps at 11-46x lower than overhead sunlight for equivalent exposure duration; cadaveric nail-plate testing found the nail blocks essentially all UVB but transmits 0.6%-2.4% of UVA to the nail bed.
Verified
CHFN-9
Consumer awareness of UV nail lamp cancer risk is poor: surveyed nail-lamp users showed fewer than a third correctly understood the potential carcinogenic hazard, and only 3% took any precaution (e.g. sunscreen) before treatment -- a similar educational gap was independently found among Polish UV nail lamp users.
Verified
CHFN-10
A focused systematic review + SEER-registry analysis found no reported nonmelanoma or melanoma skin cancer cases in gel-manicure users under age 40, and no shift in melanoma incidence trends 2007-2016 among patients under 65 -- a true but narrow finding (limited to under-40 case reports in its own search window), not a contradiction of the wider, later literature's 'real but low, evidence still thin' conclusion.
Verified
CHFN-11
Two published case reports describe new cutaneous lupus erythematosus skin lesions appearing shortly after patients with existing lupus resumed regular gel-manicure UV exposure over 4-12 years -- a specific, actionable exclusion for photosensitive autoimmune skin conditions.
Verified
CHFN-12
A 2026 California DTSC laboratory study of 178 nail products (21 product types, 52 chemicals tested) found methyl methacrylate (MMA) at concentrations up to 8,760 ug/mL, formaldehyde up to 15,600 ug/mL, and toluene up to 187,000 ug/mL; 92% of tested products contained at least one chemical not on the ingredient label, and products marketed to children were not lower in harmful-chemical content. Modeled noncancer risk from single-product home use every 2-3 days is negligible; exposure and risk are meaningfully higher for people using multiple products and for salon workers.
Verified
CHFN-13
California DTSC maintains an active regulatory listing, 'Nail Products Containing MMA at Concentrations Greater Than 1,000 ppm,' as an Adopted Priority Product; DTSC states MMA can be found as a contaminant in EMA-containing nail products per manufacturer-submitted information -- meaning EMA-labeled/intended products are not lab-guaranteed MMA-free.
Verified
CHFN-14
A 5-year, 13-department retrospective study in Portugal documented 230 confirmed cases of allergic contact dermatitis from (meth)acrylates in nail cosmetics -- 56 in consumers only, 119 mixed consumer/occupational, 55 in technicians only -- with 2-hydroxyethyl methacrylate (HEMA, 90%), 2-hydroxypropyl methacrylate (HPMA, 64.1%), and ethylene glycol dimethacrylate (EGDMA, 54.5%) as the dominant sensitizers, not classic MMA. Confirms gel/dip-powder systems carry their own allergy risk independent of whether MMA or EMA is the base monomer.
Verified
CHFN-15
A 10-year German patch-test surveillance network (114,440 patients tested) confirms (meth)acrylate contact sensitization from nail cosmetics is a real, non-trivial population-level problem among both nail artists and consumers, with HEMA/HPMA/hydroxyethyl acrylate as the leading sensitizers.
Verified
CHFN-16
Case report: a woman using gel manicures recreationally for four months (to protect nails prone to splitting) then began working as a nail technician and developed severe hand/face allergic contact dermatitis plus occupational asthma, patch-testing positive to MMA, HEMA, EGDMA, and hydroxyethyl acrylate -- illustrates a consumer-to-technician sensitization pipeline, not an occupational-only phenomenon.
Verified
CHFN-17
Occupational-context finding (not a customer-exposure claim): despite MMA use being restricted/banned in professional nail liquid monomer since the 1970s, air sampling in 17 Michigan nail salons still detected MMA in 15 of 17 salons at 100-36,000 ug/min, alongside formaldehyde and other VOCs in some salons -- confirms MMA persists in the industry supply chain/air even where products are marketed MMA-free.
Verified
CHFN-18
Occupational-context finding (not a customer-exposure claim): a community-based study of 112 Asian nail salon workers on the US East Coast measured personal MMA exposure at a mean 39.45 ppm and documented self-reported headaches, lightheadedness, and nose/eye/throat/skin irritation emerging or worsening after starting salon work -- confirms customer occasional-visit exposure and technician chronic occupational exposure are genuinely different risk categories and should not share a single risk figure.
Verified
CHFN-19
Foot odor (bromodosis/bromhidrosis) arises from eccrine sweat metabolized by resident skin bacteria (Staphylococcus, Corynebacterium) into volatile compounds, e.g. diacetyl from L-lactate.
Verified
CHFN-20
Foot-odor severity correlates with, and is causally reduced by lowering, Corynebacterium/Staphylococcus bacterial load (topical benzoyl peroxide reduced odor scores in a controlled study).
Verified
CHFN-22
The same dilute apple cider vinegar soak protocol caused mild skin irritation in 72.7% of subjects and did not improve skin barrier integrity.
Verified
CHFN-23
Topical sodium bicarbonate (baking soda) for foot odor specifically: no PubMed-indexed study located.
Verified
CHFN-26
Pitted keratolysis is a distinct bacterial condition causing persistent malodor plus characteristic sole pitting, frequently misdiagnosed as tinea pedis or plantar warts; responds well to correct topical antibiotic/benzoyl peroxide treatment.
Verified
CHFN-27
Inflammatory pitted-keratolysis lesions can leave post-inflammatory hyperpigmentation (PIH); no dedicated Fitzpatrick IV-VI or Black-specific PK prevalence/presentation data was located.
Verified
CHFN-28
Topical aluminum chloride is established first-line conservative hyperhidrosis therapy, but succeeded in only ~2% of a severe, treatment-refractory surgical-referral population before they went to surgery — a refractory-case statistic, not evidence against ordinary antiperspirant use.
Verified
CHFN-29
Callus formation is a protective, adaptive skin response to repeated pressure/friction, not inherently pathological.
Verified
CHFN-30
In people with diabetes, especially with peripheral neuropathy, plantar callus and heel fissures are validated risk markers for foot ulceration.
Verified
CHFN-31
A structured, supervised diabetic foot-care program (including professional callus care and explicit caution against unsupervised 'bathroom surgery') reduces ulcer incidence versus non-compliance.
Verified
CHFN-35
Randomized controlled trials compare salicylic acid patches or plasters with scalpel debridement for foot corns and callosities (CHFN-36), but no controlled trial was located comparing a hydrocolloid or other non-salicylic medicated corn/callus pad with mechanical debridement. The closest located evidence for a hydrocolloid plaster is non-interventional and industry-authored.
Verified
CHFN-36
Randomized controlled trials have compared salicylic acid patches or plasters with scalpel debridement for foot corns and callosities: 62 patients with plantar callosities (pain was significantly lower after scalpel debridement at 15 days and 6 weeks), and 202 adults with corns randomized to scalpel debridement or 40% salicylic acid plasters, with a long-term analysis of 324 corns in 201 participants (corn resolution rate higher in the plaster group, but no significant difference in time to recurrence over 12 months, hazard ratio 1.189, 95% CI 0.780-1.813).
Verified
CHOCL-1
BrioTech ASIN B094MZNW5V ("Pure Hypochlorous Acid Cleanser, Multi-Use, Refill, 1 Gal") contains 0.02% hypochlorous acid (200 ppm) at pH 4.0-5.2, per Briotech's own current product page. This corrects the internal note stating 0.002% (20 ppm) for this SKU and confirms the separate note stating 0.02% (200 ppm).
Verified
CHOCL-3
BrioTech ASIN B094YXS9KX ("Sanitizer Disinfectant", Part No. SD-1G) is EPA registered (EPA Reg. No. 93108-1), contains 0.016-0.019% hypochlorous acid (approx. 160-190 ppm) per its SDS, and its labeled Recommended Use is "Surface sanitizer, disinfectant, and deodorizer" with Restrictions on Use: "External use only" — sold and labeled as a surface product, not marketed as a skin product.
Verified
CHOCL-4
SDS storage and stability instructions for BrioTech Sanitizer Disinfectant (B094YXS9KX / EPA Reg. 93108-1): "Keep only in the original container. Protect from sunlight... Avoid excessive heat, direct sunlight, and freezing temperatures... Material is stable under normal and recommended storage conditions. Use within expiration."
Verified
CHOCL-5
BrioTech ASIN B08S79WTJ4 ("Extra Strength HOCl Cleaner", Part No. EX-1G / Model AIR-1G) contains 500 ppm (0.05%) hypochlorous acid per Briotech's own product page, and is marketed for ULV foggers, humidifiers, and larger cleaning/deodorizing jobs (dental offices, schools, homes) — matching the internal note of 500 ppm for foggers/humidifiers.
Verified
CHOCL-7
Briotech Inc. holds multiple patents/published applications (assignee Briotech, Inc.) covering hypohalous acid compositions and methods of inactivating infectious agents and treating disease/inflammation (e.g., CA3096850A1, EP3773616A2, US20220202853A1, US20230149448A1) and a manufacturing-system patent (WO2022032115A2). None of the located Briotech-assigned patents claim indefinite/guaranteed in-bottle stability ("first drop to last"); one Briotech patent-application family (CA3096850A1) instead discusses a bounded shelf life of "about four to about six weeks in a sealed container" for a related hypohalous-acid embodiment and explicitly states certain claimed compositions do "not include a hypohalous acid stabilizer."
Verified
CHOCL-8
Briotech's own marketing/blog content (distinct from patent claim language) states the company spent "years into solving the stability issues that surrounded HOCl," and gives general shelf-life guidance; a third-party industry blog reports Briotech shared stability-test data showing a claimed half-life "of over 450 days" for its cleaner. This is a manufacturer marketing claim about their own product; the underlying stability-test dataset itself was not located or independently verified by this leg.
Verified
CHOCL-11
Container-material compatibility with HOCl is specific to plastic type, not a blanket "plastic denatures HOCl" rule. HDPE and PET (particularly opaque/white PET, and PET loaded with TiO2 per patent data) are broadly reported by manufacturers and industry sources as HOCl-compatible; Briotech's own guidance states amber/glass is not required for stability and that its products ship in PET. Metal parts (including stainless steel) are reported to corrode and to consume/deplete the oxidant on contact. PVC and unvalidated/"low-grade" plastics are flagged as risk categories by industry sources. The internal note "plastic denatures HOCl, use amber glass" is not supported as written.
Verified
CHOCL-12
HOCl/free available chlorine corrodes metal sprayer components (springs, valves) with repeated contact, which both rusts the part and consumes/depletes the active oxidant in the solution. Practical fix per industry sources: a metal-free / all-plastic pump or trigger sprayer. Useful shopper search terms: "metal-free sprayer," "chemical-resistant trigger sprayer," "PET/HDPE trigger sprayer," "fine mist / airless sprayer, no metal spring." Example listings pulled live (examples of what to search, not recommendations): Amazon, 32oz Clear PET Trigger Sprayer, "Chemical Resistant" (ASIN B096KXP4MG); store.hocl.com, "Fine Mist Spray Bottle for Hypochlorous Acid (HOCL) - 8 oz. PET Plastic," airless/propellant-free, marketed specifically for HOCl.
Verified
CHOCL-14
For eyelid hygiene / blepharitis and meibomian gland dysfunction, 0.01% HOCl (approx. 100 ppm) applied via spray, wipe, or ultrasonic atomization once to several times daily is the concentration used in periocular/lid-margin care; randomized data support atomization protocols of approximately two weeks. 0.01% HOCl eye drops have also been used as adjunctive therapy in infectious keratitis.
Verified
CHOCL-17
A FIFRA/EPA product registration number on an HOCl (or any) disinfectant means that specific formulation was reviewed by EPA's Antimicrobials Division for efficacy and safety data, storage/use parameters, and kill claims before being legally allowed to make a disinfectant claim; FIFRA registration is mandatory for any product marketed with a disinfectant claim in the US, with only narrow minimum-risk exemptions. Verification is done by looking up the EPA Reg. No. on the product label via EPA's NPRO lookup tool or List N/List P.
Verified
CHOCL-19
HOCl fogging/ULV and electrostatic-spraying applications are marketed and used at concentrations up to 500 ppm -- matching Briotech's Extra Strength SKU (leg 1 CHOCL-5, 500 ppm, explicitly labeled for ULV foggers and humidifiers) -- versus the 160-200 ppm range on Briotech's skin/surface-labeled SKUs (leg 1 CHOCL-1, CHOCL-3). Industry guidance for fogging recommends an aerosol particle size under approximately 20 microns. This substantiates the claim that a fogger-labeled product and a skin-spray-labeled product from the same brand are formulated at different (roughly 2.5-3x) concentrations and carry different Directions for Use -- 'a fogger product is not the same as what's on Amazon [for skin]' because the labeled ppm and use-site differ, not because the underlying chemistry differs.
Verified
CHOCL-20
CDC guidance on electrostatic sprayers, foggers, misters, and vaporizers (issued for COVID-19, general chemical-disinfectant applicability) states: only the person applying the product, wearing appropriate PPE, should be in the room during application; the applicator should leave afterward; people should stay out of the treated area for the time specified on the product label/device; chemical residue should be wiped or rinsed per label directions before others re-enter; children and people with asthma are called out by name as more vulnerable, and any disinfectant can trigger an asthma attack. Separately, CDC/EPA state that if a product's label does not include fogging/fumigation/wide-area/electrostatic-spraying directions, EPA has not reviewed data on whether that product is safe and effective applied that way.
Verified
CHOCL-22
Dilution arithmetic (C1V1 = C2V2), verifying the internal-note discrepancy: starting from Briotech's 500 ppm Extra Strength SKU (leg 1 CHOCL-5), a '4:1 dilution' -- read as 1 part concentrate to 4 parts water, i.e. 1/5 of the original strength -- yields 500 / 5 = 100 ppm (0.01%), NOT the 0.002% (20 ppm) figure a Gemini-sourced internal note claimed. To actually reach 0.002% (20 ppm) from a 500 ppm starting solution requires a 25x total dilution (500/20 = 25), i.e. approximately 1 part concentrate to 24 parts water ('about 24:1' additional water, matching the internal correction note). The Gemini-sourced '4:1 dilution of 500 ppm = 0.002%' claim is arithmetically wrong by roughly 20x; the corrected internal note's own figure of 100 ppm (0.01%) for a 4:1 dilution of 500 ppm is arithmetically correct.
Verified
CHOCL-24
The same multi-country Electro-Clean study is itself the closest available independent test of DIY-generator output CONSISTENCY: using nominally the same salt-water-vinegar electrolysis protocol, free-chlorine yield varied roughly 5-fold across sites and builds (259 ppm to 1377 ppm) depending on device scale, electrolysis duration, and current -- i.e., DIY output is not tightly consistent even when following one documented protocol, which is exactly why the study authors recommend erring toward higher target concentrations as a safety margin.
Verified
CHOCL-33
One study located addresses HOCl on toys: atomized Ionless hypochlorous acid water in a nursery school reduced bacteria on rubber and textile toys after 1 hour and on plastic toys after 3 hours (PMID 37758000). No PubMed-indexed study was located addressing HOCl use on phones or electronics, makeup or hair brushes, ultrasonic diffusers, or cut-flower water, and no strong cross-verified industry consensus was located for these items within the time available. Do not present HOCl for these specific items as evidence-backed without follow-up research.
Verified
CHOCL-34
What HOCl should not be used on or mixed with, per cross-source industry guidance and leg 1 findings: (1) should not be mixed with other cleaning chemicals/disinfectants (bleach, hydrogen peroxide, etc.) -- a general 'do not mix' caution repeated across HOCl industry sources, consistent with the CDC's general disinfectant-mixing warnings; (2) should not be stored or repeatedly sprayed through metal-spring sprayer components or reactive-metal (iron, copper, nickel) containers/surfaces, which corrode and deplete the active oxidant (leg 1 CHOCL-11/CHOCL-12); (3) a higher-ppm product labeled for fogging/surface use (e.g., Briotech's 500 ppm Extra Strength SKU) should not be substituted for a lower-ppm product labeled for skin/eye use (leg 1 CHOCL-1, this leg's CHOCL-19) -- the concentrations and Directions for Use are not interchangeable across labeled use-sites even within one brand's product line.
Verified
CHOCL-35
In a French cohort of 607 women (EGEA study follow-up), frequent bleach use for home cleaning (4-7 days/week, 11% of women) was associated with increased odds of current asthma versus non-users (adjusted OR 1.7, 95% CI 1.0-3.0), and was significantly associated with non-allergic asthma (aOR 3.3, 95% CI 1.5-7.1) and specifically non-allergic adult-onset asthma (aOR 4.9, 95% CI 2.0-11.6), plus higher blood neutrophil counts among asthmatic women and higher bronchial hyperresponsiveness/chronic cough among non-allergic women overall. No association was found for allergic asthma.
Verified
CHOCL-36
In a Spanish cross-sectional study of 4,521 women aged 30-65, current employment in domestic cleaning work was associated with asthma versus women who never worked in cleaning (OR 1.46, 95% CI 1.10-1.92); former domestic cleaning work carried an even stronger association (OR 2.09, 95% CI 1.70-2.57). Authors estimate 25% of asthma cases in the study population were attributable to domestic cleaning work. Non-domestic cleaning work (current or former) was NOT significantly associated with asthma in this study -- the effect is specific to domestic/home-type cleaning exposure.
Verified
CHOCL-38
Mixing bleach (sodium hypochlorite) with ammonia-based products produces chloramine gas (irritates eyes, nose, throat, airway: tearing, runny nose, sore throat, coughing, chest congestion); mixing bleach with an acid (including vinegar, or residual acidic cleaner left on a surface) produces chlorine gas. Both are documented, repeatedly-warned-against household hazards (CDC, poison control, children's hospital poison centers).
Verified
CHOCL-39
CDC guidance instructs 'clean first, then disinfect': cleaning with soap and water removes dirt, debris, and most germs from a surface but does not necessarily kill remaining germs; disinfecting (e.g., with bleach solution or an EPA-registered disinfectant) kills germs but does not itself remove soil/dirt -- impurities like dirt can shield germs from a disinfectant's contact, so surfaces should be cleaned before they are disinfected. This directly confirms 'bleach does not remove soil' as CDC-stated guidance, not a claim needing further sourcing.
Verified
CHOCL-40
The current (post-reformulation) Original Pine-Sol Multi-Surface Cleaner formula, per the brand's own published ingredient list, contains NO pine oil -- ingredients are water, alcohol ethoxylates, an alkyl sulfonate surfactant, fragrance, citric acid, colorant, xanthan gum, and a preservative. It IS registered with the EPA as a disinfectant when used full-strength as directed, per the brand's own FAQ, killing 99.9% of germs/household bacteria including Salmonella enterica, Staphylococcus aureus, and Influenza A (Hong Kong strain) on hard, nonporous surfaces; when diluted, the concentrated formula still disinfects. Separately, an older, differently-formulated 'Pine Sol Cleaner Disinfectant' product whose active ingredient WAS pine oil (EPA Reg. No. 5813-36) had its EPA registration cancelled September 21, 2016 -- that cancelled registration is for a different, no-longer-sold formulation, not evidence against the current product's active disinfectant registration.
Verified
CHOCL-42
Household bleach (sodium hypochlorite) corrodes reactive metals including stainless steel, iron, copper and nickel with prolonged/repeated contact, and manufacturers (LG, Samsung, Whirlpool) advise against using it on stainless steel appliance surfaces.
Verified
CHOCL-43
CDC's own guidance for disinfecting with bleach instructs never mixing bleach with any other cleaner or disinfectant, because the combination can release dangerous vapors.
Verified
CHOCL-44
CDC states cleaning (soap and water) removes dirt and most germs but does not necessarily kill remaining germs, while disinfecting kills germs but does not remove soil; CDC's explicit instruction is to clean first, then sanitize or disinfect.
Verified
CHOCL-45
For a homemade bleach sanitizing solution on food-contact surfaces, MSU Extension gives a target concentration of 50-100 ppm available chlorine (verified with chlorine test strips, not pool test strips), distinct from the higher 1:10 bleach dilution (~5,250-6,150 ppm) used for general disinfecting of non-food surfaces.
Verified
CHOCL-46
Hypochlorous acid is a weak acid with a pKa of about 7.5; below that pH the neutral HOCl species predominates over the hypochlorite ion (OCl-), and above it the ion predominates.
Verified
CHOCL-47
The neutral HOCl molecule penetrates bacterial cell envelopes more readily than the negatively charged hypochlorite ion and kills by oxidizing and chlorinating cellular components (sulfhydryl and amino groups on proteins, membranes, nucleic acids), which is why HOCl is a markedly stronger antimicrobial than OCl- at equal free chlorine.
Verified
CINT-1
Vaginal douching disrupts the lactobacilli/hydrogen-peroxide-dominant vaginal ecosystem and is associated with increased bacterial vaginosis (BV) risk and BV recurrence; a Cochrane review of BV treatments found hydrogen-peroxide douching performed worse than standard antimicrobial therapy on both clinical-failure and adverse-event rates.
Verified
CINT-2
Black women douche at markedly higher rates than non-Hispanic White or Mexican-American women (47% vs 17% vs 12.5%/19%), a disparity that persists independent of socioeconomic status.
Verified
CINT-3
Vitiligoid vulvar lichen sclerosus (hypopigmented presentation) is an underrecognized variant in patients with skin of color; the hypopigmentation-contrast presentation is frequently misdiagnosed as vitiligo, which means the case is not biopsied and the scarring/architectural-change/vulvar-SCC-risk pathway lichen sclerosus carries goes unmonitored.
Verified
CKOJIC-4
Kojic acid's known chemical instability (oxidation/degradation) has driven reformulation into more stable derivatives (kojic dipalmitate, kojyl-3-aminopropylphosphonic acid) and novel encapsulated delivery systems (nanoemulsion, ethosomal gel), explicitly developed because plain kojic acid is less stable and penetrates skin less effectively than these alternatives.
Verified
CKOJIC-5
A small, dated patch-test study (5 of 8 kojic-acid product users reacted, out of 220 patients screened; Japan, 1995) found high allergic contact sensitization potential to kojic acid in a clinic population already suspected of cosmetic-related contact dermatitis. This is a different adverse-reaction category (allergic sensitization in a pre-selected clinic population) from the low general irritation rate (5.3%) reported in a much larger, more recent meta-analysis (CAGE-LIP-3 / PMID 36566490, 45 studies / 2359 unselected trial patients); the two findings measure different endpoints in different populations and are not contradictory, but neither settles the other.
Verified
CKOJIC-6
A split-face RCT (n=30, Thailand) comparing 5% alpha-arbutin + 2% kojic acid cream against gold-standard triple combination cream (hydroquinone/tretinoin/steroid) for melasma found similar efficacy on melanin index and mMASI, but significantly lower recurrence after treatment discontinuation and fewer adverse effects (erythema, stinging) with the arbutin/kojic acid cream.
Verified
CKOJIC-7
No PubMed-indexed study was located that stratifies kojic acid-specific efficacy, irritation or sensitization outcomes by Fitzpatrick type. Studies of kojic acid-containing products report Fitzpatrick ranges without isolating kojic acid: a 12-week clinical evaluation of a tranexamic acid, kojic acid and niacinamide serum in Brazilian women of Fitzpatrick types I-IV (PMID 31141852), and a six-woman case series with a compounded kojic acid-containing mask after 1,927-nm laser in Fitzpatrick III-V (PMID 42499700).
Verified
CKOJIC-9
EWG Skin Deep flags kojic acid with a HIGH "use restrictions" rating and moderate allergy/immunotoxicity concern. An EU regulatory draft opinion (2012) states kojic acid is unsafe for use on injured or damaged skin and recommends use/concentration restrictions. The U.S. Cosmetic Ingredient Review's 1% safe-use finding applies specifically to leave-on cosmetics; soap-format products are not required to disclose or hold to that ceiling, and marketed kojic-acid soap concentration is manufacturer-undisclosed and varies widely.
Verified
CKOJIC-10
Multiple dermatologist-sourced consumer health sources independently confirm contact dermatitis (redness, swelling, itching, pain) as kojic acid's most common documented adverse reaction, more likely at concentrations above 1% or with prolonged/repeated skin contact. Soap-format marketing and common user behavior (leaving soap on skin longer, using it more frequently, to compensate for wash-off contact time) directly increase exposure duration/frequency versus the leave-on, controlled-concentration use pattern the safety data was built on.
Verified
CLED-3
In a single-center human study of melanocompetent Fitzpatrick III-VI subjects, visible LED exposure produced dose-responsive pigment darkening in 80% of subjects beginning at 60 J/cm2.
Verified
CLED-4
In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
Verified
CLED-6
A multicenter randomized double-blind sham-controlled study of a home-use mask using 630-nm LED and 850-nm IRED reported improvement in crow's feet after 16 weeks and described the treatment as safe, well-tolerated, and painless.
Verified
CLED-7
No PubMed-indexed study was located that directly tests a named consumer home LED mask for prevention or clearance of post-inflammatory hyperpigmentation in Fitzpatrick IV-VI skin.
Verified
CLEMON-1
Raw lemon or lime juice applied to skin followed by UV/sun exposure is a well-documented cause of phytophotodermatitis -- a phototoxic reaction via furocoumarin photosensitization producing burn-like erythema and blistering. Documented including in a pediatric case requiring burn-center admission.
Verified
CLEMON-2
The phytophotodermatitis injury from citrus contact resolves into hyperpigmentation at the injury site as part of the melanocyte response to acute UV overexposure -- i.e. the lightening practice can directly cause new, visible hyperpigmentation rather than lightening.
Verified
CLIP-1
Lip vermilion lacks sebaceous glands, sweat glands, and hair follicles, and has a thinner, less protective stratum corneum than facial skin, contributing to greater trans-epidermal water loss and vulnerability to irritants/penetration.
Verified
CLIP-3
Lipstick and lip-balm ingestion is a real, quantifiable exposure pathway for trace metals (notably lead), but modeled/measured exposure in most studied products does not raise blood lead above background/regulatory concern for typical consumer use; risk concentrates in specific colorants (e.g., lead-chromate-based orange/pink pigments) and high-frequency/occupational use.
Verified
CLIP-5
Allergic contact cheilitis is a well-documented condition caused primarily by cosmetic and personal-care product ingredients (fragrance, flavorings, preservatives, sunscreen filters, castor oil, propolis/beeswax residue), confirmed via patch testing in dermatology clinic populations.
Verified
CLIP-8
Hydroquinone- and mercury-containing skin-lightening products remain widely available outside regulatory limits and are disproportionately used by and marketed toward people with darker skin; measured products contain hydroquinone at concentrations exceeding legal thresholds and sometimes added corticosteroids.
Verified
CLIP-9
Prolonged unregulated use of hydroquinone-containing skin-lightening products, often combined with topical corticosteroids, is associated with exogenous ochronosis and, in a documented case series, with cutaneous squamous cell carcinoma.
Verified
CLIP-11
Lip darkening is a normal pigmentary variant correlated with constitutive skin melanin, not necessarily an effect of smoking, though tobacco smoking is independently documented to cause labial and buccal mucosal melanosis via a separate mechanism (tar/nicotine-associated melanocyte stimulation).
Verified
CLIP-12
Centrofacial melasma, a hyperpigmentation disorder disproportionately affecting Fitzpatrick IV-VI skin, commonly involves the upper lip as one of its classic anatomic sites alongside cheeks, forehead, nose, and chin.
Verified
CLIP-13
Cosmetic lip micro-pigmentation ('lip blush'/'dark lip neutralization' tattooing), marketed specifically to darker-lipped clients as a corrective procedure, carries a documented risk of adverse pigmentary tattoo reactions, including lichenoid reactions producing new pigmented macules.
Verified
CLIPS-1
Actinic cheilitis is a potentially malignant lower-lip condition driven by chronic UV exposure; risk factors include age, male sex, fair phototypes, and tobacco; clinically it presents as dryness, scaling, atrophy, and indistinct borders; malignant transformation to squamous cell carcinoma is reported at 10–30%.
Verified
CLUBE-1
Hyperosmolar personal lubricants (osmolality above ~1500 mOsm/kg, roughly 4x physiologic vaginal fluid osmolality of 370±40 mOsm/kg) cause dose-correlated cytotoxicity, loss of intercellular junctions, and epithelial barrier disruption in human vaginal epithelial cell monolayer and 3D tissue models; lubricants under ~400 mOsm/kg show no such damage.
Verified
CLUBE-2
Nonoxynol-9 causes epithelial disruption, histologic inflammation, and reduction of protective lactobacilli with repeated use, and paradoxically increases susceptibility to HIV and HSV-2 transmission rather than providing protection.
Verified
CLUBE-3
Intravaginal use of petroleum jelly as a lubricant is associated with significantly increased bacterial vaginosis risk — adjusted relative risk 2.2 (95% CI 1.3-3.9) in a US cohort (40% African American) and odds ratio 2.8 (95% CI 1.4-5.6) in a Kenyan cohort.
Verified
CLUBE-5
Animal toxicology on decamethylcyclopentasiloxane (D5) exists, including endocrine and reproductive endpoints in rats and a two-year inhalation bioassay with uterine tumors at the highest concentration (CLUBE-9). No study was located reporting human endocrine or cancer outcomes from cyclomethicone or cyclopentasiloxane exposure (CLUBE-10).
Verified
CLUBE-6
No PubMed-indexed study was located testing irritation or sensitization from parabens specifically on genital or vulvar skin. Adjacent literature exists: a systematic review of chemicals in menstrual products reports parabens among the chemicals detected and notes vaginal and vulvar tissue is highly permeable (PMID 37743685); a narrative review discusses endocrine disruptors including parabens and the female genital tract microbiome (PMID 40868824); and one case report describes genital allergic contact dermatitis with a positive patch test to paraben mix among other allergens (PMID 15518180).
Verified
CLUBE-7
The WHO's 2012 lubricant safety advisory (WHO/UNFPA/FHI360, cited secondarily via Ayehunie et al. 2017) recommends lubricant osmolality remain at or below approximately 1200 mOsm/kg; many commercial water-based lubricants test at 2,000-6,000+ mOsm/kg, well above this threshold.
Verified
CLUBE-8
No study was located evaluating personal-lubricant ingredient irritation specifically on Fitzpatrick IV-VI skin or on genital or perineal tissue in Black or brown populations. Population-relevant evidence located is on bacterial vaginosis (BV), not irritation: a 2025 observational comparison of BV incidence after a single hyperosmolal lubricant exposure reported a secondary analysis in Black participants (N = 73), in which 88% (23/26) of new-onset or newly symptomatic BV cases occurred in Black participants; it reports race, not Fitzpatrick type.
Verified
CLUBE-9
Animal toxicology of decamethylcyclopentasiloxane (D5) exists: a two-year inhalation bioassay in Fischer 344 rats found an increase in uterine endometrial adenocarcinomas at the highest concentration (8% incidence at 160 ppm), which has been examined for mode of action and relevance to humans; oral D5 for four weeks in female rats increased ovarian follicle numbers and gonadotropin and estradiol and reduced progesterone; a 14-day rat feeding study reported an effect on estradiol production; and a 2024 review addresses dermal absorption of cyclic and linear siloxanes. These are animal or review data, not studies of human outcomes from lubricant use.
Verified
CLUBE-10
No PubMed-indexed study was located reporting human endocrine or cancer outcomes from exposure to cyclomethicone or cyclopentasiloxane. Human data retrieved concern exposure only (plasma concentrations of cyclic volatile methylsiloxanes in Norwegian women) or in vitro human breast epithelial cells.
Verified
CMASK-2
The Cosmetic Ingredient Review (CIR) Expert Panel assessed 8 naturally-sourced cosmetic clay ingredients (including kaolin) and concluded they are safe in cosmetics at present practices of use and concentration, with one exception: available data are insufficient to establish safety in products that may be incidentally inhaled.
Verified
CMASK-3
Retail 'healing clay' products purchased for laboratory use (including a calcium-bentonite product sold under the Aztec Secret brand name, a French green clay, and an 'ultra-pure' sodium bentonite) were found via ICP-MS to contain arsenic and lead; USP limits for bentonite clay products are cited as 40 ppm lead and 5 ppm arsenic. Daily topical application of one tested clay (French green) for 2 weeks produced measurably elevated lead concentrations in mouse liver and kidney versus saline-treated controls, with no significant change in a lead-toxicity enzyme marker (ALAD) or in arsenic tissue levels.
Verified
CMASK-4
The FDA issued a 2016 consumer safety warning after its own laboratory analysis (triggered by a Minnesota Department of Health alert) found elevated lead levels in 'Bentonite Me Baby' by Alikay Naturals, a calcium bentonite clay product; the FDA and the manufacturer both stated no confirmed human lead-poisoning cases were tied to the product at the time.
Verified
CMASK-5
The California Attorney General filed a Proposition 65 enforcement complaint alleging that Wakaya Perfection bentonite clay powder and related 'detox' products (including masques and detox capsules) contained lead and/or inorganic arsenic at levels exceeding Prop 65 safe-harbor thresholds, and that the company's 'non-toxic' marketing claims were false or misleading.
Verified
CMASK-7
In a randomized trial of three sheet-mask types (plain water, hyaluronan, bifida ferment lysate) worn for 5/15/25/40 minutes, hydration and TEWL rose then fell with wear time; sebum rose with all mask types especially after 40 minutes. Wear under 25 minutes improved hydration and reduced redness; longer wear (especially plain water masks over 25 minutes) increased dryness (57% of subjects) and redness (11% of subjects).
Verified
CMASK-8
A single-manufacturer clinical program on a >92%-native-bovine-collagen sheet mask reported improved hydration and skin roughness (versus a pre-soaked cellulose sheet mask), reduced UV-induced erythema, reduced eye-wrinkle volume, and maintained skin-microbiome diversity, with good tolerability including on atopic-dermatitis-lesional skin.
Verified
CMASK-10
No PubMed-indexed human clinical study was located for Fuller's earth / Multani Mitti as a facial mask ingredient. Oil/sebum absorption is mechanistically plausible by the same clay-adsorption pathway verified for kaolin and bentonite (CMASK-1, CMASK-2), which is an inference, not a finding for Fuller's earth. The 'mild bleaching' / pigmentation-lightening claim found circulating in consumer sources is anecdotal and not clinically verified.
Verified
CMASK-12
Small formulation/optimization studies of polyvinyl-alcohol (PVA) film-forming peel-off masks (polyherbal and red-bean-extract formulations) reported acceptable physicochemical properties and no observable irritation in an in vitro HET-CAM chorio-allantoic-membrane assay or a small in-vivo skin-analyzer irritation check.
Verified
CMELDISP-1
Black patients with melanoma have longer time to definitive surgical treatment (TTDS) than non-Hispanic White patients; racial differences in TTDS persist within each insurance type.
VerifiedOne of 2 sources behind this claim · see the other
The record
Tripathi et al. 2020, J Am Acad Dermatol, PMID 32277971, DOI 10.1016/j.jaad.2020.03.094
VerifiedOne of 2 sources behind this claim · see the other
The record
Shao & Feng 2022, J Clin Aesthet Dermatol, PMID 35942012
CMELDISP-2
UK national registry data (2013-2020) confirms acral lentiginous melanoma incidence is highest in the Black ethnic group despite overall melanoma incidence being 16x lower in Black than White ethnic group; ALM less likely referred on Urgent Suspected Cancer pathway, more likely to present late. Cross-national confirmation of existing US-sourced ALM canon (CHFN-1 through CHFN-4).
VerifiedOne source behind this claim
The record
Ahmed et al. 2026, Br J Dermatol, PMID 40926687, DOI 10.1093/bjd/ljaf352
CMELDISP-3
In genitourinary melanoma (a rare subtype occurring overwhelmingly in women), predictors of poor survival were increasing age, Black race, and female sex — named as independent factors in the same statistical model.
VerifiedOne source behind this claim
The record
Vyas et al. 2016, J Am Acad Dermatol, PMID 27317515, DOI 10.1016/j.jaad.2015.10.015
CMELDISP-4
In vulvar/vaginal melanoma specifically, median survival for Black patients was 16 months versus 39 months for non-Black patients — a far larger racial gap than in cutaneous melanoma overall (124 vs 319 months, same dataset).
VerifiedOne source behind this claim
The record
Mert et al. 2013, Int J Gynecol Cancer, PMID 23765206, DOI 10.1097/IGC.0b013e3182980ffb
CMELDISP-5
In a California cohort of women of childbearing age (15-44) with melanoma, worse survival was associated with Asian, Black, and Native American race/ethnicity vs non-Hispanic White women, independent of pregnancy status; pregnancy itself had no significant effect on survival.
VerifiedOne source behind this claim
The record
Kiuru et al. 2022, J Eur Acad Dermatol Venereol, PMID 35870141, DOI 10.1111/jdv.18458
CMELDISP-6
Squamous cell carcinoma, not basal cell carcinoma, is the most common skin cancer type in Black/African American patients — the inverse of the general (majority-White) population pattern where BCC predominates. A 1987 case series found BCC was 30% of skin cancers in Black patients vs 80% in a contemporaneous White-patient survey; a 2023 modern biopsy cohort independently confirms the same inversion.
VerifiedOne of 3 sources behind this claim · see the others
The record
Bang et al. 1987, J Natl Med Assoc, PMID 3820333
VerifiedOne of 3 sources behind this claim · see the others
The record
Stan et al. 2023, Am J Dermatopathol, PMID 38153289, DOI 10.1097/DAD.0000000000002592
VerifiedOne of 3 sources behind this claim · see the others
The record
Halder & Bridgeman-Shah 1995, Cancer, PMID 7804993
CMELDISP-7
An estimated 20-40% of cutaneous squamous cell carcinoma in Black/African American patients arises from chronic scarring or inflammatory processes (burn scars, chronic skin ulcers, radiation sites, discoid lupus erythematosus) — a mechanistically distinct pathway from sun-exposure-driven SCC.
VerifiedOne of 2 sources behind this claim · see the other
The record
Harb et al. 2017, J Drugs Dermatol, PMID 28914954
VerifiedOne of 2 sources behind this claim · see the other
The record
Halder & Bridgeman-Shah 1995, Cancer, PMID 7804993
CMELDISP-9
In an insured cohort (Kaiser Permanente Southern California, 1988-2018), no significant racial/ethnic survival disparity was found for cutaneous angiosarcoma, dermatofibrosarcoma protuberans, Merkel cell carcinoma, or sebaceous carcinoma — contrary to the disparity pattern in melanoma and SCC. Authors frame this as evidence healthcare access, not race or biology, drives many observed skin-cancer survival disparities.
VerifiedOne source behind this claim
The record
Rosenthal et al. 2023, J Am Acad Dermatol, PMID 37714218, DOI 10.1016/j.jaad.2023.08.087
CMELDISP-10
Black and Hispanic patients with Merkel cell carcinoma more often present on UV-protected body sites, which are more likely to be virus-positive Merkel cell carcinoma — a subtype with significantly better prognosis than virus-negative disease.
VerifiedOne source behind this claim
The record
Martin et al. 2025, J Am Acad Dermatol, PMID 41242630, DOI 10.1016/j.jaad.2025.11.023
CMIST-1
In one randomized hydration study, cream alone produced favorable moisturization, especially for dry skin; repeated toner complemented cream better than repeated spray water. This was not an identical-formula format comparison.
Verified
CNAIL-1
Repeated soak-off/peel removal of gel polish causes measurable nail plate thinning and damage (pseudoleukonychia, onychoschizia lamellina), confirmed by ultrasound and reflectance confocal microscopy pre/post measurement in a small case series.
Verified
CNAIL-2
Longitudinal melanonychia striata with a brown/black dermatoscopic background in Fitzpatrick IV-VI patients is, in the large majority of biopsied cases, benign racial hypermelanosis rather than malignant nail matrix disease -- distinguishable from concerning (single-digit, changing, Hutchinson-sign-positive) presentations via dermatoscopy.
Verified
CNAT-COFFEE-REVIEW-1
PMID 38099120 reviews preclinical and clinical evidence for caffeine in skincare; it does not establish that DIY coffee-ground scrubs deliver equivalent doses or outcomes.
Verified
CNAT-GINGER-REVIEW-1
PMID 41305557 reviews ginger bioactives in allergy modulation, including preclinical mechanisms and early clinical evidence in rhinitis and asthma; clinical results remain heterogeneous.
Verified
CNAT-WITCHHAZEL-3
Aqueous witch hazel bark extract and isolated hamamelitannin reduced inflammatory mediator release (ROS, IL-1beta, CXCL-8, TNF-alpha) from human neutrophils/keratinocytes, supported keratinocyte migration in vitro and inhibited S. aureus growth (MIC 0.5 mg/mL). Preclinical only; no human facial-skin trial.
VerifiedOne source behind this claim
The record
Skowrońska W, Pawłowska KA, Obrębski M, Piwowarski JP, Żyżyńska-Granica B, Granica S. J Ethnopharmacol 2025 Aug;353(Pt B):120433. PMID 40819781
CNETSPONGE-1
Loofah/net sponges support growth of pathogenic bacteria (Pseudomonas, Klebsiella, Xanthomonas, Enterococcus, group B Streptococcus) and are a documented reservoir/vehicle for transmitting them to skin, including a traced case of Pseudomonas aeruginosa folliculitis from a contaminated loofah; regular decontamination (10% bleach) is recommended.
Verified
CODOR-1
Baseline vaginal/vulvar odor (mild, musky, or slightly acidic) is a normal feature of the area's resident bacterial flora and is not itself a sign of poor hygiene or infection.
Verified
CODOR-2
The anogenital region, along with the axillae and areolae, is a classic apocrine-sweat-gland-bearing site; apocrine secretions are broken down by resident skin bacteria into body odor.
Verified
CODOR-3
Vaginal odor and discharge normally vary across the menstrual cycle as part of dynamic, non-pathological shifts in the vaginal microbiome.
Verified
CODOR-4
Bacterial vaginosis (BV) prevalence is estimated at 10-20% among White women and 30-50% among Black women.
Verified
CODOR-5
Bacterial vaginosis is diagnosed clinically via Amsel criteria (thin gray-white discharge, vaginal pH >4.5, positive KOH whiff/amine odor test, clue cells on microscopy); 3 of 4 criteria confirm diagnosis. The characteristic fishy odor is a specific clinical sign, not reliably self-diagnosable.
Verified
CODOR-6
Vaginal douching disrupts the lactobacilli-dominant vaginal ecosystem and is consistently associated with increased risk of bacterial vaginosis and mixed vaginal infections across multiple independent studies.
Verified
CODOR-7
A Cochrane systematic review (24 trials, 4,422 participants) found hydrogen-peroxide vaginal douching performed worse than a single dose of oral metronidazole for treating bacterial vaginosis on both clinical-failure (RR 1.75) and adverse-event (RR 2.33) measures.
Verified
CODOR-8
Black women report significantly higher use of vaginal douches, feminine spray, feminine powder, and feminine wipes/towelettes than White or Mexican American women.
Verified
CODOR-9
Vaginal douching is associated with higher urinary phthalate (MEP) concentrations in a dose-response relationship, and douching statistically mediates a significant portion of the Black-white disparity in phthalate exposure.
Verified
CODOR-10
Black, Latina, and Mixed Race women report the highest regular use of feminine wash/wipes/spray as a product class among US women; White and Vietnamese women report the lowest.
Verified
CODOR-11
Lactobacillus vaginal tablets/probiotics have not been shown to significantly reduce recurrence of bacterial vaginosis in randomized controlled trials; oral probiotics in pregnancy show no significant benefit for BV or vulvovaginal candidiasis clearance.
Verified
CODOR-13
"Freshness"/feminine-hygiene marketing has a documented history of specifically targeting Black women's insecurity about vaginal odor (1920s-1960s Lysol advertising in the Black press; the 2011 Summer's Eve 'Hail to the V' campaign's ethnically-coded ad copy).
Verified
CODOR-14
No PubMed-indexed study testing a benefit of vaginal steaming or general-wellness 'vaginal detox' products (yoni pearls) was located. The published items located are one case report of second-degree burns after vaginal steaming (PMID 30366886), qualitative studies of perceptions and representations of vaginal steaming (PMIDs 41618892, 27719108), and other items on vaginal hygiene practices.
Verified
CPAN-2
Panthenol/dexpanthenol use is associated with reduced diaper dermatitis severity in observational (non-RCT) research.
Verified
CPEEL-1
No PubMed-indexed study was located evaluating PPET ("Permanent Pigment Eraser Treatment") or any silicone-tape-plus-abrasion peel protocol for melasma or dark-spot removal.
Verified
CPEEL-8
No PubMed-indexed study was located testing a retail, over-the-counter, at-home peel PAD product (as distinct from an in-office professional peel) for efficacy or PIH risk, in Fitzpatrick IV-VI skin or any population.
Verified
CPEPTAN-1
Melanotan I/II and afamelanotide are synthetic analogs of alpha-melanocyte-stimulating hormone (α-MSH) that bind the melanocortin-1 receptor (MC1R) and stimulate melanogenesis.
Verified
CPEPTAN-2
Afamelanotide is the only alpha-MSH analog with regulatory approval (EU, for phototoxicity prevention in erythropoietic protoporphyria), administered as a dosed, controlled-release subcutaneous implant under medical supervision; long-term studies (up to 8 years) report no late effects in this supervised context.
Verified
CPEPTAN-3
Multiple independent case reports (Ireland, UK, Germany, Belgium/Netherlands, Sweden, Spain, Australia, US) document new eruptive/atypical/dysplastic nevi and darkening or growth changes in pre-existing moles following unregulated melanotan I/II use; case reports alone do not establish direct causation.
Verified
CPEPTAN-4
A 2017 dermatology review identifies at least four case reports of melanoma emerging from existing moles during or shortly after melanotan use and names unregulated melanotan use as a public-health concern.
Verified
CPEPTAN-5
A 2025 case report describes oral mucosal malignant melanoma following use of a melanotan II nasal spray.
Verified
CPEPTAN-6
Melanotan-associated dermoscopic changes in existing nevi have been documented to make visual differentiation from melanoma difficult, independent of any causation question.
Verified
CPEPTAN-7
Melanotan II sold illegally online has been chemically analysed: vials bought from three online shops contained unknown impurities of 4.1 to 5.9% in two shops' products and 4.32 to 8.84 mg of melanotan II per vial against the 10 mg each shop claimed (PMID 24771717), and a forensic laboratory found a purity of 30% in one vial labelled melanotan II (PMID 39302005, a single case report). A review states that illegal melanotans are likely risky, with questions regarding their preparation, administration and dosage (PMID 28266027). No PubMed study was located on the sterility of illicit melanotan supply (PubMed 'melanotan sterility', run 2026-09-30, 1 result, PMID 24280586, a single user case study that does not test sterility).
Verified
CPEPTAN-8
No PubMed-indexed study was located examining melanotan/alpha-MSH-analog effects specifically in Fitzpatrick IV-VI or melanin-rich populations; located case reports are concentrated in fair-skinned clinical populations.
Verified
CPFB-6
An entrapped PFB hair left to grow to about 10 mm is pulled back out of the inflammatory papule and the lesion regresses; discontinuing hair removal for about 30 days is the conventional first step.
CPFB-8
In the Dakar police-student cross-sectional study, PFB was associated with acne keloidalis nuchae (OR 8.8, 95% CI 5.55-14.08), family history of PFB (OR 5.0) and male sex (OR 5.7); overall PFB prevalence was 38.8% (43.7% in men).
VerifiedOne source behind this claim
The record
Seck B, Diallo M, Ndiaye MT, Bouidida B, Diatta BA, Ndiaye M, Diop A, Diadie S, Seck NB, Ly F, Niang SO. Med Trop Sante Int 2024 Apr;4(2). PMID 39099716
CREPEL-1
Picaridin is as efficacious as DEET as a topical insect repellent with a lower toxicity risk; concurrent use of picaridin with sunscreen may decrease percutaneous absorption of both compounds, whereas concurrent use of DEET with sunscreen results in significantly higher absorption of both. Inorganic (mineral) sunscreens show little or no percutaneous absorption versus organic filters.
Verified
CREPEL-2
In a formulation trial against host-seeking Aedes aegypti, picaridin and DEET gel formulations at 20% and 33% provided equal or better biting protection than commercial cream formulations at similar concentrations for up to 48 hours; military users' most common complaint with topical repellents is oily/greasy residue (a compliance issue).
Verified
CREPEL-3
Controlled laboratory study (15 volunteers): DEET-based repellents gave the longest complete protection (a 23.8% DEET product: mean 301.5 minutes); a soybean-oil repellent 94.6 minutes; an IR3535 product 22.9 minutes; all other botanical repellents tested under 20 minutes; a moisturizer commonly claimed to repel mosquitoes was among the products tested; repellent-impregnated wristbands offered no protection.
Verified
CRICE-2
Isolated/purified rice-derived compounds (ethyl acetate extract of Oryza sativa Indica panicle, rice-derived glucosylceramides/elasticamide, purple glutinous rice extract) show tyrosinase-inhibitory and anti-melanogenic activity in cellular, animal, and limited human-trial models. A 2022 systematic review of 50 studies found the Oryza sativa panicle ethyl-acetate extract to be one of only two plant extracts (with ginsenoside F1) proven effective specifically in human trials, versus cellular/animal-only evidence for most other plant actives reviewed.
Verified
CSPOT-1
Progressive macular hypomelanosis (PMH) is frequently misdiagnosed and treated inadequately with antifungals or topical steroids; it is common, particularly in Fitzpatrick skin types IV–VI.
CSPOT-2
Treatment of choice for PMH is 1% clindamycin lotion by day, 5% benzoyl peroxide gel at night, plus UVA irradiation three times weekly for 12 weeks. PMH lesions show red follicular fluorescence under Wood's light that is absent in normal skin; Propionibacterium (Cutibacterium) acnes is cultured from lesional follicles and not from normal follicles. Distribution is the trunk, often confluent around the midline, rarely extending to proximal extremities and neck/head.
CSPOT-3
Complete repigmentation of PMH was achieved with narrowband UVB phototherapy plus benzoyl peroxide wash and clindamycin lotion in an adolescent female (single case).
CSPOT-4
Coral-red perifollicular fluorescence under Wood's lamp is characteristic of PMH (present extralesionally on the back even in extra-truncal presentations); one biopsy-confirmed case showed complete response to antimicrobial therapy plus sun exposure.
CSPOT-5
In PMH, KOH examinations are negative; the back is the most common site (also abdomen); mean age of onset ~21 years; lesional melanocyte counts (S-100) do not differ from perilesional skin — the hypopigmentation is reduced melanin, not fewer melanocytes.
CSPOT-6
Narrowband UVB therapy produced >90% repigmentation in 56.2% (9/16) of PMH patients and ≥50% repigmentation in 81.3%, with excellent color match and no recurrence in 68.7% at ~13 months (uncontrolled, non-blinded prospective study).
CSPOT-7
In a 108-patient retrospective PMH series, 38% treated with topical antimicrobials and 90% treated with phototherapy achieved remission; after 2 years, relapse occurred only in the phototherapy group; 23% of untreated patients recovered spontaneously. Authors suggest combining antimicrobials with NB-UVB to hasten recovery and minimize relapse.
CSPOT-8
Pityriasis alba is a common benign condition in children; lesions normally resolve within months to years without intervention; emollients and mild topical corticosteroids may accelerate repigmentation but have limited efficacy; incidence correlates with atopy, sun exposure, lack of sunscreen use, and bathing frequency.
CSPOT-9
A Wood's lamp (340–450 nm, max 365 nm) aids diagnosis of dermatoses with characteristic fluorescence, including tinea capitis, erythrasma, tinea versicolor, Pseudomonas infections, porphyrias, and pigmentary alterations.
CSPOT-10
Coral-red UV-induced fluorescence is a bacterial porphyrin signal (Corynebacterium minutissimum / erythrasma); tinea versicolor and candidiasis lack coral-red fluorescence. A bacterial mimic of tinea versicolor persisted through multiple antifungal courses with a negative KOH until UV fluorescence identified it, then cleared on antibacterial therapy.
CSPOT-11
Vitiligo lesions exhibit bright blue-white fluorescence under Wood's lamp (PMID 39723023, a background statement in a pediatric case report). No PubMed study was located that states the Wood's lamp appearance of pityriasis alba (PubMed 'pityriasis alba Wood lamp', run 2026-09-30, 1 result, PMID 40708909, a dermoscopy paper that does not state it). A Wood's lamp appearance is a clinical sign, not a diagnosis; light spots that persist or spread should be evaluated by a clinician.
CSPOT-12
Tinea versicolor reliably fluoresces coppery yellow-green under a Wood's lamp.
CSUN-1
In a predominantly skin-of-color patient survey, the most common reported barrier to daily sunscreen use was forgetting to apply it, followed by the perception that sunscreen is unnecessary when spending most of the day indoors; non-Hispanic Black patients were less likely than other groups to prioritize how the product feels/looks; Hispanic/Latino patients were less likely to prioritize broad-spectrum protection.
Verified
CSUN-2
Acral lentiginous melanoma (ALM) — the melanoma subtype disproportionately affecting Black, Hispanic, and Asian patients (occurring on palms, soles, and nail beds) — is not primarily induced by UV radiation. Its pathogenesis is instead associated with mechanical stress/trauma on weight-bearing or high-friction glabrous skin and distinct recurrent mutations (KIT, NF1, TERT, TP53), not cumulative sun exposure.
Verified
CSUN-3
Global and regional population-attributable-fraction studies of UV-radiation-attributable cutaneous melanoma explicitly exclude or separately adjust for acral lentiginous melanoma because it is understood to be non-UV-associated — this is a structural feature of how melanoma epidemiologists calculate sun-exposure burden, not a fringe position.
Verified
CSUN-4
No primary literature was located that directly studies sunscreen application, coverage, or reapplication specifically at acral sites (palms, soles, nail beds/folds) as a skin-cancer-prevention or photoprotection intervention.
Verified
CSUN-5
A 2025 Australian open-label RCT (Sun-D Trial, N=639, general population, not Fitzpatrick-stratified) found that routine daily application of SPF50+ sunscreen over ~1 year measurably LOWERED serum 25(OH)D vitamin D concentration versus discretionary sunscreen use, and increased vitamin D deficiency prevalence at study end (45.7% vs 36.9%, prevalence ratio 1.33, 95% CI 1.14-1.55). This contradicts common consumer-facing reassurance that sunscreen has no meaningful real-world effect on vitamin D.
Verified
CTHIA-3
Randomized double-blind vehicle-controlled trial, 200 participants (Thailand, both sexes), 12 weeks, 0.2% thiamidol cream vs vehicle: mMASI reduction 36.1% vs 16.1% at week 12 (P<0.001); physician global assessment improved; patient global assessment and digital colour analysis showed no significant difference between groups; no effect on freckles or solar lentigines; no significant adverse events.
Verified
CTHIA-4
Double-blinded randomized split-face study, women with mild-to-moderate melasma, 12 weeks: thiamidol improved mMASI significantly more than hydroquinone; 79% improved on thiamidol side vs 61% on hydroquinone; ~10% worsened on hydroquinone side, none on thiamidol side.
Verified
CTHIA-5
Thiamidol-containing regimen significantly improved acne-related PIH over 12 weeks in a vehicle-controlled double-blinded randomized study and an observational study; suction-blister-induced PIH sites treated with thiamidol were significantly lighter than control from week 2.
Verified
CTHIA-8
Allergic contact dermatitis to isobutylamido thiazolyl resorcinol (thiamidol) documented by patch testing (case report).
Verified
CTHIA-9
Uncontrolled case series, 10 Indian women, Fitzpatrick III-V, melasma, 0.2% thiamidol twice daily for 12 weeks: mean mMASI reduction 34.4%; patient satisfaction 62%; adverse effects minimal and self-limiting.
Verified
CTOOTH-3
Toothpaste applied to burned or otherwise compromised skin as home first aid is a documented, clinically discouraged practice.
Verified
CTOOTH-4
In Fitzpatrick IV-V skin, a daily broad-spectrum sunscreen containing sclareolide and niacinamide significantly prevented pigmentation induced by controlled UV and visible-light exposure with or without tape stripping (investigator-masked randomized intra-individual study, n=20). The trial tests a sunscreen, not toothpaste, and does not itself establish that irritation from any product worsens PIH.
Verified
CTOYC-1
Benzalkonium chloride (BZK), the dominant active antibacterial ingredient in most commercial sex-toy cleaners (~0.10% per ingredient-disclosure survey), is directly cytotoxic to vaginal epithelium and was found more damaging to vaginal mucosa than nonoxynol-9, sodium dodecyl sulfate, or sodium monolaurate in a comparative microbicide-safety study (fastest/strongest IL-1 and IL-6 induction).
Verified
CTOYC-2
In a mouse model, intravaginal benzalkonium chloride produced dose-dependent vaginal toxicity (colposcopic changes, epithelial thinning, increased HSV-2 susceptibility, inflammatory cell infiltration); toxicity was detectable across all safety measures at 0.2% and above, and epithelial thinning was detectable by histology alone even at 0.02% — one-fifth the concentration typically disclosed in commercial toy cleaners.
Verified
CTOYC-3
Benzalkonium chloride, alongside nonoxynol-9, is characterized in review literature as an effective spermicide that is nonetheless toxic to the vaginal epithelium and does not provide protection against sexually transmitted infections.
Verified
CTOYC-4
Benzalkonium chloride is used as a standard positive irritant/damage-control benchmark in vaginal-mucosal-toxicity safety testing for experimental microbicide candidates, the same evidentiary role sodium lauryl sulfate plays for skin-irritation patch testing.
Verified
CTOYC-5
Repeated intravaginal exposure to methylisothiazolinone (MI) — a preservative present in some commercial toy-cleaner formulations — produced persistent, mast-cell-dependent genital pain resembling vulvodynia in a mouse model, with increased vaginal mast cells/eosinophils and elevated serum IgE; described by the study authors as the first preclinical evidence linking repeated MI exposure to allergy-driven genital pain.
Verified
CTOYC-6
A documented human case of vulvar allergic contact dermatitis was caused by methylchloroisothiazolinone/methylisothiazolinone exposure via a mucosal-contact leave-on product (moist flushable wipes); confirmed by patch testing and fully resolved on discontinuation.
Verified
CTOYC-8
Cetrimide, a quaternary ammonium antiseptic closely related to benzalkonium chloride, caused a documented irritant contact dermatitis case series (18 patients, ages 2-62) concentrated in flexural and genital skin after 1-4 weeks of daily antiseptic use, resolving within 2-4 weeks of discontinuation.
Verified
CTOYC-9
No PubMed-indexed study was located directly testing sex-toy-cleaner residue exposure (as opposed to direct spermicide/antiseptic application) on vaginal or vulvar tissue, in any population, and none was located addressing sex-toy-cleaner ingredient irritation specifically in a Fitzpatrick IV-VI or Black/melanated population.
Verified
CTURM-1
A systematic review of 18 human clinical studies found early evidence that oral and topical turmeric/curcumin may benefit several dermatologic conditions, but concluded that the evidence base was limited and required further study.
Verified
CTURM-2
In a randomized placebo-controlled trial of a standardized topical curcumin gel applied to the knee, skin staining occurred and resolved two to three days after application stopped.
Verified
CTURM-3
Topically used Curcuma longa products have documented potential to cause allergic contact dermatitis; the evidence does not establish a Fitzpatrick-specific incidence rate or the safety of a raw DIY facial preparation.
Verified
CTURM-5
In an in-vitro reconstructed human epidermal tissue model (EPI-200-SIT), solid lipid nanoparticle encapsulation of curcumin and turmerone produced a significant reduction in measured skin irritation compared with non-encapsulated curcumin/turmerone; the study did not measure or report any effect on visible skin staining, and was not conducted in living human skin.
Verified
HUNT0906-1
Isobutylamido-thiazolyl-resorcinol (thiamidol), a tyrosinase inhibitor, effectively reduces post-inflammatory hyperpigmentation in suction-blister and acne-PIH models.
Verified
HUNT0906-2
A 2024 systematic review of clinical studies characterizes isobutylamido thiazolyl resorcinol (ITR) as a human-tyrosinase inhibitor.
Verified
HUNT0906-3
Topical isobutylamido thiazolyl resorcinol demonstrates efficacy and safety in melasma patients, a condition that over-indexes in Fitzpatrick IV-VI populations.
Verified
HUNT0906-4
A 2-MNG-containing serum improves skin-tone evenness and hyperpigmentation as measured by individual typology angle (ITA), a colorimetric metric relevant to darker skin.
Verified
HUNT0906-5
A 2-MNG-containing serum and sunscreen regimen improves facial dyschromia in women with skin of color.
Verified
HUNT0906-7
Mela B3, formulated with 0.5% 2-mercaptonicotinoyl glycine, is non-inferior to 4% hydroquinone for treating facial melasma.
Verified
HUNT0906-8
2-Mercaptonicotinoyl glycine prevents UV-induced skin darkening and delayed tanning in a randomized controlled clinical study.
Verified
HUNT0906-10
Paula's Choice CLINICAL Discoloration Repair Serum discloses concentrations of 3% tranexamic acid, 5% niacinamide, and 0.5% bakuchiol on its brand product page.
Verified
HUNT0906-11
Allies of Skin Tranexamic & Arbutin Advanced Brightening Serum discloses concentrations of 3% tranexamic acid and 2% alpha arbutin.
Verified
CAMIST-13
Injectable or intra-articular PDRN and polynucleotide human studies exist in esthetic medicine, knee osteoarthritis and tendon injury (CAMIST-14), but this evidence is route-specific and should not be cited to reassure a reader about topical cosmetic PDRN use.
SYNTHESIZED
Synthesized from:
  • CAMIST-14 Injected polynucleotide or PDRN has been studied in humans in three settings: esthetic medicine (a systematic review of nine low to moderate quality studies, 219 patients, reporting side effects as generally mild and transient), knee osteoarthritis (a meta-analysis of five randomized trials against hyaluronic acid, with no significant difference in adverse events, relative risk 2.15, 95% CI 0.17-26.67), and partial-thickness supraspinatus tear (17 patients, open-label, no significant adverse events leading to hospitalization). These are injected, not topical, studies and do not address topical cosmetic PDRN.
  • CAMIST-9 PDRN's mechanism (adenosine A2A receptor agonism, nucleotide salvage-pathway activation, suppression of TNF-alpha/IL-6/IL-1beta) is well-established via preclinical and injectable-clinical evidence.
CBPEEL-5
Tannin-driven astringency and mechanical friction from peel application are a plausible (not directly studied) irritant contact pathway; barrier disruption followed by UV exposure is verified to worsen pigmentation in Fitzpatrick III-IV skin (CPEEL-9). Bridging into 'banana-peel friction could worsen the hyperpigmentation it claims to treat' is a reasoned inference, not a literature finding.
SYNTHESIZED
Synthesized from:
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
CDET-10
No PubMed-indexed study was located examining detergent-residue-related or textile-related contact dermatitis specifically in a Fitzpatrick IV-VI or self-identified Black/melanated population. Adjacent patch-testing literature (not detergent-specific) reports that patch-test reactions can be difficult to interpret in higher Fitzpatrick types because of limited erythema or vesiculation (CDET-11), which suggests that detergent- or textile-related irritation could be under-recognized or misread as unrelated hyperpigmentation when evaluated with erythema-first diagnostic criteria.
SYNTHESIZED
Synthesized from:
  • C8-2 Erythema-based severity scales are validated on Fitzpatrick I-III; skin-of-color patients are systematically underdiagnosed or misclassified by tools not designed for their presentations. PMID 41262823 PMC12626340 DOI
  • CDET-11 Significant differences were found in the frequency of borderline (doubtful) patch-test reactions between Fitzpatrick skin types I/II and V/VI and across all six types (P < 0.0001) in a retrospective cohort of 1,899 comprehensively patch-tested patients in one US metropolitan area over 4 years, and patients with type V or VI had 43% lower odds of a borderline reaction. The authors' stated background is that patch-test reactions can be difficult to interpret in higher Fitzpatrick types because of limited erythema or vesiculation, and that missed reactions may prolong allergic contact dermatitis.
CDYIMASK-3
Honey's low pH, high sugar content and, in medical-grade honey, hydrogen peroxide production are described as mechanisms of antibacterial activity, demonstrated primarily in wound-care and medical-grade-honey contexts (CDYIMASK-8). This antibacterial action has not been demonstrated to make an unpreserved, multi-ingredient DIY cosmetic mixture microbiologically safe for repeated use or extended home storage; the antibacterial evidence base is wound-care and medical-grade honey.
SYNTHESIZED
Synthesized from:
  • CDYIMASK-8 Two narrative reviews attribute honey's antibacterial activity to low pH, high sugar content, hydrogen peroxide production (medical-grade honey) and methylglyoxal (Manuka honey). The settings reviewed are medical-grade honey for bacterial vaginosis (with in vitro antibacterial data; the authors state more clinical research is required) and Manuka honey in surgical and chronic wound care, not unpreserved multi-ingredient DIY cosmetic mixtures.
  • CDYIMASK-1 A challenge-test survey of 32 commercial skin/body-care cosmetic products found most samples contaminated; two products (a foaming gel and a body/face cream) failed to meet pharmacopeial (European Pharmacopeia 7.0) microbiocidal-effect standards against S. aureus. This is the contamination-risk floor for a professionally formulated, preserved product; an unpreserved home-mixed combination of honey, aloe vera, squalane, and turmeric has no equivalent testing and is expected to carry materially higher risk.
  • CDYIMASK-2 Raw materials, including natural/plant-derived ingredients, are a documented major reservoir of microbial contamination in daily chemical and cosmetic products; some contaminant bacterial lineages (Burkholderia cepacia complex, Pseudomonas aeruginosa) show tolerance to preservatives even at maximum permitted concentrations. 'Natural' ingredients are not inherently self-preserving or lower-risk.
CHFN-34
For Fitzpatrick IV-VI skin generally, cutaneous injury/irritation carries elevated postinflammatory hyperpigmentation (and lower, keloid) risk versus lighter skin; no foot-specific study located.
SYNTHESIZED
Synthesized from:
CHOCL-26
No study or manufacturer data source located this session directly measures the shelf life of a homemade (DIY electrolysis) HOCl solution in days. DIY-generator sellers' own marketing instructs users to make solution fresh/as-needed rather than store it long-term, and the general HOCl degradation mechanisms confirmed in leg 1 (CHOCL-9: light, heat, air/CO2 ingress, pH drift, metal/organic contact) apply at least as strongly to an unstabilized, unpackaged DIY batch as to a commercial product, but this is a reasoned inference bridging leg 1's degradation mechanism to the DIY context, not a directly-studied DIY-shelf-life dataset.
SYNTHESIZED

Synthesized by us. No study is claimed for this.

CKOJIC-8
No PubMed-indexed study was located evaluating kojic-acid or turmeric BAR SOAP formulations specifically for hyperpigmentation/brightening efficacy; every located positive efficacy signal for kojic acid used a leave-on cream, serum, gel, or laser-assisted delivery format, none a rinse-off soap. Soap as a cleanser class independently produces the greatest skin-surface pH rise and barrier disruption of any cleanser type tested (existing claims C27-1, C34-3), the opposite direction from the pH-controlled, extended-contact formats in which kojic acid showed measurable effect.
SYNTHESIZED
Synthesized from:
  • C27-1 Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect. DOI
  • C34-3 Soap produces the greatest barrier change and greatest pH rise among cleansers. PMID 12858234
  • CKOJIC-1 Kojic acid is a PubMed-studied topical melasma treatment among 35 RCT agents reviewed in a 2019 systematic review, but sits in the "more research needed on optimal concentration/formulation" evidence tier rather than the "strong clinical recommendation" tier earned by cysteamine, triple combination therapy, and tranexamic acid.
  • CKOJIC-2 Plain topical kojic acid applied alone shows only modest melasma improvement in trials; laser-assisted delivery (Q-switched 1064nm Nd:YAG, fractional Er:YAG) produced significantly greater improvement than kojic acid applied alone in split-face RCTs.
  • CKOJIC-4 Kojic acid's known chemical instability (oxidation/degradation) has driven reformulation into more stable derivatives (kojic dipalmitate, kojyl-3-aminopropylphosphonic acid) and novel encapsulated delivery systems (nanoemulsion, ethosomal gel), explicitly developed because plain kojic acid is less stable and penetrates skin less effectively than these alternatives.
  • CKOJIC-6 A split-face RCT (n=30, Thailand) comparing 5% alpha-arbutin + 2% kojic acid cream against gold-standard triple combination cream (hydroquinone/tretinoin/steroid) for melasma found similar efficacy on melanin index and mMASI, but significantly lower recurrence after treatment discontinuation and fewer adverse effects (erythema, stinging) with the arbutin/kojic acid cream.
CLIP-2
There is no established physiological or pharmacological addiction mechanism for lip balm. Compulsive reapplication is better explained by an irritant-response cycle (dryness/irritation leading to reapplication and further barrier disruption) than by an addictive ingredient.
SYNTHESIZED
Synthesized from:
  • CLIP-1 Lip vermilion lacks sebaceous glands, sweat glands, and hair follicles, and has a thinner, less protective stratum corneum than facial skin, contributing to greater trans-epidermal water loss and vulnerability to irritants/penetration.
  • CLIP-5 Allergic contact cheilitis is a well-documented condition caused primarily by cosmetic and personal-care product ingredients (fragrance, flavorings, preservatives, sunscreen filters, castor oil, propolis/beeswax residue), confirmed via patch testing in dermatology clinic populations.
CLIP-6
Because contact-cheilitis studies never report Fitzpatrick type, and post-inflammatory hyperpigmentation is the dominant way cutaneous inflammation resolves in Fitzpatrick IV-VI skin, an allergic or irritant lip reaction in deeply pigmented skin may present as diffuse/patchy darkening rather than the erythema these studies use as a reaction marker — plausibly under-recognized by the wearer and by clinicians, and misread as unrelated hyperpigmentation rather than a product reaction.
SYNTHESIZED
Synthesized from:
  • CLIP-5 Allergic contact cheilitis is a well-documented condition caused primarily by cosmetic and personal-care product ingredients (fragrance, flavorings, preservatives, sunscreen filters, castor oil, propolis/beeswax residue), confirmed via patch testing in dermatology clinic populations.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C8-2 Erythema-based severity scales are validated on Fitzpatrick I-III; skin-of-color patients are systematically underdiagnosed or misclassified by tools not designed for their presentations. PMID 41262823 PMC12626340 DOI
CLIPS-2
Sleeping with the mouth open (night guards, sleep-apnea appliances, nasal obstruction) moves air across the vermilion for hours and plausibly dries it, given the vermilion's absent glands and thin stratum corneum (CLIP-1) and the established effect of dry air on the stratum corneum (C25-1).
SYNTHESIZED
Synthesized from:
  • CLIP-1 Lip vermilion lacks sebaceous glands, sweat glands, and hair follicles, and has a thinner, less protective stratum corneum than facial skin, contributing to greater trans-epidermal water loss and vulnerability to irritants/penetration.
  • C25-1 Ambient humidity and temperature strongly affect the stratum corneum; colder/drier regions show markedly higher population-level dry-skin burden than warm/humid ones. PMID 42184334 PMC13200769 DOI PMID 27306376 DOI
CMASK-11
Mechanical or chemical irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin signaling that stimulates neighboring melanocytes to overproduce melanin -- the general PIH pathway. No study directly testing a peel-off (PVA) mask or an over-frequently-used clay mask for PIH outcomes was located; applying the general mechanism to these mask categories on Fitzpatrick IV-VI skin is a reasoned extrapolation, not a direct literature finding.
SYNTHESIZED
Synthesized from:
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
CPEEL-2
PPET (repeated peeling/abrasion under occlusive silicone tape) is mechanically a form of repetitive tape-stripping, the technique used to experimentally induce PIH in Fitzpatrick III-V skin (see CPEEL-9, CPEEL-10); no study tests PPET itself.
SYNTHESIZED
Synthesized from:
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-10 In an investigator-masked, randomized, intra-individual study of 20 participants with Fitzpatrick skin types IV-V, pigmentation was induced by controlled UV and visible-light exposure with or without tape stripping (mild barrier disruption), and a daily broad-spectrum sunscreen containing sclareolide and niacinamide applied for 20 days significantly prevented pigmentation: in stripped, exposed zones protected skin changed by +5.96 delta-ITA versus -9.88 delta-ITA in unprotected skin (P < 0.001), and no adverse events were reported.
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
RLIP-1
Every oil, butter and wax on the shelf is a seal step: apply over damp skin or a still-wet water-based layer, last in the routine (Prep with a non-stripping cleanse, Treat with the actives for the concern, Seal with the lipid), because an occlusive holds water and actives in rather than adding moisture.
SYNTHESIZED
Synthesized from:
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • CMIST-2 The water-transport resistance of a deposited occlusive or emulsion film can increase stratum-corneum hydration and alter permeability and TEWL; the relevant mechanism is the film left on skin.
  • C11-2 Occlusion and hydration increase how deeply/quickly topical actives penetrate skin. PMID 41610072 DOI DOI
  • C27-1 Alkaline soap raised skin pH/TEWL and produced significantly more redness in a 7-day forearm test; acidic syndet caused least damage; glycerin softened soap's effect. DOI
  • C27-3 Surfactants remove not just grease and dirt but also corneocytes, lipids, and proteins; repeated over-exposure causes irritant dermatitis. DOI
  • C34-3 Soap produces the greatest barrier change and greatest pH rise among cleansers. PMID 12858234
RLIP-2
Keep heavy or comedogenic butters and oils (coconut, cocoa, avocado, tamanu, hair oils) off the face and hairline if acne- or PIH-prone, and use them on the body and hair; prefer light linoleic-rich oils on the face. A breakout from a comedogenic oil on a PIH-prone face becomes the dark mark.
SYNTHESIZED
Synthesized from:
  • C16-4 Comedogenic cosmetics cause 'acne cosmetica'; non-comedogenic reformulation cut incidence from ~25% to under 5%. PMID 138532
  • C16-5 Cocoa butter induces microcomedones (confocal-microscopy confirmed). DOI
  • CLIPID-12 Vegetable oils higher in linoleic acid show positive barrier effects, while high-oleic, low-linoleic oils can damage an inflamed stratum corneum (review). PMID 35548366
  • C23-3 In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment. PMID 42109558 PMC13155718 DOI PMID 25227244 DOI
RLIP-3
On reactive, eczema-prone or barrier-fragile skin avoid oils that weaken the barrier (olive, other high-oleic oils); an oil-induced barrier weakening and redness is a first step toward the marks we are trying to prevent in skin that pigments after inflammation.
SYNTHESIZED
Synthesized from:
  • CLIPID-17 In a randomized trial, olive oil applied twice daily for 4 weeks significantly reduced stratum corneum integrity and induced erythema (with or without atopic-dermatitis history), while sunflower oil preserved the barrier and improved hydration. PMID 22995032
  • CLIPID-12 Vegetable oils higher in linoleic acid show positive barrier effects, while high-oleic, low-linoleic oils can damage an inflamed stratum corneum (review). PMID 35548366
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • C23-3 In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment. PMID 42109558 PMC13155718 DOI PMID 25227244 DOI
RPET-1
Slugging: apply a thin layer of petrolatum as the last step of the night routine, over (not instead of) a moisturizer, to hold overnight moisture in.
SYNTHESIZED
Synthesized from:
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • CMIST-2 The water-transport resistance of a deposited occlusive or emulsion film can increase stratum-corneum hydration and alter permeability and TEWL; the relevant mechanism is the film left on skin.
  • CTOOTH-6 Petrolatum is a well-tolerated occlusive emollient with an established safety profile, including in pediatric atopic dermatitis and neonatal skin care; it carries no comparable harm signal to toothpaste in this DIY combination and has no plausible brightening mechanism either.
RPET-2
Do not slug over retinoids or acids on the same night: let actives absorb first, or keep slugging for nights without them, and add the combination only once you know how your skin responds.
SYNTHESIZED
Synthesized from:
  • C11-2 Occlusion and hydration increase how deeply/quickly topical actives penetrate skin. PMID 41610072 DOI DOI
  • C21-3 Retinoid efficacy for photoaging is dose-dependent; irritation is concentration-dependent. PMID 37683070 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
RPET-3
Minor wound routine: rinse with water, apply a thin layer of petrolatum, cover; skip hydrogen peroxide.
SYNTHESIZED
Synthesized from:
  • C9-1 Moist wound healing accelerates re-epithelialization by approximately 50% vs air-drying (seminal study: ~2x faster). PMID 14007593 DOI PMID 36151766 PMC10030937 DOI
  • CTOOTH-6 Petrolatum is a well-tolerated occlusive emollient with an established safety profile, including in pediatric atopic dermatitis and neonatal skin care; it carries no comparable harm signal to toothpaste in this DIY combination and has no plausible brightening mechanism either.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
RPICK-1
Picking a pimple makes the PIH mark darker and longer-lasting on Fitzpatrick IV-VI skin than leaving it alone: manual extraction adds mechanical injury and bacterial exposure to the original inflammatory event, and a larger, deeper inflammatory event gives a larger pigment response.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
  • C31-2 Eczema in skin of color may appear psoriasiform, lichenoid, scaly or papular with a violaceous color, with higher prevalence of PIH than White patients. PMID 37119261 DOI
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CFITZ-1 The Fitzpatrick scale (developed 1975 by Thomas Fitzpatrick) classifies UV response, not appearance; Types I-VI run from always-burns/never-tans to never-burns/tans-deeply; higher melanin density means higher PIH risk, not more protection; product concentrations formulated/tested on Fitzpatrick I-III can inflame IV-VI skin. PMID 3377516 DOI PMID 31367171 PMC6645720 DOI PMID 21348540 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-11 In an experimental model using TCA to create standardized PIH lesions, pigmentation severity increased dose-dependently as TCA concentration rose from 20% to 30%; 30% reliably matched natural acne-PIH without causing necrosis.
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C24-1 Acne is a common cause of PIH, particularly in skin of color; resulting marks are often more distressing to patients than the acne itself. PMID 34751927 PMC8776661 DOI
  • C11-5 PIH is often chronic; improves only partially and slowly. DOI DOI
RPICK-2
Cover an active whitehead or papule with a hydrocolloid patch instead of touching it: it keeps the lesion moist and covered and removes the tactile target for picking.
SYNTHESIZED
Synthesized from:
  • C9-1 Moist wound healing accelerates re-epithelialization by approximately 50% vs air-drying (seminal study: ~2x faster). PMID 14007593 DOI PMID 36151766 PMC10030937 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
  • C31-2 Eczema in skin of color may appear psoriasiform, lichenoid, scaly or papular with a violaceous color, with higher prevalence of PIH than White patients. PMID 37119261 DOI
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
  • CFITZ-1 The Fitzpatrick scale (developed 1975 by Thomas Fitzpatrick) classifies UV response, not appearance; Types I-VI run from always-burns/never-tans to never-burns/tans-deeply; higher melanin density means higher PIH risk, not more protection; product concentrations formulated/tested on Fitzpatrick I-III can inflame IV-VI skin. PMID 3377516 DOI PMID 31367171 PMC6645720 DOI PMID 21348540 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-11 In an experimental model using TCA to create standardized PIH lesions, pigmentation severity increased dose-dependently as TCA concentration rose from 20% to 30%; 30% reliably matched natural acne-PIH without causing necrosis.
  • C24-1 Acne is a common cause of PIH, particularly in skin of color; resulting marks are often more distressing to patients than the acne itself. PMID 34751927 PMC8776661 DOI
  • C11-5 PIH is often chronic; improves only partially and slowly. DOI DOI
RPIH-1
Prevention first: because every PIH mark follows an inflammatory trigger, the two places to interrupt it are before the inflammation (avoid the trigger) and after the melanin is deposited (treat the mark); avoiding the trigger gives the most leverage because treated marks fade only partially and slowly.
SYNTHESIZED
Synthesized from:
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
  • C11-5 PIH is often chronic; improves only partially and slowly. DOI DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
  • CPIHM-1 Post-inflammatory hyperpigmentation follows any inflammatory trigger, including physical or mechanical injury: tissue injury releases prostaglandins, leukotrienes and reactive oxygen species that activate melanocytes (Nordlund & Abdel-Malek 1988). In Fitzpatrick IV-VI skin melanocytes are more reactive, so the same inflammatory signal produces more pigment. PMID 2835778
RPW-1
Post-workout sequence: rinse or cleanse promptly with cool-to-lukewarm water, apply a light barrier-supportive product (panthenol, centella, ceramides) while skin is slightly damp, hold retinoids, exfoliating acids and strong niacinamide until the skin has cooled, keep heavy occlusives for the end of the routine, and finish with sunscreen if going outdoors.
SYNTHESIZED
Synthesized from:
  • C11-2 Occlusion and hydration increase how deeply/quickly topical actives penetrate skin. PMID 41610072 DOI DOI
  • C21-3 Retinoid efficacy for photoaging is dose-dependent; irritation is concentration-dependent. PMID 37683070 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • CPAN-1 Panthenol (pro-vitamin B5) accelerates post-procedure skin barrier recovery, reduces transepidermal water loss, and improves stratum corneum moisture and barrier markers. PMC12232337 Open source PMC10772476 Open source
  • CMAD-1 Madecassoside (from Centella asiatica) has documented anti-inflammatory activity (NF-κB inhibition; reduced TNF-α, IL-6, IL-1β), antioxidant activity, and stimulates type I/III collagen synthesis via the TGF-β1 pathway; wound-healing benefit is well-established for oral/systemic use, but topical clinical evidence specifically is comparatively sparse versus the abundant in vivo/animal evidence. PMC11510310 Open source PMC8627341 Open source
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • CMIST-2 The water-transport resistance of a deposited occlusive or emulsion film can increase stratum-corneum hydration and alter permeability and TEWL; the relevant mechanism is the film left on skin.
  • CBITE-2 PIH hypermelanosis follows local skin inflammation and cytokine/growth-factor signaling between keratinocytes, melanocytes, and dermal fibroblasts; this is a unified pathway across triggers, not a bite-unique mechanism. Photoprotection is the cornerstone of PIH management generally given its photosensitive nature.
RPW-2
After a workout, apply a fragrance-free, alcohol-free lotion to high-friction, high-sweat folds (inner thighs, underarms, stomach folds) after showering to lower the inflammatory contribution of the session.
SYNTHESIZED
Synthesized from:
  • C23-1 Intertrigo is a superficial inflammatory condition of skin folds triggered by friction/moisture/heat/poor ventilation; can become secondarily infected (often Candida). PMID 30285384 PMID 21396557 DOI
  • C11-1 Chronic friction induces hyperpigmentation (frictional melanosis). PMID 36461803 DOI DOI
  • C23-2 Frictional melanosis is an acquired pigmentary disorder — brown pigmentation from repeated rubbing — recognized among frictional dermatoses, prevalent in more pigmented skin. PMID 23278271 DOI PMID 36461803 DOI
  • C23-3 In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment. PMID 42109558 PMC13155718 DOI PMID 25227244 DOI
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
RPW-3
During a workout, pat sweat from shaved or abraded areas with a clean towel rather than dragging it, to limit friction on already-irritated skin.
SYNTHESIZED
Synthesized from:
  • C11-1 Chronic friction induces hyperpigmentation (frictional melanosis). PMID 36461803 DOI DOI
  • C23-2 Frictional melanosis is an acquired pigmentary disorder — brown pigmentation from repeated rubbing — recognized among frictional dermatoses, prevalent in more pigmented skin. PMID 23278271 DOI PMID 36461803 DOI
  • C23-3 In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment. PMID 42109558 PMC13155718 DOI PMID 25227244 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
RSCALP-1
After a scalp shave, use a non-occlusive layer (a serum or light lotion) rather than a thick balm or butter, because the shaved scalp sweats, sits under hats and meets clipper blades weekly.
SYNTHESIZED
Synthesized from:
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • CMIST-2 The water-transport resistance of a deposited occlusive or emulsion film can increase stratum-corneum hydration and alter permeability and TEWL; the relevant mechanism is the film left on skin.
  • C11-2 Occlusion and hydration increase how deeply/quickly topical actives penetrate skin. PMID 41610072 DOI DOI
  • C23-1 Intertrigo is a superficial inflammatory condition of skin folds triggered by friction/moisture/heat/poor ventilation; can become secondarily infected (often Candida). PMID 30285384 PMID 21396557 DOI
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
  • CPFB-1 The core lesion of pseudofolliculitis barbae (PFB) is a foreign-body inflammatory reaction around an ingrown hair; the African hair follicle is curved, and shaving causes the hair to re-enter skin by extrafollicular (hair tip grows into skin beside its follicle) or transfollicular (cut tip retracts and pierces the follicle wall) penetration. PMID 31354326 PMID 6354618 PMID 3048823
RSCALP-2
The scalp follows the same razor-bump biology as the face: a hair cut to a sharp tip by clipper or razor curls back, re-enters the skin, is read as a foreign body, and repeated inflammation leaves PIH.
SYNTHESIZED
Synthesized from:
  • CPFB-1 The core lesion of pseudofolliculitis barbae (PFB) is a foreign-body inflammatory reaction around an ingrown hair; the African hair follicle is curved, and shaving causes the hair to re-enter skin by extrafollicular (hair tip grows into skin beside its follicle) or transfollicular (cut tip retracts and pierces the follicle wall) penetration. PMID 31354326 PMID 6354618 PMID 3048823
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • CPFB-3 Where a close shave is required, adjustable clipper guards that leave at least about 1 mm of hair are associated with fewer PFB lesions (Ogunbiyi 2019 review; Seck 2024 clipper OR 0.5). No source located specifies 0.5 mm. PMID 31354326 PMID 39099716
RSCRUB-1
Physical scrubs on Fitzpatrick IV-VI skin: abrasion that disrupts the barrier or irritates is a PIH trigger, so a scrub marketed for dark spots can add new pigment instead of lifting the old; repeated scrubbing can keep low-grade inflammation going; physical exfoliation is therefore the wrong tool for hyperpigmentation.
SYNTHESIZED
Synthesized from:
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-10 In an investigator-masked, randomized, intra-individual study of 20 participants with Fitzpatrick skin types IV-V, pigmentation was induced by controlled UV and visible-light exposure with or without tape stripping (mild barrier disruption), and a daily broad-spectrum sunscreen containing sclareolide and niacinamide applied for 20 days significantly prevented pigmentation: in stripped, exposed zones protected skin changed by +5.96 delta-ITA versus -9.88 delta-ITA in unprotected skin (P < 0.001), and no adverse events were reported.
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C11-1 Chronic friction induces hyperpigmentation (frictional melanosis). PMID 36461803 DOI DOI
  • C23-2 Frictional melanosis is an acquired pigmentary disorder — brown pigmentation from repeated rubbing — recognized among frictional dermatoses, prevalent in more pigmented skin. PMID 23278271 DOI PMID 36461803 DOI
  • C23-3 In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment. PMID 42109558 PMC13155718 DOI PMID 25227244 DOI
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
RSCRUB-2
Leaving scrubs: stop the physical scrub, let the barrier recover (page says two to three weeks), then introduce a chemical exfoliant at low concentration and low frequency, once a week to start, and step up the AHA ladder (mandelic, then lactic, then glycolic) only once the previous one is tolerated.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C21-3 Retinoid efficacy for photoaging is dose-dependent; irritation is concentration-dependent. PMID 37683070 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • CPEEL-5 Sequential in-office high-concentration glycolic acid + TCA peels produced significant melasma improvement at 12 weeks in Fitzpatrick IV-VI skin, but with irritation in 77.5%, post-peel cracking in 62.5%, transient hyperpigmentation in 12.5%, and 70% melasma recurrence by 12 weeks post-treatment; no scarring.
  • CPEEL-7 30% mandelic acid and 30% lactic acid peels were both effective and safe for periorbital hyperpigmentation; lactic acid produced significantly greater pigment reduction and satisfaction; exfoliation more common with lactic, irritation more common with mandelic.
RSCRUB-3
Where physical exfoliation still has a place: a soft washcloth with light pressure on the face, a soft brush with light pressure on the scalp before shampooing, firmer use on elbows, knees and heels.
SYNTHESIZED
Synthesized from:
  • C11-1 Chronic friction induces hyperpigmentation (frictional melanosis). PMID 36461803 DOI DOI
  • C23-2 Frictional melanosis is an acquired pigmentary disorder — brown pigmentation from repeated rubbing — recognized among frictional dermatoses, prevalent in more pigmented skin. PMID 23278271 DOI PMID 36461803 DOI
  • C23-3 In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment. PMID 42109558 PMC13155718 DOI PMID 25227244 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
RSHEA-1
Shea butter as the seal: apply water-based products and moisturizer first, shea butter last in a small (pea-sized) amount, so the occlusive layer holds in the water and actives beneath it; the same order for hair (water or leave-in first, butter to seal, the L.O.C. idea).
SYNTHESIZED
Synthesized from:
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • CMIST-2 The water-transport resistance of a deposited occlusive or emulsion film can increase stratum-corneum hydration and alter permeability and TEWL; the relevant mechanism is the film left on skin.
  • C11-2 Occlusion and hydration increase how deeply/quickly topical actives penetrate skin. PMID 41610072 DOI DOI
  • C11-1 Chronic friction induces hyperpigmentation (frictional melanosis). PMID 36461803 DOI DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • CLIPID-1 Triterpene constituents of shea butter's unsaponifiable fraction have anti-inflammatory activity. PMID 20484832
RSHEA-2
On a bald or closely cut head, shea butter after a shave, over actives and a light moisturizer, as part of a moisturizing routine in dry climates.
SYNTHESIZED
Synthesized from:
  • C25-2 Humectants (urea, glycerol) increase stratum-corneum hydration; occlusives reduce water loss by sealing the surface. PMID 24786192 DOI
  • CLIPID-1 Triterpene constituents of shea butter's unsaponifiable fraction have anti-inflammatory activity. PMID 20484832
  • CBHF-1 A review of photobiomodulation (red and near-infrared light) describes reduction of inflammation as one of its most reproducible effects, with cytochrome c oxidase and calcium ion channels as primary chromophores, secondary effects on ATP, reactive oxygen species and nitric oxide, and a biphasic dose response in which low levels of light stimulate and high levels inhibit. The reductions in inflammatory markers it cites are in cells and animal models, with wounds among the tissues listed. The review does not address scalp skin, razor bumps or Fitzpatrick IV-VI skin.
  • CBHF-2 No PubMed-indexed study was located testing red-light LED or photobiomodulation for pseudofolliculitis barbae or razor bumps. The light-based literature located for pseudofolliculitis barbae concerns laser and intense pulsed light hair reduction (for example PMIDs 20101340 and 12140474), a different intervention.
  • CLED-2 An open-label randomized trial of an at-home 660-nm red/415-nm blue LED device for mild-to-moderate inflammatory acne found significant inflammatory-lesion reduction at 4 and 8 weeks; total-lesion reduction was significant with the red/blue device but not the blue-only comparator, and there was no significant between-group difference for total, inflammatory, or noninflammatory lesion reduction.
  • CLED-4 In two randomized dose-escalation trials of LED-red light, the highest tolerated fluence was 320 J/cm2 for skin-of-color participants versus 480 J/cm2 for non-Hispanic Caucasian participants; dose-limiting events at higher fluences included blistering and prolonged erythema, while transient erythema and hyperpigmentation were mild.
RSILK-1
A silk or satin pillowcase (and a bonnet or wrap) lowers overnight friction on skin and hair and absorbs less of what was applied, so it is a reasonable low-cost supporting measure for textured hair and for friction-prone skin; it is an add-on, not a treatment, and a bonnet stays in place better than a pillowcase.
SYNTHESIZED
Synthesized from:
  • CSILK-3 A 2026 narrative review states that silk scarves and pillowcases are recommended for textured (ethnic) hair, on clinician primers and expert opinion rather than trials.
  • C11-1 Chronic friction induces hyperpigmentation (frictional melanosis). PMID 36461803 DOI DOI
  • C23-3 In richly pigmented skin, frictional/postinflammatory pigmentation is common; PIH risk requires cautious, individualized treatment. PMID 42109558 PMC13155718 DOI PMID 25227244 DOI
  • CPEEL-9 Experimentally disrupting the epidermal barrier via tape stripping before UV exposure produces significantly more pronounced, longer-lasting pigment darkening and (after UVB) more pronounced delayed erythema and PIH than intact-barrier skin, scaling with barrier-damage severity.
  • C17-4 Coily/African-type hair shows lower water sorption and distinct cuticle lipid structure vs straighter hair; fragility best attributed to knotting/crack formation rather than cross-sectional shape alone. PMID 36374002 DOI PMID 32162430 DOI PMID 30866162 DOI
  • C17-5 Coconut oil (unlike mineral or sunflower oil) penetrates the hair shaft, measurably reduces protein loss from grooming, correlates with lower Hair Breakage Index. PMID 12715094 PMID 21635848
RSPOT-1
Light patches look more obvious in summer because the surrounding skin tans while the hypopigmented patches (reduced melanin, normal melanocyte count) stay put, so daily sunscreen on and around them may narrow the contrast; no study of seasonal contrast or sunscreen effect in PMH or tinea versicolor was located.
SYNTHESIZED
Synthesized from:
  • CSPOT-5 In PMH, KOH examinations are negative; the back is the most common site (also abdomen); mean age of onset ~21 years; lesional melanocyte counts (S-100) do not differ from perilesional skin — the hypopigmentation is reduced melanin, not fewer melanocytes.
  • CFITZ-1 The Fitzpatrick scale (developed 1975 by Thomas Fitzpatrick) classifies UV response, not appearance; Types I-VI run from always-burns/never-tans to never-burns/tans-deeply; higher melanin density means higher PIH risk, not more protection; product concentrations formulated/tested on Fitzpatrick I-III can inflame IV-VI skin. PMID 3377516 DOI PMID 31367171 PMC6645720 DOI PMID 21348540 DOI
RSPOT-2
Light patches limited to the face are less typical of progressive macular hypomelanosis (trunk-predominant, rarely neck/head) than patches on chest, back or abdomen; this is a pointer for the clinician conversation, not a way to clear a spot.
SYNTHESIZED
Synthesized from:
  • CSPOT-2 Treatment of choice for PMH is 1% clindamycin lotion by day, 5% benzoyl peroxide gel at night, plus UVA irradiation three times weekly for 12 weeks. PMH lesions show red follicular fluorescence under Wood's light that is absent in normal skin; Propionibacterium (Cutibacterium) acnes is cultured from lesional follicles and not from normal follicles. Distribution is the trunk, often confluent around the midline, rarely extending to proximal extremities and neck/head.
  • CSPOT-5 In PMH, KOH examinations are negative; the back is the most common site (also abdomen); mean age of onset ~21 years; lesional melanocyte counts (S-100) do not differ from perilesional skin — the hypopigmentation is reduced melanin, not fewer melanocytes.
  • CSPOT-4 Coral-red perifollicular fluorescence under Wood's lamp is characteristic of PMH (present extralesionally on the back even in extra-truncal presentations); one biopsy-confirmed case showed complete response to antimicrobial therapy plus sun exposure.
RSPOT-3
Avoiding scrubbing, hot water and harsh actives on light patches is a low-risk precaution because irritation can trigger pigment change on skin of color; no PMH- or tinea-versicolor-specific study.
SYNTHESIZED
Synthesized from:
  • C21-6 On skin of color, irritation itself can trigger PIH; clinical approach is to start low and titrate up. PMID 15113286 DOI PMID 35720053 PMC9165627 DOI
  • C24-2 In skin of color, acne treatment must balance efficacy against irritation, because irritation itself triggers PIH; treat early, titrate gently. PMID 35720053 PMC9165627 DOI PMID 20725554 PMC2921758
  • CPEEL-12 Injury or irritation to keratinocytes (from a peel, tape, or other insult) triggers inflammatory cytokine/interleukin release that stimulates neighboring melanocytes to produce more melanin — the general pathway connecting irritation of any kind to increased pigment.
RSPOT-4
Repigmentation of PMH is a months-scale process; a two-week lack of change is not treatment failure. Extrapolated from 12-week regimens and 13-24-month follow-up.
SYNTHESIZED
Synthesized from:
  • CSPOT-2 Treatment of choice for PMH is 1% clindamycin lotion by day, 5% benzoyl peroxide gel at night, plus UVA irradiation three times weekly for 12 weeks. PMH lesions show red follicular fluorescence under Wood's light that is absent in normal skin; Propionibacterium (Cutibacterium) acnes is cultured from lesional follicles and not from normal follicles. Distribution is the trunk, often confluent around the midline, rarely extending to proximal extremities and neck/head.
  • CSPOT-6 Narrowband UVB therapy produced >90% repigmentation in 56.2% (9/16) of PMH patients and ≥50% repigmentation in 81.3%, with excellent color match and no recurrence in 68.7% at ~13 months (uncontrolled, non-blinded prospective study).
  • CSPOT-7 In a 108-patient retrospective PMH series, 38% treated with topical antimicrobials and 90% treated with phototherapy achieved remission; after 2 years, relapse occurred only in the phototherapy group; 23% of untreated patients recovered spontaneously. Authors suggest combining antimicrobials with NB-UVB to hasten recovery and minimize relapse.
RSPOT-5
Because PMH is frequently misdiagnosed as a fungal condition and the two fluoresce and test differently, asking for a Wood's lamp and KOH examination is a reasonable way to prompt a differential; no study measures the effect of asking.
SYNTHESIZED
Synthesized from:
  • CSPOT-1 Progressive macular hypomelanosis (PMH) is frequently misdiagnosed and treated inadequately with antifungals or topical steroids; it is common, particularly in Fitzpatrick skin types IV–VI.
  • CSPOT-2 Treatment of choice for PMH is 1% clindamycin lotion by day, 5% benzoyl peroxide gel at night, plus UVA irradiation three times weekly for 12 weeks. PMH lesions show red follicular fluorescence under Wood's light that is absent in normal skin; Propionibacterium (Cutibacterium) acnes is cultured from lesional follicles and not from normal follicles. Distribution is the trunk, often confluent around the midline, rarely extending to proximal extremities and neck/head.
  • CSPOT-4 Coral-red perifollicular fluorescence under Wood's lamp is characteristic of PMH (present extralesionally on the back even in extra-truncal presentations); one biopsy-confirmed case showed complete response to antimicrobial therapy plus sun exposure.
  • CSPOT-5 In PMH, KOH examinations are negative; the back is the most common site (also abdomen); mean age of onset ~21 years; lesional melanocyte counts (S-100) do not differ from perilesional skin — the hypopigmentation is reduced melanin, not fewer melanocytes.
  • CSPOT-9 A Wood's lamp (340–450 nm, max 365 nm) aids diagnosis of dermatoses with characteristic fluorescence, including tinea capitis, erythrasma, tinea versicolor, Pseudomonas infections, porphyrias, and pigmentary alterations.
RSUN-1
Fresh-shave sunscreen choice: after shaving the head or face, a chemical (non-mineral) sunscreen is the lower-friction choice, because applying a particulate mineral film over just-shaved skin adds mechanical rubbing to an already irritated surface, and irritation-driven inflammation is what becomes a dark mark on Fitzpatrick IV-VI.
SYNTHESIZED
Synthesized from:
  • C8-3 The core PIH mechanism (melanocytes overproduce pigment in response to inflammation on elevated-melanin-density skin). PMID 21348540 DOI
  • C11-1 Chronic friction induces hyperpigmentation (frictional melanosis). PMID 36461803 DOI DOI
  • C7-2 With-the-grain shaving and single-blade/foil razors are the standard mechanism-based recommendation for PFB; direct comparative clinical evidence is limited and partly mixed — a consistent regimen with pre/post-shave care may matter as much as blade count. PMID 27212468 DOI

Doctor Djeli is an educational resource. She reads, she explains, she refers. She does not diagnose — for that, see a clinician.